data_6jpd_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6jpd _Structure_validation_residue.Date_analyzed 2020-10-30 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.74 127.9 19.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.65 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.29 128.95 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' B' ' 4' ' ' ASN . 61.3 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.91 47.37 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.593 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.94 137.68 56.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.657 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.613 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 10' ' ' ILE . 93.1 mt -125.21 126.53 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.591 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.3 1.38 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -77.66 144.52 37.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 61.96 27.75 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.78 85.74 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.28 153.09 43.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.555 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.417 ' HB3' HD12 ' B' ' 16' ' ' LEU . 55.6 tp -144.83 124.7 13.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.84 124.26 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.49 161.85 73.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.426 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.8 Cg_endo -77.28 112.02 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.985 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.05 146.54 52.51 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.885 2.39 . . . . 0.0 112.031 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.62 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -141.83 127.89 19.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.627 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.3 128.91 50.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.618 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 4' ' ' ASN . 61.1 t30 -104.71 -57.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.766 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.95 -177.08 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.625 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 96.8 p -87.04 174.97 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.599 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.95 47.32 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.653 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.93 137.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.58 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.61 127.58 27.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.431 HD11 HG21 ' B' ' 10' ' ' ILE . 92.8 mt -125.24 126.49 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.645 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.29 1.37 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.67 144.5 37.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.644 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.96 27.7 16.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.69 85.69 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.646 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.21 153.05 43.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.567 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' A' ' 16' ' ' LEU . 55.9 tp -144.83 124.68 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.89 124.22 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.365 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.41 161.85 73.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.426 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.23 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.876 2.384 . . . . 0.0 111.945 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.02 146.63 52.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.834 2.356 . . . . 0.0 112.059 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.547 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.76 127.91 19.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.32 128.94 50.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.592 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' D' ' 4' ' ' ASN . 61.2 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.1 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.633 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.99 47.32 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.602 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.92 137.66 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.613 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.431 HG21 HD11 ' C' ' 10' ' ' ILE . 92.9 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.619 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.62 131.3 1.37 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.62 144.53 37.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.773 0.321 . . . . 0.0 110.672 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.94 27.72 16.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.526 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.79 85.78 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.592 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.7 m -70.26 153.12 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' B' ' 16' ' ' LEU . 55.7 tp -144.94 124.65 13.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.79 124.2 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.38 161.83 73.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.478 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.0 Cg_endo -77.31 111.99 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.955 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.96 146.51 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.581 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.81 127.91 19.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.595 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.33 128.97 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' C' ' 4' ' ' ASN . 61.2 t30 -104.74 -57.66 2.0 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.645 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p -86.99 174.92 8.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.64 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.96 47.29 12.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.626 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 137.76 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.603 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.64 127.64 27.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' ILE . . . . . 0.43 HG21 HD11 ' D' ' 10' ' ' ILE . 92.6 mt -125.24 126.5 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.34 1.38 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.78 144.58 37.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.621 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.97 27.71 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.72 85.74 7.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.1 m -70.25 153.07 43.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' C' ' 16' ' ' LEU . 55.9 tp -144.87 124.69 13.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.88 124.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.338 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.44 161.85 73.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.426 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.1 Cg_endo -77.25 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.806 2.338 . . . . 0.0 111.95 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.96 146.61 53.21 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.385 . . . . 0.0 112.081 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.57 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.8 127.93 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.613 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -123.39 129.02 50.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' D' ' 4' ' ' ASN . 61.2 t30 -104.8 -57.56 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.03 -177.07 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.62 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -87.01 174.89 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.606 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.98 47.34 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.64 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.91 137.64 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.59 27.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.565 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.431 HG21 HD11 ' E' ' 10' ' ' ILE . 93.1 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.619 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.61 131.27 1.37 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.64 144.5 37.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.95 27.74 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.75 85.81 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.23 153.09 43.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' D' ' 16' ' ' LEU . 55.7 tp -144.94 124.69 13.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.17 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.44 161.87 73.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.42 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.24 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.771 2.314 . . . . 0.0 112.034 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.95 146.53 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.063 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.536 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.5 HD13 HD22 ' B' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' B' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.5 HD22 HD13 ' A' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.5 HD13 HD22 ' C' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' A' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.502 ' HB3' ' HD2' ' B' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' B' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' ASN . . . . . 0.5 HD22 HD13 ' B' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.5 HD13 HD22 ' D' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' D' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' C' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' C' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.5 HD22 HD13 ' C' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' ILE . . . . . 0.5 HD13 HD22 ' E' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' C' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' ALA . . . . . 0.502 ' HB3' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . 0.5 HD22 HD13 ' D' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . 0.407 HD11 ' HB3' ' D' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' E' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' E' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.46 136.45 49.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.65 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -131.96 131.08 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.588 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.07 -55.49 2.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.42 -171.51 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.2 p -91.61 179.37 5.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.2 58.81 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.66 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.44 150.93 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.54 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.76 116.44 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.633 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.3 mt -125.07 125.08 68.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.61 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.57 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.86 0.362 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.71 16.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.95 84.59 7.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.573 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.76 153.56 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.411 ' HB3' HD11 ' B' ' 16' ' ' LEU . 54.3 tp -145.38 124.61 12.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.458 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.39 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.353 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.48 161.94 72.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.358 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.24 111.96 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 111.989 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.45 148.26 53.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.386 . . . . 0.0 112.054 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.55 179.9 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -129.49 136.49 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.597 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -132.05 131.06 42.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.545 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.705 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.35 -171.5 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.654 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 91.7 p -91.67 179.44 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.607 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.19 58.72 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.34 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.594 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.75 116.5 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.6 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.14 125.14 68.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.539 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.96 131.58 1.52 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.51 145.54 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.615 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.74 16.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.534 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.62 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.653 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.57 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' C' ' 16' ' ' LEU . 54.6 tp -145.35 124.59 12.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.508 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.82 124.33 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.435 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.48 161.97 72.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.399 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.95 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 112.01 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.48 148.25 53.79 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.91 2.407 . . . . 0.0 112.1 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.555 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -131.99 131.12 42.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.592 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -102.16 -55.41 2.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.692 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.3 -171.41 3.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.674 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 91.8 p -91.72 179.38 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.643 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 58.22 58.82 3.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.597 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.38 151.01 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.595 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.82 116.4 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.661 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.02 125.06 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.693 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.56 34.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.1 26.64 16.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.494 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.68 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.5 43.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.585 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' B' ' 16' ' ' LEU . 54.4 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 70.4 t -113.85 124.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.366 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.47 162.02 72.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.432 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.28 111.99 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 111.989 -176.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.54 148.27 53.47 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.835 2.356 . . . . 0.0 112.018 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.654 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -129.55 136.5 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -132.01 131.02 42.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.44 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.712 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -171.52 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.654 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.3 p -91.59 179.33 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.693 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.25 58.72 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.692 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.37 150.96 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.571 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.77 116.46 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 91.2 mt -125.03 125.07 68.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.56 1.51 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 26.75 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.556 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.97 84.59 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.7 153.53 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' E' ' 16' ' ' LEU . 54.2 tp -145.34 124.64 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.48 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.35 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.38 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.49 162.06 72.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.28 111.94 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 112.017 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.49 148.29 53.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.843 2.362 . . . . 0.0 112.089 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.576 180.0 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -132.0 131.06 42.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.551 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.705 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.33 -171.47 3.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.648 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 91.5 p -91.71 179.4 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 58.3 58.67 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.31 150.96 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.78 116.45 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.08 125.13 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.619 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.5 34.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.611 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.12 26.66 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.507 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.99 84.68 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.57 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.72 153.5 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.575 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' D' ' 16' ' ' LEU . 54.5 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.89 124.35 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.4 162.06 72.41 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.432 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.33 112.01 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.786 2.324 . . . . 0.0 112.017 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.59 148.32 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.869 2.379 . . . . 0.0 111.992 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.638 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.1 129.66 21.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.543 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.421 ' HB3' HG21 ' A' ' 8' ' ' VAL . 81.2 m-20 -128.39 129.57 46.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.606 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.84 -170.92 3.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.6 p -91.02 178.62 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 57.62 58.23 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.592 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' A' ' 3' ' ' ASN . 18.0 m -127.53 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.612 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.18 124.68 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.78 145.75 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 110.544 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.69 27.25 16.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.631 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -87.21 85.16 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.678 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.07 153.45 43.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.581 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.413 ' HB3' HD12 ' B' ' 16' ' ' LEU . 54.3 tp -145.45 124.71 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.59 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.6 t -113.83 124.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.53 161.98 72.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.1 Cg_endo -77.3 111.94 3.28 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.78 2.32 . . . . 0.0 111.96 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.0 146.59 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.067 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.592 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -142.05 129.62 21.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.589 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.422 ' HB3' HG21 ' B' ' 8' ' ' VAL . 81.0 m-20 -128.36 129.49 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.653 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.673 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -171.0 3.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 93.7 p -90.91 178.61 5.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 57.6 58.28 3.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' B' ' 3' ' ' ASN . 18.0 m -127.56 151.73 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.478 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 91.0 mt -123.18 124.69 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.7 27.25 16.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.23 85.18 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.04 153.42 43.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 16' ' ' LEU . 54.3 tp -145.48 124.72 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.514 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.22 111.88 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.004 -176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.94 146.59 53.28 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.817 2.345 . . . . 0.0 112.097 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.556 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.07 129.71 21.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' ASN . . . . . 0.421 ' HB3' HG21 ' C' ' 8' ' ' VAL . 81.1 m-20 -128.4 129.53 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.624 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.18 -55.27 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.682 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.622 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 93.5 p -90.98 178.61 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.545 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 57.61 58.28 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.58 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' C' ' 3' ' ' ASN . 17.9 m -127.49 151.69 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.545 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.58 114.95 4.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 90.9 mt -123.16 124.67 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.514 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.77 27.16 16.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.651 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.24 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.9 m -70.07 153.43 43.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . 0.414 ' HB3' HD12 ' D' ' 16' ' ' LEU . 54.4 tp -145.48 124.68 12.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.17 111.87 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.33 . . . . 0.0 112.048 -176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.98 146.59 53.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.097 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.568 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.1 129.71 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.524 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.421 ' HB3' HG21 ' D' ' 8' ' ' VAL . 81.1 m-20 -128.34 129.64 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.18 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.82 -170.9 3.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 93.9 p -90.99 178.61 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 57.58 58.27 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.642 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' D' ' 3' ' ' ASN . 18.0 m -127.54 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.57 114.97 4.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.536 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.16 124.62 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.8 145.75 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.513 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.81 27.12 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.648 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.22 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.566 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.08 153.41 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' C' ' 16' ' ' LEU . 54.4 tp -145.43 124.74 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.591 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.27 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' ALA . . . . . 0.514 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.54 161.99 72.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.409 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.21 111.87 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.783 2.322 . . . . 0.0 112.048 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.02 146.62 52.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.773 2.316 . . . . 0.0 112.046 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.568 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.06 129.68 21.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.568 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . 0.421 ' HB3' HG21 ' E' ' 8' ' ' VAL . 81.0 m-20 -128.4 129.59 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.568 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.16 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.91 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.622 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p -90.92 178.59 5.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.632 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 57.58 58.23 3.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' E' ' 3' ' ' ASN . 18.0 m -127.47 151.78 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.64 114.97 4.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.2 124.66 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.0 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.65 145.67 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.584 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.77 27.15 16.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.628 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.18 85.1 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -69.99 153.42 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.58 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' D' ' 16' ' ' LEU . 54.3 tp -145.46 124.74 12.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.591 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.5 162.0 72.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.87 3.27 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 112.013 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.95 146.56 53.14 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.126 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.596 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.05 131.6 50.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.46 128.4 49.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.543 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.73 -59.39 1.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.72 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.8 -177.39 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.675 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.9 p -84.55 173.99 10.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.49 42.96 16.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.2 134.3 65.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.521 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -143.96 140.22 29.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.568 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 1' ' ' VAL . 88.0 mt -127.57 122.11 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.599 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.89 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.29 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.73 25.65 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.56 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.94 7.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.614 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -70.25 153.13 43.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD13 ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.509 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -114.35 123.59 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . . . -76.39 161.59 74.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 57.1 Cg_endo -79.84 111.65 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.767 2.312 . . . . 0.0 112.01 -175.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' B' ' 20' ' ' PRO . 31.3 Cg_exo -60.69 142.3 97.41 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.909 2.406 . . . . 0.0 112.015 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.616 179.711 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' B' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -126.96 131.56 51.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.45 128.34 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.66 -59.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.84 -177.44 5.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 97.0 p -84.55 174.1 10.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 59.37 43.05 17.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.624 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.2 134.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.541 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.0 140.17 29.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.571 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' B' ' 1' ' ' VAL . 88.3 mt -127.57 122.04 58.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.577 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.48 132.87 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.14 147.21 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 110.63 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.87 25.53 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.552 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.1 85.94 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.652 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.1 m -70.18 153.08 43.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.587 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 16' ' ' LEU . 53.9 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.461 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -114.32 123.56 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.358 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.59 74.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' B' ' 18' ' ' ALA . 57.2 Cg_endo -79.82 111.58 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.836 2.358 . . . . 0.0 112.007 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 31.3 Cg_exo -60.66 142.32 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.665 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' C' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -127.02 131.66 50.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.609 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -123.46 128.36 49.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.605 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.67 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.679 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.86 -177.39 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 96.4 p -84.55 174.01 10.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.604 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.39 43.03 17.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.65 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.18 134.26 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.567 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.9 140.2 29.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.598 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' C' ' 1' ' ' VAL . 88.0 mt -127.55 122.11 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.92 2.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.24 32.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.83 25.56 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.552 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.15 85.99 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.634 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.21 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.52 12.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.471 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 69.5 t -114.3 123.51 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.371 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.59 74.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' C' ' 18' ' ' ALA . 57.3 Cg_endo -79.75 111.64 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' B' ' 20' ' ' PRO . 31.3 Cg_exo -60.74 142.33 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.834 2.356 . . . . 0.0 112.06 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.552 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.589 179.731 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 1' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' D' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -126.95 131.63 51.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -123.51 128.29 49.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -103.62 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.82 -177.4 5.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.683 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 96.4 p -84.57 174.06 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.599 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.43 42.97 17.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.625 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 57.2 t -128.11 134.2 65.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.629 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.91 140.19 29.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.605 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' D' ' 1' ' ' VAL . 88.0 mt -127.58 122.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.623 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.56 132.9 2.08 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.26 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.78 25.61 15.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.96 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.624 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.23 153.07 43.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD13 ' E' ' 16' ' ' LEU . 54.2 tp -145.19 124.49 13.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.522 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -114.35 123.62 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.342 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' ALA . . . . . 0.48 ' HB3' ' HD2' ' D' ' 19' ' ' PRO . . . -76.41 161.65 73.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' D' ' 18' ' ' ALA . 57.2 Cg_endo -79.83 111.57 2.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.807 2.338 . . . . 0.0 111.969 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' C' ' 20' ' ' PRO . 31.2 Cg_exo -60.66 142.28 97.4 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.623 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 1' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' E' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -127.02 131.55 50.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.63 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -123.45 128.35 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.616 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.64 -59.36 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.758 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.85 -177.38 5.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.648 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 96.5 p -84.56 174.03 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.595 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 59.39 43.08 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.611 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.21 134.25 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.592 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.92 140.17 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.655 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' E' ' 1' ' ' VAL . 87.9 mt -127.49 122.05 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.52 132.93 2.09 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.22 32.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 110.684 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.82 25.61 15.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.579 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -85.24 85.95 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.57 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.2 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.548 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' D' ' 16' ' ' LEU . 54.2 tp -145.28 124.41 12.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.1 t -114.32 123.59 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.344 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' E' ' 19' ' ' PRO . . . -76.35 161.65 74.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.416 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' E' ' 18' ' ' ALA . 57.2 Cg_endo -79.9 111.61 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.763 2.309 . . . . 0.0 111.976 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' D' ' 20' ' ' PRO . 31.2 Cg_exo -60.69 142.31 97.44 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.609 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.426 ' HA ' HD13 ' A' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.21 131.93 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.19 129.55 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.7 -58.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.643 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.12 3.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.734 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.94 176.65 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.0 47.67 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.1 t -128.44 136.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.566 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.94 128.32 30.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 1' ' ' VAL . 93.8 mt -125.03 121.11 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.33 1.12 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.98 146.32 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.841 0.353 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.56 27.05 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.549 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.26 80.51 8.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.618 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.01 114.65 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.11 53.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.573 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.68 124.93 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.504 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -73.71 162.34 74.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.404 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -78.59 111.76 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.806 2.337 . . . . 0.0 111.895 -175.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.33 147.8 53.75 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.742 2.295 . . . . 0.0 112.105 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.6 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' VAL . . . . . 0.425 ' HA ' HD13 ' B' ' 10' ' ' ILE . 22.6 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -126.19 129.49 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.66 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.682 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.75 -173.19 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.752 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.92 176.67 6.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.08 47.63 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.524 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.42 136.02 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.561 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' B' ' 1' ' ' VAL . 93.6 mt -124.93 121.09 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 177.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.5 127.29 1.12 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.9 146.29 33.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.572 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.54 27.07 16.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.592 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.35 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.4 m -67.06 114.74 6.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.17 53.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.551 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.79 124.93 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -73.69 162.41 74.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.5 Cg_endo -78.63 111.76 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.871 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.37 147.79 53.46 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.802 2.335 . . . . 0.0 112.068 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.582 179.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.426 ' HA ' HD13 ' C' ' 10' ' ' ILE . 22.2 t . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.23 131.93 50.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.585 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -126.17 129.49 49.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.548 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.69 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.605 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.24 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.753 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p -90.82 176.63 6.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.02 47.68 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.48 136.05 60.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.97 128.23 30.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.536 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' C' ' 1' ' ' VAL . 93.9 mt -125.06 121.18 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.547 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.56 127.24 1.11 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.79 146.24 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 61.55 27.07 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.613 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.33 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.618 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.04 114.65 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.621 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.25 127.1 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -109.82 124.94 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' ALA . . . . . 0.505 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -73.69 162.36 74.52 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.447 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . 0.505 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.5 Cg_endo -78.57 111.71 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.798 2.332 . . . . 0.0 111.957 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.29 147.74 53.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.772 2.315 . . . . 0.0 112.105 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.652 179.867 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 1' ' ' VAL . . . . . 0.425 ' HA ' HD13 ' D' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.19 129.51 49.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.68 -58.67 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.679 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.85 -173.2 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.87 176.68 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.543 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.02 47.71 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.566 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -128.5 135.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.543 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -135.92 128.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.566 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' D' ' 1' ' ' VAL . 94.0 mt -125.01 121.23 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.518 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.57 127.22 1.11 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.83 146.31 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.53 27.12 16.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.57 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.42 80.52 8.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.554 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -67.0 114.68 5.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.598 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.14 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -109.71 124.91 66.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' ALA . . . . . 0.504 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -73.75 162.4 74.32 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.5 Cg_endo -78.59 111.79 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.828 2.352 . . . . 0.0 111.933 -175.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.43 147.79 53.14 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.759 2.306 . . . . 0.0 112.029 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.644 179.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 1' ' ' VAL . . . . . 0.426 ' HA ' HD13 ' E' ' 10' ' ' ILE . 22.4 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -127.26 131.87 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.617 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.17 129.49 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.523 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.63 -58.64 1.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.8 -173.19 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 92.1 p -90.92 176.7 6.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.543 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.05 47.63 11.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.524 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 61.7 t -128.44 136.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.517 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.487 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' E' ' 1' ' ' VAL . 93.6 mt -124.95 121.11 60.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.25 1.11 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.81 146.31 33.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.574 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.51 27.07 16.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.592 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.37 80.6 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.58 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 73.5 m -67.07 114.75 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.548 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.18 53.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.485 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.74 124.93 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.423 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' ALA . . . . . 0.505 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -73.58 162.33 74.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' PRO . . . . . 0.505 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -78.63 111.82 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.843 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.42 147.71 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.049 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.618 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' B' ' 1' ' ' VAL . 10.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.631 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -125.69 151.37 46.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.621 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.53 -56.74 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.704 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.81 -175.96 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.6 p -88.49 174.12 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.562 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 58.99 45.5 14.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.9 140.04 49.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.569 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -149.01 138.75 21.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.635 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.19 124.26 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 136.5 2.89 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.56 31.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.623 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.95 25.34 15.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.548 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.21 85.42 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.628 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.05 153.14 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD11 ' B' ' 16' ' ' LEU . 54.9 tp -144.87 124.62 13.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.542 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.23 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.338 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . . . -76.36 161.8 73.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.441 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 56.2 Cg_endo -77.88 111.97 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.71 2.273 . . . . 0.0 112.0 -176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.1 147.07 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.874 2.383 . . . . 0.0 112.1 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.566 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 10.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -125.72 151.33 46.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.527 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.51 -56.75 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.97 4.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.633 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 93.4 p -88.47 174.17 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.618 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.97 139.97 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.02 138.8 21.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 98.4 mt -127.2 124.21 63.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.41 2.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.54 31.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 61.98 25.37 15.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.548 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.2 85.35 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.609 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -69.96 153.1 43.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.581 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 16' ' ' LEU . 54.4 tp -144.9 124.7 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.483 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.81 124.14 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' B' ' 19' ' ' PRO . . . -76.32 161.75 73.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.441 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.78 112.01 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.04 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.13 147.11 47.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.874 2.383 . . . . 0.0 112.022 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.576 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' D' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -142.89 162.27 35.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.57 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -125.76 151.33 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.527 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.52 -56.73 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.727 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.72 -175.95 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.632 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 93.5 p -88.53 174.11 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.91 45.56 14.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.639 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.9 140.02 49.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.09 138.75 21.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.17 124.23 63.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.97 136.41 2.86 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.91 147.54 31.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.598 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.92 25.44 15.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.497 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.26 85.37 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.602 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.98 153.06 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.594 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' B' ' 16' ' ' LEU . 54.5 tp -144.84 124.71 13.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.453 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.9 t -113.82 124.19 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.35 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' ALA . . . . . 0.5 ' HB3' ' HD2' ' C' ' 19' ' ' PRO . . . -76.37 161.72 73.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.402 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' C' ' 18' ' ' ALA . 56.4 Cg_endo -77.78 111.97 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.791 2.328 . . . . 0.0 111.972 -176.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.16 147.1 47.53 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.057 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.572 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 1' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' C' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.82 162.24 35.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.609 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -125.76 151.32 46.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.537 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.5 -56.75 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.95 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.608 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.617 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.88 140.04 49.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.572 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.07 138.76 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.603 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.17 124.24 63.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.65 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.95 136.44 2.87 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.98 147.55 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.0 110.599 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.529 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.17 85.3 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.658 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.94 153.11 43.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD11 ' E' ' 16' ' ' LEU . 54.6 tp -144.91 124.67 13.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.83 124.22 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' ALA . . . . . 0.5 ' HB3' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.72 73.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 112.02 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.005 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.14 147.09 47.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.863 2.375 . . . . 0.0 111.993 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.561 179.877 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 1' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' D' ' 1' ' ' VAL . 10.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.82 162.27 35.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.653 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -125.74 151.28 46.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.51 -56.7 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.7 -175.96 4.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.624 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.92 45.62 14.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.95 140.04 49.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.516 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.1 138.84 21.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 98.4 mt -127.2 124.3 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.0 136.45 2.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.94 147.52 31.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.529 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.14 85.35 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.02 153.17 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' D' ' 16' ' ' LEU . 54.7 tp -144.92 124.63 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.525 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.85 124.21 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.303 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' ALA . . . . . 0.5 ' HB3' ' HD2' ' E' ' 19' ' ' PRO . . . -76.33 161.72 73.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.4 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -77.76 111.96 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.785 2.323 . . . . 0.0 112.035 -176.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.13 147.16 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.04 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.586 179.88 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.75 122.12 32.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.652 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.546 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.86 -59.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.707 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.75 -171.42 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.66 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.79 171.86 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.87 45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.577 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.494 HG11 ' H ' ' B' ' 8' ' ' VAL . 32.5 m -135.95 155.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.585 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.49 19.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.23 125.86 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.617 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.48 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.26 147.25 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.663 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.89 26.12 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.54 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.31 84.79 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.29 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.56 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD12 ' B' ' 16' ' ' LEU . 55.0 tp -144.92 124.65 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.466 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.78 124.28 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.353 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . . . -76.43 161.79 73.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.443 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.07 112.02 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.787 2.325 . . . . 0.0 111.99 -176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.92 147.66 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.832 2.355 . . . . 0.0 112.107 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.65 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.77 122.16 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.557 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.546 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.84 -59.68 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.78 -171.39 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.601 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.78 171.83 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.588 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.83 45.43 12.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.494 ' H ' HG11 ' A' ' 8' ' ' VAL . 32.5 m -135.91 155.89 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -156.21 144.45 19.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.609 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.25 125.88 57.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.36 147.29 31.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.629 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.88 26.15 15.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.528 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.71 7.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.569 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.68 153.31 43.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 16' ' ' LEU . 54.8 tp -144.92 124.68 13.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.32 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.83 73.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.429 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' B' ' 18' ' ' ALA . 55.8 Cg_endo -77.09 112.08 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.747 2.298 . . . . 0.0 111.99 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.615 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -127.74 122.13 32.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.569 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.93 -59.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.668 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.82 -171.42 3.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.77 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.89 45.4 12.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.605 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' VAL . . . . . 0.495 HG11 ' H ' ' D' ' 8' ' ' VAL . 32.6 m -135.89 155.92 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.607 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.18 144.57 19.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.545 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 92.6 mt -131.32 125.79 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.41 136.51 2.68 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.25 147.25 31.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.322 . . . . 0.0 110.663 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.86 26.1 15.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.568 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -86.23 84.78 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.72 153.32 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . 0.404 HD12 ' HB3' ' B' ' 16' ' ' LEU . 54.8 tp -144.96 124.67 13.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.436 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.6 t -113.79 124.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.369 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' C' ' 19' ' ' PRO . . . -76.42 161.85 73.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.415 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.09 112.03 3.33 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.843 2.362 . . . . 0.0 111.984 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 147.75 55.34 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.316 . . . . 0.0 112.095 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.62 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.79 122.17 32.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.635 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.58 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.86 -59.61 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.708 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.79 -171.39 3.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.583 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.83 171.83 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.589 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.82 45.41 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.652 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' VAL . . . . . 0.495 ' H ' HG11 ' C' ' 8' ' ' VAL . 32.5 m -135.87 155.82 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.641 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.55 20.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.621 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.32 125.9 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.556 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.33 147.28 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.323 . . . . 0.0 110.609 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 61.84 26.18 15.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.81 7.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.32 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.584 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD12 ' E' ' 16' ' ' LEU . 54.7 tp -144.97 124.66 13.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.426 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.78 124.29 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.299 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' D' ' 19' ' ' PRO . . . -76.51 161.86 72.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.446 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' D' ' 18' ' ' ALA . 55.9 Cg_endo -77.02 111.99 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.791 2.327 . . . . 0.0 112.007 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.97 147.74 55.71 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.787 2.325 . . . . 0.0 112.039 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.563 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.8 122.16 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.589 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.02 56.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.554 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.89 -59.64 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.682 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.73 -171.39 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.668 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 80.3 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.57 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.92 45.43 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.591 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . 0.493 ' H ' HG11 ' D' ' 8' ' ' VAL . 32.6 m -135.96 155.86 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.21 144.54 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -131.25 125.84 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.588 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.39 136.49 2.67 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.34 147.24 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.94 26.07 15.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -86.23 84.8 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.77 153.28 43.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' D' ' 16' ' ' LEU . 54.8 tp -144.89 124.61 13.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.453 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.76 124.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.334 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' E' ' 19' ' ' PRO . . . -76.46 161.83 73.15 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.429 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' E' ' 18' ' ' ALA . 55.8 Cg_endo -77.03 112.03 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.0 111.991 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.598 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.15 161.42 38.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -131.94 155.18 48.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.5 3.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.62 -171.34 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.568 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.6 p -95.06 -178.68 4.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.639 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.11 55.39 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.667 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.7 m -130.13 153.94 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.682 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.19 130.63 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.653 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.68 124.48 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.15 131.77 1.6 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.61 145.7 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.33 28.48 17.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.526 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.1 83.29 7.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.4 m -70.09 114.12 7.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.566 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.85 127.39 53.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.56 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.73 125.38 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.384 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -74.41 161.85 76.29 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.8 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.968 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.0 147.31 48.86 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.798 2.332 . . . . 0.0 112.059 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.677 179.814 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.16 161.43 38.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -131.94 155.22 48.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.614 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.09 -50.59 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -171.35 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.623 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.01 -178.64 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.37 6.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.656 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 13.7 m -130.11 153.91 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -155.17 130.69 9.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.601 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.78 124.48 50.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.559 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.79 1.61 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.58 145.7 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.47 17.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.56 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.11 83.37 7.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.608 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.12 114.06 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.603 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.83 127.4 53.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.77 125.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -74.39 161.85 76.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.403 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 111.8 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.03 147.28 48.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.85 2.366 . . . . 0.0 112.032 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.588 179.873 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -143.1 161.42 38.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.593 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -131.93 155.18 48.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.639 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.52 3.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.36 3.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.629 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.03 -178.62 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.683 -176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.41 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -130.21 153.91 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.57 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.16 130.75 9.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.595 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.78 124.43 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.587 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.85 1.62 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.64 145.76 34.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.24 28.52 18.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.39 7.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.626 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.25 114.12 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.49 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.86 127.37 53.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.513 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -109.71 125.35 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.379 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' ALA . . . . . 0.514 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -74.3 161.86 76.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.375 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.1 Cg_endo -77.97 111.88 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.741 2.294 . . . . 0.0 111.975 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.12 147.31 48.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.866 2.377 . . . . 0.0 111.98 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.595 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.12 161.37 38.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -131.95 155.19 48.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.04 -50.6 3.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.49 -171.33 3.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -95.12 -178.63 4.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.63 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 57.04 55.46 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.646 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.15 153.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.2 130.68 9.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.72 124.41 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.604 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.11 131.75 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.54 145.8 34.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.22 28.5 18.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.602 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.33 7.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.18 114.18 8.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.525 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.92 127.33 53.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.51 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.7 125.4 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.35 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -74.35 161.8 76.59 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.434 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.82 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.944 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.97 147.24 48.93 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.861 2.374 . . . . 0.0 112.109 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.598 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.17 161.42 38.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -131.95 155.22 48.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.534 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.1 -50.52 3.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.645 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.34 3.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.556 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 84.2 p -95.14 -178.63 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.569 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.07 55.43 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 m -130.13 154.0 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.63 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.23 130.66 9.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.573 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.74 124.49 50.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.14 131.71 1.59 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.5 145.74 34.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.664 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.46 17.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.542 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.16 83.4 7.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.18 114.13 8.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.9 127.43 53.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.7 125.29 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.361 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -74.43 161.87 76.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.5 Cg_endo -77.8 111.82 3.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.755 2.303 . . . . 0.0 112.029 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.06 147.28 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.782 2.322 . . . . 0.0 112.076 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.683 179.83 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.672 ' H ' HD11 ' A' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.96 117.78 11.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -125.86 130.98 52.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.58 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.69 -56.15 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.691 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.77 4.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.3 p -91.57 176.15 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.7 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.59 48.94 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.716 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.54 140.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.43 127.8 24.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.613 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.672 HD11 ' H ' ' A' ' 1' ' ' VAL . 88.9 mt -127.89 129.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.94 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.576 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.98 83.99 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.601 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.4 m -69.7 153.66 43.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.588 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.415 ' HB3' HD12 ' B' ' 16' ' ' LEU . 55.4 tp -145.21 124.67 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.479 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.03 124.39 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.45 161.92 72.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.406 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.92 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.979 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.86 146.38 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.902 2.402 . . . . 0.0 112.069 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' VAL . . . . . 0.671 ' H ' HD11 ' B' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -139.99 117.79 11.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.622 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -125.88 131.02 52.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.72 -56.14 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.689 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.68 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.67 176.18 6.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.638 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.61 48.94 11.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.47 127.74 24.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.64 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.671 HD11 ' H ' ' B' ' 1' ' ' VAL . 88.8 mt -127.79 129.92 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.09 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.41 145.06 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.95 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.576 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.92 83.98 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 70.1 m -69.69 153.59 43.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 16' ' ' LEU . 55.4 tp -145.22 124.65 13.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.98 124.36 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.339 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 162.0 72.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.17 111.9 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.824 2.349 . . . . 0.0 112.016 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 179.654 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.672 ' H ' HD11 ' C' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.93 117.77 11.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -125.86 131.01 52.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.65 -56.22 2.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.693 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.72 4.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.69 176.19 6.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.596 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.62 48.95 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.591 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.672 HD11 ' H ' ' C' ' 1' ' ' VAL . 88.9 mt -127.87 129.91 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.08 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 62.0 27.89 16.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.574 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.9 84.02 6.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.611 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -69.62 153.6 43.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.658 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' B' ' 16' ' ' LEU . 55.3 tp -145.28 124.72 13.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.9 t -113.98 124.34 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.92 72.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.951 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.89 146.38 53.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.872 2.381 . . . . 0.0 112.069 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 1' ' ' VAL . . . . . 0.672 ' H ' HD11 ' D' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.95 117.74 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.645 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -125.83 130.99 52.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.613 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.69 -56.24 2.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.686 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.67 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.682 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.69 176.25 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.6 48.93 11.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.669 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.59 140.43 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.48 127.72 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.647 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' ILE . . . . . 0.672 HD11 ' H ' ' D' ' 1' ' ' VAL . 88.6 mt -127.85 129.97 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.566 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.48 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.36 145.03 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.669 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.96 16.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.575 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.89 83.98 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 70.0 m -69.75 153.63 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.564 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' LEU . . . . . 0.415 ' HB3' HD12 ' E' ' 16' ' ' LEU . 55.4 tp -145.23 124.73 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.94 124.35 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.356 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.43 161.92 72.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.15 111.94 3.31 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.766 2.311 . . . . 0.0 112.021 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 1' ' ' VAL . . . . . 0.672 ' H ' HD11 ' E' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.92 117.73 11.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.659 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -125.82 131.01 52.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.575 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.67 -56.12 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.7 4.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.73 176.26 6.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.57 48.91 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.681 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.672 HD11 ' H ' ' E' ' 1' ' ' VAL . 88.8 mt -127.89 129.93 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.15 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.43 145.01 35.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.65 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.98 16.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.575 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -89.0 84.04 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -69.67 153.62 43.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' D' ' 16' ' ' LEU . 55.3 tp -145.25 124.7 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.9 t -113.91 124.37 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.318 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.45 161.87 73.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.406 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 55.9 Cg_endo -77.2 112.0 3.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.806 2.337 . . . . 0.0 111.951 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.96 146.4 52.69 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.828 2.352 . . . . 0.0 112.048 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.584 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.74 127.9 19.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.65 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.29 128.95 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' B' ' 4' ' ' ASN . 61.3 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.91 47.37 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.593 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.94 137.68 56.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.657 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.613 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 10' ' ' ILE . 93.1 mt -125.21 126.53 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.591 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.3 1.38 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -77.66 144.52 37.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 61.96 27.75 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.78 85.74 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.28 153.09 43.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.555 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.417 ' HB3' HD12 ' B' ' 16' ' ' LEU . 55.6 tp -144.83 124.7 13.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.84 124.26 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.49 161.85 73.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.426 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.8 Cg_endo -77.28 112.02 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.985 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.05 146.54 52.51 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.885 2.39 . . . . 0.0 112.031 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.62 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -141.83 127.89 19.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.627 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.3 128.91 50.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.618 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 4' ' ' ASN . 61.1 t30 -104.71 -57.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.766 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.95 -177.08 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.625 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 96.8 p -87.04 174.97 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.599 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.95 47.32 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.653 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.93 137.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.58 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.61 127.58 27.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.431 HD11 HG21 ' B' ' 10' ' ' ILE . 92.8 mt -125.24 126.49 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.645 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.29 1.37 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.67 144.5 37.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.644 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.96 27.7 16.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.69 85.69 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.646 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.21 153.05 43.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.567 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' A' ' 16' ' ' LEU . 55.9 tp -144.83 124.68 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.89 124.22 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.365 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.41 161.85 73.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.426 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.23 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.876 2.384 . . . . 0.0 111.945 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.02 146.63 52.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.834 2.356 . . . . 0.0 112.059 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.547 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.76 127.91 19.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.32 128.94 50.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.592 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' D' ' 4' ' ' ASN . 61.2 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.1 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.633 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.99 47.32 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.602 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.92 137.66 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.613 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.431 HG21 HD11 ' C' ' 10' ' ' ILE . 92.9 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.619 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.62 131.3 1.37 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.62 144.53 37.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.773 0.321 . . . . 0.0 110.672 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.94 27.72 16.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.526 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.79 85.78 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.592 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.7 m -70.26 153.12 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' B' ' 16' ' ' LEU . 55.7 tp -144.94 124.65 13.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.79 124.2 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.38 161.83 73.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.478 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.0 Cg_endo -77.31 111.99 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.955 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.96 146.51 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.581 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.81 127.91 19.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.595 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.33 128.97 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' C' ' 4' ' ' ASN . 61.2 t30 -104.74 -57.66 2.0 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.645 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p -86.99 174.92 8.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.64 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.96 47.29 12.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.626 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 137.76 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.603 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.64 127.64 27.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' ILE . . . . . 0.43 HG21 HD11 ' D' ' 10' ' ' ILE . 92.6 mt -125.24 126.5 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.34 1.38 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.78 144.58 37.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.621 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.97 27.71 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.72 85.74 7.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.1 m -70.25 153.07 43.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' C' ' 16' ' ' LEU . 55.9 tp -144.87 124.69 13.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.88 124.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.338 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.44 161.85 73.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.426 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.1 Cg_endo -77.25 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.806 2.338 . . . . 0.0 111.95 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.96 146.61 53.21 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.385 . . . . 0.0 112.081 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.57 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.8 127.93 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.613 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -123.39 129.02 50.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' D' ' 4' ' ' ASN . 61.2 t30 -104.8 -57.56 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.03 -177.07 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.62 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -87.01 174.89 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.606 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.98 47.34 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.64 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.91 137.64 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.59 27.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.565 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.431 HG21 HD11 ' E' ' 10' ' ' ILE . 93.1 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.619 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.61 131.27 1.37 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.64 144.5 37.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.95 27.74 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.75 85.81 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.23 153.09 43.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' D' ' 16' ' ' LEU . 55.7 tp -144.94 124.69 13.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.17 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.44 161.87 73.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.42 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.24 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.771 2.314 . . . . 0.0 112.034 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.95 146.53 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.063 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.536 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.5 HD13 HD22 ' B' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' B' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.5 HD22 HD13 ' A' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.5 HD13 HD22 ' C' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' A' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.502 ' HB3' ' HD2' ' B' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' B' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . 0.5 HD22 HD13 ' B' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.5 HD13 HD22 ' D' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' D' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' C' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' C' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.5 HD22 HD13 ' C' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' ILE . . . . . 0.5 HD13 HD22 ' E' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' C' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . 0.502 ' HB3' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . 0.5 HD22 HD13 ' D' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . 0.407 HD11 ' HB3' ' D' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' E' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' E' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.46 136.45 49.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.65 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -131.96 131.08 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.588 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.07 -55.49 2.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.42 -171.51 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.2 p -91.61 179.37 5.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.2 58.81 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.66 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.44 150.93 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.54 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.76 116.44 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.633 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.3 mt -125.07 125.08 68.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.61 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.57 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.86 0.362 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.71 16.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.95 84.59 7.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.573 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.76 153.56 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.411 ' HB3' HD11 ' B' ' 16' ' ' LEU . 54.3 tp -145.38 124.61 12.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.458 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.39 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.353 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.48 161.94 72.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.358 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.24 111.96 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 111.989 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.45 148.26 53.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.386 . . . . 0.0 112.054 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.55 179.9 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -129.49 136.49 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.597 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -132.05 131.06 42.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.545 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.705 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.35 -171.5 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.654 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 91.7 p -91.67 179.44 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.607 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.19 58.72 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.34 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.594 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.75 116.5 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.6 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.14 125.14 68.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.539 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.96 131.58 1.52 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.51 145.54 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.615 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.74 16.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.534 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.62 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.653 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.57 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' C' ' 16' ' ' LEU . 54.6 tp -145.35 124.59 12.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.508 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.82 124.33 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.435 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.48 161.97 72.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.399 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.95 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 112.01 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.48 148.25 53.79 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.91 2.407 . . . . 0.0 112.1 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.555 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -131.99 131.12 42.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.592 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -102.16 -55.41 2.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.692 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.3 -171.41 3.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.674 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 91.8 p -91.72 179.38 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.643 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 58.22 58.82 3.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.597 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.38 151.01 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.595 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.82 116.4 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.661 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.02 125.06 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.693 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.56 34.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.1 26.64 16.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.494 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.68 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.5 43.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.585 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' B' ' 16' ' ' LEU . 54.4 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 70.4 t -113.85 124.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.366 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.47 162.02 72.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.432 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.28 111.99 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 111.989 -176.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.54 148.27 53.47 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.835 2.356 . . . . 0.0 112.018 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.654 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -129.55 136.5 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -132.01 131.02 42.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.44 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.712 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -171.52 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.654 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.3 p -91.59 179.33 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.693 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.25 58.72 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.692 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.37 150.96 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.571 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.77 116.46 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 91.2 mt -125.03 125.07 68.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.56 1.51 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 26.75 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.556 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.97 84.59 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.7 153.53 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' E' ' 16' ' ' LEU . 54.2 tp -145.34 124.64 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.48 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.35 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.38 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.49 162.06 72.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.28 111.94 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 112.017 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.49 148.29 53.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.843 2.362 . . . . 0.0 112.089 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.576 180.0 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -132.0 131.06 42.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.551 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.705 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.33 -171.47 3.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.648 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 91.5 p -91.71 179.4 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 58.3 58.67 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.31 150.96 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.78 116.45 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.08 125.13 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.619 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.5 34.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.611 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.12 26.66 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.507 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.99 84.68 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.57 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.72 153.5 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.575 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' D' ' 16' ' ' LEU . 54.5 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.89 124.35 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.4 162.06 72.41 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.432 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.33 112.01 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.786 2.324 . . . . 0.0 112.017 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.59 148.32 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.869 2.379 . . . . 0.0 111.992 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.638 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.1 129.66 21.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.543 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.421 ' HB3' HG21 ' A' ' 8' ' ' VAL . 81.2 m-20 -128.39 129.57 46.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.606 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.84 -170.92 3.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.6 p -91.02 178.62 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 57.62 58.23 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.592 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' A' ' 3' ' ' ASN . 18.0 m -127.53 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.612 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.18 124.68 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.78 145.75 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 110.544 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.69 27.25 16.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.631 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -87.21 85.16 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.678 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.07 153.45 43.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.581 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.413 ' HB3' HD12 ' B' ' 16' ' ' LEU . 54.3 tp -145.45 124.71 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.59 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.6 t -113.83 124.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.53 161.98 72.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.1 Cg_endo -77.3 111.94 3.28 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.78 2.32 . . . . 0.0 111.96 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.0 146.59 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.067 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.592 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -142.05 129.62 21.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.589 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.422 ' HB3' HG21 ' B' ' 8' ' ' VAL . 81.0 m-20 -128.36 129.49 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.653 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.673 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -171.0 3.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 93.7 p -90.91 178.61 5.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 57.6 58.28 3.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' B' ' 3' ' ' ASN . 18.0 m -127.56 151.73 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.478 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 91.0 mt -123.18 124.69 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.7 27.25 16.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.23 85.18 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.04 153.42 43.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 16' ' ' LEU . 54.3 tp -145.48 124.72 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.514 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.22 111.88 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.004 -176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.94 146.59 53.28 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.817 2.345 . . . . 0.0 112.097 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.556 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.07 129.71 21.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . 0.421 ' HB3' HG21 ' C' ' 8' ' ' VAL . 81.1 m-20 -128.4 129.53 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.624 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.18 -55.27 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.682 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.622 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 93.5 p -90.98 178.61 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.545 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 57.61 58.28 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.58 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' C' ' 3' ' ' ASN . 17.9 m -127.49 151.69 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.545 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.58 114.95 4.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 90.9 mt -123.16 124.67 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.514 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.77 27.16 16.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.651 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.24 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.9 m -70.07 153.43 43.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . 0.414 ' HB3' HD12 ' D' ' 16' ' ' LEU . 54.4 tp -145.48 124.68 12.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.17 111.87 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.33 . . . . 0.0 112.048 -176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.98 146.59 53.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.097 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.568 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.1 129.71 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.524 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.421 ' HB3' HG21 ' D' ' 8' ' ' VAL . 81.1 m-20 -128.34 129.64 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.18 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.82 -170.9 3.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 93.9 p -90.99 178.61 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 57.58 58.27 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.642 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' D' ' 3' ' ' ASN . 18.0 m -127.54 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.57 114.97 4.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.536 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.16 124.62 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.8 145.75 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.513 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.81 27.12 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.648 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.22 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.566 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.08 153.41 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' C' ' 16' ' ' LEU . 54.4 tp -145.43 124.74 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.591 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.27 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . 0.514 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.54 161.99 72.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.409 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.21 111.87 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.783 2.322 . . . . 0.0 112.048 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.02 146.62 52.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.773 2.316 . . . . 0.0 112.046 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.568 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.06 129.68 21.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.568 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . 0.421 ' HB3' HG21 ' E' ' 8' ' ' VAL . 81.0 m-20 -128.4 129.59 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.568 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.16 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.91 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.622 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p -90.92 178.59 5.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.632 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 57.58 58.23 3.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' E' ' 3' ' ' ASN . 18.0 m -127.47 151.78 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.64 114.97 4.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.2 124.66 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.0 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.65 145.67 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.584 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.77 27.15 16.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.628 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.18 85.1 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -69.99 153.42 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.58 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' D' ' 16' ' ' LEU . 54.3 tp -145.46 124.74 12.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.591 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.5 162.0 72.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.87 3.27 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 112.013 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.95 146.56 53.14 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.126 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.596 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.05 131.6 50.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.46 128.4 49.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.543 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.73 -59.39 1.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.72 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.8 -177.39 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.675 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.9 p -84.55 173.99 10.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.49 42.96 16.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.2 134.3 65.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.521 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -143.96 140.22 29.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.568 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 1' ' ' VAL . 88.0 mt -127.57 122.11 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.599 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.89 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.29 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.73 25.65 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.56 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.94 7.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.614 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -70.25 153.13 43.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD13 ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.509 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -114.35 123.59 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . . . -76.39 161.59 74.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 57.1 Cg_endo -79.84 111.65 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.767 2.312 . . . . 0.0 112.01 -175.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' B' ' 20' ' ' PRO . 31.3 Cg_exo -60.69 142.3 97.41 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.909 2.406 . . . . 0.0 112.015 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.616 179.711 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' B' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -126.96 131.56 51.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.45 128.34 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.66 -59.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.84 -177.44 5.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 97.0 p -84.55 174.1 10.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 59.37 43.05 17.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.624 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.2 134.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.541 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.0 140.17 29.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.571 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' B' ' 1' ' ' VAL . 88.3 mt -127.57 122.04 58.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.577 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.48 132.87 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.14 147.21 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 110.63 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.87 25.53 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.552 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.1 85.94 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.652 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.1 m -70.18 153.08 43.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.587 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 16' ' ' LEU . 53.9 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.461 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -114.32 123.56 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.358 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.59 74.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' B' ' 18' ' ' ALA . 57.2 Cg_endo -79.82 111.58 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.836 2.358 . . . . 0.0 112.007 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 31.3 Cg_exo -60.66 142.32 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.665 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' C' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -127.02 131.66 50.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.609 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -123.46 128.36 49.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.605 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.67 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.679 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.86 -177.39 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 96.4 p -84.55 174.01 10.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.604 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.39 43.03 17.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.65 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.18 134.26 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.567 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.9 140.2 29.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.598 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' C' ' 1' ' ' VAL . 88.0 mt -127.55 122.11 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.92 2.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.24 32.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.83 25.56 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.552 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.15 85.99 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.634 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.21 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.52 12.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.471 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 69.5 t -114.3 123.51 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.371 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.59 74.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' C' ' 18' ' ' ALA . 57.3 Cg_endo -79.75 111.64 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' B' ' 20' ' ' PRO . 31.3 Cg_exo -60.74 142.33 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.834 2.356 . . . . 0.0 112.06 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.552 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.589 179.731 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' D' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -126.95 131.63 51.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -123.51 128.29 49.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -103.62 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.82 -177.4 5.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.683 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 96.4 p -84.57 174.06 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.599 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.43 42.97 17.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.625 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 57.2 t -128.11 134.2 65.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.629 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.91 140.19 29.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.605 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' D' ' 1' ' ' VAL . 88.0 mt -127.58 122.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.623 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.56 132.9 2.08 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.26 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.78 25.61 15.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.96 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.624 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.23 153.07 43.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD13 ' E' ' 16' ' ' LEU . 54.2 tp -145.19 124.49 13.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.522 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -114.35 123.62 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.342 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . 0.48 ' HB3' ' HD2' ' D' ' 19' ' ' PRO . . . -76.41 161.65 73.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' D' ' 18' ' ' ALA . 57.2 Cg_endo -79.83 111.57 2.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.807 2.338 . . . . 0.0 111.969 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' C' ' 20' ' ' PRO . 31.2 Cg_exo -60.66 142.28 97.4 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.623 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' E' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -127.02 131.55 50.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.63 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -123.45 128.35 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.616 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.64 -59.36 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.758 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.85 -177.38 5.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.648 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 96.5 p -84.56 174.03 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.595 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 59.39 43.08 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.611 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.21 134.25 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.592 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.92 140.17 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.655 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' E' ' 1' ' ' VAL . 87.9 mt -127.49 122.05 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.52 132.93 2.09 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.22 32.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 110.684 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.82 25.61 15.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.579 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -85.24 85.95 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.57 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.2 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.548 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' D' ' 16' ' ' LEU . 54.2 tp -145.28 124.41 12.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.1 t -114.32 123.59 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.344 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' E' ' 19' ' ' PRO . . . -76.35 161.65 74.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.416 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' E' ' 18' ' ' ALA . 57.2 Cg_endo -79.9 111.61 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.763 2.309 . . . . 0.0 111.976 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' D' ' 20' ' ' PRO . 31.2 Cg_exo -60.69 142.31 97.44 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.609 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.426 ' HA ' HD13 ' A' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.21 131.93 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.19 129.55 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.7 -58.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.643 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.12 3.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.734 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.94 176.65 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.0 47.67 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.1 t -128.44 136.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.566 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.94 128.32 30.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 1' ' ' VAL . 93.8 mt -125.03 121.11 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.33 1.12 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.98 146.32 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.841 0.353 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.56 27.05 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.549 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.26 80.51 8.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.618 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.01 114.65 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.11 53.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.573 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.68 124.93 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.504 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -73.71 162.34 74.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.404 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -78.59 111.76 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.806 2.337 . . . . 0.0 111.895 -175.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.33 147.8 53.75 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.742 2.295 . . . . 0.0 112.105 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.6 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.425 ' HA ' HD13 ' B' ' 10' ' ' ILE . 22.6 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -126.19 129.49 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.66 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.682 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.75 -173.19 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.752 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.92 176.67 6.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.08 47.63 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.524 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.42 136.02 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.561 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' B' ' 1' ' ' VAL . 93.6 mt -124.93 121.09 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 177.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.5 127.29 1.12 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.9 146.29 33.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.572 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.54 27.07 16.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.592 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.35 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.4 m -67.06 114.74 6.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.17 53.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.551 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.79 124.93 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -73.69 162.41 74.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.5 Cg_endo -78.63 111.76 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.871 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.37 147.79 53.46 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.802 2.335 . . . . 0.0 112.068 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.582 179.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.426 ' HA ' HD13 ' C' ' 10' ' ' ILE . 22.2 t . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.23 131.93 50.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.585 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -126.17 129.49 49.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.548 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.69 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.605 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.24 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.753 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p -90.82 176.63 6.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.02 47.68 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.48 136.05 60.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.97 128.23 30.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.536 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' C' ' 1' ' ' VAL . 93.9 mt -125.06 121.18 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.547 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.56 127.24 1.11 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.79 146.24 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 61.55 27.07 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.613 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.33 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.618 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.04 114.65 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.621 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.25 127.1 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -109.82 124.94 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . 0.505 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -73.69 162.36 74.52 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.447 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . 0.505 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.5 Cg_endo -78.57 111.71 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.798 2.332 . . . . 0.0 111.957 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.29 147.74 53.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.772 2.315 . . . . 0.0 112.105 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.652 179.867 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.425 ' HA ' HD13 ' D' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.19 129.51 49.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.68 -58.67 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.679 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.85 -173.2 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.87 176.68 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.543 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.02 47.71 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.566 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -128.5 135.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.543 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -135.92 128.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.566 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' D' ' 1' ' ' VAL . 94.0 mt -125.01 121.23 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.518 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.57 127.22 1.11 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.83 146.31 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.53 27.12 16.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.57 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.42 80.52 8.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.554 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -67.0 114.68 5.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.598 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.14 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -109.71 124.91 66.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . 0.504 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -73.75 162.4 74.32 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.5 Cg_endo -78.59 111.79 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.828 2.352 . . . . 0.0 111.933 -175.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.43 147.79 53.14 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.759 2.306 . . . . 0.0 112.029 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.644 179.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' VAL . . . . . 0.426 ' HA ' HD13 ' E' ' 10' ' ' ILE . 22.4 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -127.26 131.87 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.617 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.17 129.49 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.523 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.63 -58.64 1.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.8 -173.19 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 92.1 p -90.92 176.7 6.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.543 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.05 47.63 11.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.524 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 61.7 t -128.44 136.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.517 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.487 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' E' ' 1' ' ' VAL . 93.6 mt -124.95 121.11 60.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.25 1.11 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.81 146.31 33.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.574 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.51 27.07 16.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.592 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.37 80.6 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.58 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 73.5 m -67.07 114.75 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.548 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.18 53.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.485 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.74 124.93 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.423 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . 0.505 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -73.58 162.33 74.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . 0.505 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -78.63 111.82 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.843 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.42 147.71 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.049 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.618 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' B' ' 1' ' ' VAL . 10.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.631 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -125.69 151.37 46.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.621 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.53 -56.74 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.704 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.81 -175.96 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.6 p -88.49 174.12 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.562 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 58.99 45.5 14.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.9 140.04 49.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.569 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -149.01 138.75 21.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.635 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.19 124.26 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 136.5 2.89 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.56 31.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.623 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.95 25.34 15.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.548 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.21 85.42 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.628 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.05 153.14 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD11 ' B' ' 16' ' ' LEU . 54.9 tp -144.87 124.62 13.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.542 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.23 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.338 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . . . -76.36 161.8 73.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.441 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 56.2 Cg_endo -77.88 111.97 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.71 2.273 . . . . 0.0 112.0 -176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.1 147.07 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.874 2.383 . . . . 0.0 112.1 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.566 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 10.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -125.72 151.33 46.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.527 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.51 -56.75 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.97 4.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.633 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 93.4 p -88.47 174.17 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.618 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.97 139.97 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.02 138.8 21.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 98.4 mt -127.2 124.21 63.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.41 2.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.54 31.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 61.98 25.37 15.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.548 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.2 85.35 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.609 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -69.96 153.1 43.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.581 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 16' ' ' LEU . 54.4 tp -144.9 124.7 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.483 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.81 124.14 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' B' ' 19' ' ' PRO . . . -76.32 161.75 73.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.441 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.78 112.01 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.04 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.13 147.11 47.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.874 2.383 . . . . 0.0 112.022 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.576 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' D' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -142.89 162.27 35.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.57 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -125.76 151.33 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.527 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.52 -56.73 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.727 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.72 -175.95 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.632 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 93.5 p -88.53 174.11 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.91 45.56 14.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.639 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.9 140.02 49.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.09 138.75 21.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.17 124.23 63.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.97 136.41 2.86 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.91 147.54 31.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.598 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.92 25.44 15.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.497 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.26 85.37 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.602 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.98 153.06 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.594 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' B' ' 16' ' ' LEU . 54.5 tp -144.84 124.71 13.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.453 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.9 t -113.82 124.19 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.35 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . 0.5 ' HB3' ' HD2' ' C' ' 19' ' ' PRO . . . -76.37 161.72 73.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.402 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' C' ' 18' ' ' ALA . 56.4 Cg_endo -77.78 111.97 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.791 2.328 . . . . 0.0 111.972 -176.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.16 147.1 47.53 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.057 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.572 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' C' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.82 162.24 35.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.609 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -125.76 151.32 46.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.537 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.5 -56.75 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.95 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.608 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.617 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.88 140.04 49.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.572 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.07 138.76 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.603 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.17 124.24 63.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.65 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.95 136.44 2.87 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.98 147.55 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.0 110.599 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.529 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.17 85.3 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.658 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.94 153.11 43.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD11 ' E' ' 16' ' ' LEU . 54.6 tp -144.91 124.67 13.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.83 124.22 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . 0.5 ' HB3' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.72 73.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 112.02 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.005 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.14 147.09 47.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.863 2.375 . . . . 0.0 111.993 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.561 179.877 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' D' ' 1' ' ' VAL . 10.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.82 162.27 35.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.653 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -125.74 151.28 46.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.51 -56.7 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.7 -175.96 4.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.624 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.92 45.62 14.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.95 140.04 49.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.516 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.1 138.84 21.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 98.4 mt -127.2 124.3 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.0 136.45 2.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.94 147.52 31.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.529 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.14 85.35 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.02 153.17 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' D' ' 16' ' ' LEU . 54.7 tp -144.92 124.63 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.525 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.85 124.21 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.303 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . 0.5 ' HB3' ' HD2' ' E' ' 19' ' ' PRO . . . -76.33 161.72 73.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.4 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -77.76 111.96 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.785 2.323 . . . . 0.0 112.035 -176.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.13 147.16 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.04 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.586 179.88 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.75 122.12 32.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.652 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.546 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.86 -59.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.707 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.75 -171.42 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.66 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.79 171.86 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.87 45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.577 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.494 HG11 ' H ' ' B' ' 8' ' ' VAL . 32.5 m -135.95 155.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.585 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.49 19.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.23 125.86 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.617 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.48 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.26 147.25 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.663 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.89 26.12 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.54 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.31 84.79 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.29 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.56 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD12 ' B' ' 16' ' ' LEU . 55.0 tp -144.92 124.65 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.466 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.78 124.28 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.353 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . . . -76.43 161.79 73.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.443 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.07 112.02 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.787 2.325 . . . . 0.0 111.99 -176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.92 147.66 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.832 2.355 . . . . 0.0 112.107 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.65 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.77 122.16 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.557 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.546 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.84 -59.68 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.78 -171.39 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.601 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.78 171.83 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.588 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.83 45.43 12.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.494 ' H ' HG11 ' A' ' 8' ' ' VAL . 32.5 m -135.91 155.89 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -156.21 144.45 19.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.609 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.25 125.88 57.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.36 147.29 31.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.629 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.88 26.15 15.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.528 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.71 7.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.569 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.68 153.31 43.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 16' ' ' LEU . 54.8 tp -144.92 124.68 13.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.32 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.83 73.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.429 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' B' ' 18' ' ' ALA . 55.8 Cg_endo -77.09 112.08 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.747 2.298 . . . . 0.0 111.99 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.615 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -127.74 122.13 32.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.569 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.93 -59.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.668 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.82 -171.42 3.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.77 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.89 45.4 12.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.605 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . 0.495 HG11 ' H ' ' D' ' 8' ' ' VAL . 32.6 m -135.89 155.92 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.607 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.18 144.57 19.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.545 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 92.6 mt -131.32 125.79 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.41 136.51 2.68 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.25 147.25 31.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.322 . . . . 0.0 110.663 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.86 26.1 15.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.568 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -86.23 84.78 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.72 153.32 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . 0.404 HD12 ' HB3' ' B' ' 16' ' ' LEU . 54.8 tp -144.96 124.67 13.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.436 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.6 t -113.79 124.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.369 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' C' ' 19' ' ' PRO . . . -76.42 161.85 73.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.415 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.09 112.03 3.33 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.843 2.362 . . . . 0.0 111.984 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 147.75 55.34 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.316 . . . . 0.0 112.095 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.62 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.79 122.17 32.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.635 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.58 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.86 -59.61 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.708 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.79 -171.39 3.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.583 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.83 171.83 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.589 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.82 45.41 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.652 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' VAL . . . . . 0.495 ' H ' HG11 ' C' ' 8' ' ' VAL . 32.5 m -135.87 155.82 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.641 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.55 20.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.621 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.32 125.9 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.556 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.33 147.28 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.323 . . . . 0.0 110.609 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 61.84 26.18 15.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.81 7.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.32 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.584 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' LEU . . . . . 0.405 ' HB3' HD12 ' E' ' 16' ' ' LEU . 54.7 tp -144.97 124.66 13.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.426 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.78 124.29 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.299 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' D' ' 19' ' ' PRO . . . -76.51 161.86 72.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.446 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' D' ' 18' ' ' ALA . 55.9 Cg_endo -77.02 111.99 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.791 2.327 . . . . 0.0 112.007 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.97 147.74 55.71 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.787 2.325 . . . . 0.0 112.039 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.563 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.8 122.16 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.589 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.02 56.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.554 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.89 -59.64 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.682 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.73 -171.39 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.668 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 80.3 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.57 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.92 45.43 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.591 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . 0.493 ' H ' HG11 ' D' ' 8' ' ' VAL . 32.6 m -135.96 155.86 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.21 144.54 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -131.25 125.84 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.588 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.39 136.49 2.67 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.34 147.24 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.94 26.07 15.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -86.23 84.8 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.77 153.28 43.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' D' ' 16' ' ' LEU . 54.8 tp -144.89 124.61 13.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.453 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.76 124.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.334 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' E' ' 19' ' ' PRO . . . -76.46 161.83 73.15 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.429 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' E' ' 18' ' ' ALA . 55.8 Cg_endo -77.03 112.03 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.0 111.991 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.598 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.15 161.42 38.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -131.94 155.18 48.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.5 3.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.62 -171.34 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.568 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.6 p -95.06 -178.68 4.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.639 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.11 55.39 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.667 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.7 m -130.13 153.94 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.682 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.19 130.63 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.653 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.68 124.48 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.15 131.77 1.6 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.61 145.7 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.33 28.48 17.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.526 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.1 83.29 7.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.4 m -70.09 114.12 7.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.566 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.85 127.39 53.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.56 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.73 125.38 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.384 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -74.41 161.85 76.29 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.8 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.968 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.0 147.31 48.86 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.798 2.332 . . . . 0.0 112.059 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.677 179.814 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.16 161.43 38.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -131.94 155.22 48.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.614 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.09 -50.59 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -171.35 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.623 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.01 -178.64 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.37 6.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.656 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 13.7 m -130.11 153.91 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -155.17 130.69 9.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.601 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.78 124.48 50.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.559 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.79 1.61 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.58 145.7 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.47 17.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.56 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.11 83.37 7.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.608 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.12 114.06 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.603 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.83 127.4 53.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.77 125.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -74.39 161.85 76.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.403 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 111.8 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.03 147.28 48.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.85 2.366 . . . . 0.0 112.032 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.588 179.873 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -143.1 161.42 38.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.593 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -131.93 155.18 48.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.639 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.52 3.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.36 3.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.629 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.03 -178.62 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.683 -176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.41 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -130.21 153.91 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.57 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.16 130.75 9.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.595 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.78 124.43 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.587 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.85 1.62 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.64 145.76 34.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.24 28.52 18.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.39 7.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.626 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.25 114.12 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.49 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.86 127.37 53.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.513 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -109.71 125.35 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.379 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . 0.514 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -74.3 161.86 76.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.375 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.1 Cg_endo -77.97 111.88 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.741 2.294 . . . . 0.0 111.975 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.12 147.31 48.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.866 2.377 . . . . 0.0 111.98 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.595 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.12 161.37 38.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -131.95 155.19 48.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.04 -50.6 3.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.49 -171.33 3.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -95.12 -178.63 4.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.63 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 57.04 55.46 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.646 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.15 153.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.2 130.68 9.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.72 124.41 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.604 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.11 131.75 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.54 145.8 34.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.22 28.5 18.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.602 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.33 7.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.18 114.18 8.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.525 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.92 127.33 53.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.51 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.7 125.4 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.35 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -74.35 161.8 76.59 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.434 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.82 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.944 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.97 147.24 48.93 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.861 2.374 . . . . 0.0 112.109 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.598 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.17 161.42 38.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -131.95 155.22 48.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.534 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.1 -50.52 3.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.645 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.34 3.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.556 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 84.2 p -95.14 -178.63 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.569 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.07 55.43 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 m -130.13 154.0 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.63 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.23 130.66 9.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.573 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.74 124.49 50.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.14 131.71 1.59 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.5 145.74 34.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.664 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.46 17.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.542 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.16 83.4 7.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.18 114.13 8.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.9 127.43 53.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.7 125.29 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.361 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -74.43 161.87 76.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.5 Cg_endo -77.8 111.82 3.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.755 2.303 . . . . 0.0 112.029 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.06 147.28 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.782 2.322 . . . . 0.0 112.076 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.683 179.83 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.672 ' H ' HD11 ' A' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.96 117.78 11.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -125.86 130.98 52.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.58 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.69 -56.15 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.691 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.77 4.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.3 p -91.57 176.15 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.7 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.59 48.94 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.716 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.54 140.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.43 127.8 24.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.613 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.672 HD11 ' H ' ' A' ' 1' ' ' VAL . 88.9 mt -127.89 129.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.94 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.576 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.98 83.99 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.601 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.4 m -69.7 153.66 43.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.588 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.415 ' HB3' HD12 ' B' ' 16' ' ' LEU . 55.4 tp -145.21 124.67 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.479 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.03 124.39 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.45 161.92 72.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.406 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.92 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.979 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.86 146.38 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.902 2.402 . . . . 0.0 112.069 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.671 ' H ' HD11 ' B' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -139.99 117.79 11.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.622 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -125.88 131.02 52.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.72 -56.14 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.689 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.68 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.67 176.18 6.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.638 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.61 48.94 11.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.47 127.74 24.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.64 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.671 HD11 ' H ' ' B' ' 1' ' ' VAL . 88.8 mt -127.79 129.92 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.09 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.41 145.06 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.95 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.576 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.92 83.98 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 70.1 m -69.69 153.59 43.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 16' ' ' LEU . 55.4 tp -145.22 124.65 13.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.98 124.36 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.339 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 162.0 72.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.17 111.9 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.824 2.349 . . . . 0.0 112.016 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 179.654 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.672 ' H ' HD11 ' C' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.93 117.77 11.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -125.86 131.01 52.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.65 -56.22 2.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.693 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.72 4.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.69 176.19 6.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.596 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.62 48.95 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.591 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.672 HD11 ' H ' ' C' ' 1' ' ' VAL . 88.9 mt -127.87 129.91 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.08 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 62.0 27.89 16.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.574 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.9 84.02 6.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.611 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -69.62 153.6 43.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.658 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' B' ' 16' ' ' LEU . 55.3 tp -145.28 124.72 13.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.9 t -113.98 124.34 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.92 72.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.951 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.89 146.38 53.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.872 2.381 . . . . 0.0 112.069 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.672 ' H ' HD11 ' D' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.95 117.74 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.645 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -125.83 130.99 52.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.613 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.69 -56.24 2.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.686 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.67 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.682 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.69 176.25 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.6 48.93 11.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.669 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.59 140.43 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.48 127.72 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.647 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' ILE . . . . . 0.672 HD11 ' H ' ' D' ' 1' ' ' VAL . 88.6 mt -127.85 129.97 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.566 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.48 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.36 145.03 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.669 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.96 16.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.575 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.89 83.98 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 70.0 m -69.75 153.63 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.564 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' LEU . . . . . 0.415 ' HB3' HD12 ' E' ' 16' ' ' LEU . 55.4 tp -145.23 124.73 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.94 124.35 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.356 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.43 161.92 72.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.15 111.94 3.31 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.766 2.311 . . . . 0.0 112.021 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' VAL . . . . . 0.672 ' H ' HD11 ' E' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.92 117.73 11.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.659 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -125.82 131.01 52.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.575 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.67 -56.12 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.7 4.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.73 176.26 6.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.57 48.91 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.681 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.672 HD11 ' H ' ' E' ' 1' ' ' VAL . 88.8 mt -127.89 129.93 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.15 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.43 145.01 35.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.65 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.98 16.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.575 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -89.0 84.04 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -69.67 153.62 43.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' D' ' 16' ' ' LEU . 55.3 tp -145.25 124.7 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.9 t -113.91 124.37 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.318 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.45 161.87 73.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.406 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 55.9 Cg_endo -77.2 112.0 3.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.806 2.337 . . . . 0.0 111.951 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.96 146.4 52.69 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.828 2.352 . . . . 0.0 112.048 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.584 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.484 HG13 HG21 ' A' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.74 127.9 19.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.65 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.29 128.95 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' B' ' 4' ' ' ASN . 61.3 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.91 47.37 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.593 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.94 137.68 56.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.657 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.613 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG21 HG13 ' A' ' 1' ' ' VAL . 93.1 mt -125.21 126.53 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.591 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.3 1.38 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -77.66 144.52 37.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 61.96 27.75 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.78 85.74 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.28 153.09 43.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.555 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.533 HD23 HD13 ' B' ' 16' ' ' LEU . 55.6 tp -144.83 124.7 13.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.84 124.26 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.49 161.85 73.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.426 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.8 Cg_endo -77.28 112.02 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.985 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.2 Cg_endo -71.05 146.54 52.51 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.885 2.39 . . . . 0.0 112.031 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.62 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' VAL . . . . . 0.48 HG13 HG21 ' B' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -141.83 127.89 19.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.627 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.3 128.91 50.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.618 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' C' ' 4' ' ' ASN . 61.1 t30 -104.71 -57.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.766 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.95 -177.08 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.625 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 96.8 p -87.04 174.97 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.599 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.95 47.32 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.653 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.93 137.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.58 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.61 127.58 27.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.48 HG21 HG13 ' B' ' 1' ' ' VAL . 92.8 mt -125.24 126.49 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.645 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.29 1.37 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.67 144.5 37.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.644 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.96 27.7 16.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.69 85.69 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.646 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.21 153.05 43.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.567 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' A' ' 16' ' ' LEU . 55.9 tp -144.83 124.68 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.89 124.22 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.365 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.41 161.85 73.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.426 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.23 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.876 2.384 . . . . 0.0 111.945 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.3 Cg_endo -71.02 146.63 52.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.834 2.356 . . . . 0.0 112.059 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.547 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.481 HG13 HG21 ' C' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.76 127.91 19.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.32 128.94 50.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.592 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 4' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' B' ' 4' ' ' ASN . 61.2 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.1 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.633 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.99 47.32 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.602 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.92 137.66 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.613 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.481 HG21 HG13 ' C' ' 1' ' ' VAL . 92.9 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.619 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.62 131.3 1.37 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.62 144.53 37.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.773 0.321 . . . . 0.0 110.672 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.94 27.72 16.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.526 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.79 85.78 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.592 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.7 m -70.26 153.12 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' B' ' 16' ' ' LEU . 55.7 tp -144.94 124.65 13.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.79 124.2 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.38 161.83 73.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.478 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.0 Cg_endo -77.31 111.99 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.955 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -70.96 146.51 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.581 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 1' ' ' VAL . . . . . 0.481 HG13 HG21 ' D' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.81 127.91 19.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.595 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.33 128.97 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' C' ' 4' ' ' ASN . 61.2 t30 -104.74 -57.66 2.0 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.645 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p -86.99 174.92 8.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.64 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.96 47.29 12.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.626 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 137.76 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.603 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.64 127.64 27.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' ILE . . . . . 0.481 HG21 HG13 ' D' ' 1' ' ' VAL . 92.6 mt -125.24 126.5 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.34 1.38 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.78 144.58 37.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.621 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.97 27.71 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.72 85.74 7.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.1 m -70.25 153.07 43.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' LEU . . . . . 0.534 HD23 HD13 ' E' ' 16' ' ' LEU . 55.9 tp -144.87 124.69 13.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.88 124.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.338 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.44 161.85 73.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.426 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.1 Cg_endo -77.25 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.806 2.338 . . . . 0.0 111.95 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.4 Cg_endo -70.96 146.61 53.21 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.385 . . . . 0.0 112.081 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.57 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 1' ' ' VAL . . . . . 0.482 HG13 HG21 ' E' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.8 127.93 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.613 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -123.39 129.02 50.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 4' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' D' ' 4' ' ' ASN . 61.2 t30 -104.8 -57.56 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.03 -177.07 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.62 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -87.01 174.89 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.606 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.98 47.34 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.64 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.91 137.64 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.59 27.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.565 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.482 HG21 HG13 ' E' ' 1' ' ' VAL . 93.1 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.619 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.61 131.27 1.37 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.64 144.5 37.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.95 27.74 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.75 85.81 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.23 153.09 43.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' D' ' 16' ' ' LEU . 55.7 tp -144.94 124.69 13.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.17 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 18' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.44 161.87 73.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.42 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 19' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.24 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.771 2.314 . . . . 0.0 112.034 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.4 Cg_endo -70.95 146.53 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.063 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.536 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' A' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' B' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.519 HD23 HD13 ' B' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 10' ' ' ILE . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' A' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' B' ' 10' ' ' ILE . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' C' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' A' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' B' ' 10' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' B' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' C' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' D' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' B' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' C' ' 10' ' ' ILE . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' C' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 7' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' D' ' 10' ' ' ILE . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' E' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' C' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' D' ' 10' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' D' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 7' ' ' GLU . . . . . 0.42 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' E' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.743 ' HB ' HD12 ' D' ' 10' ' ' ILE . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' D' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 18' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.522 HG13 HG21 ' A' ' 10' ' ' ILE . 25.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.46 136.45 49.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.65 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.485 ' CB ' HG21 ' A' ' 8' ' ' VAL . 78.9 m-20 -131.96 131.08 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.588 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.07 -55.49 2.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.42 -171.51 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.2 p -91.61 179.37 5.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 58.2 58.81 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.66 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.759 HG12 HG22 ' B' ' 8' ' ' VAL . 16.5 m -127.44 150.93 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.54 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.76 116.44 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.633 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 1' ' ' VAL . 91.3 mt -125.07 125.08 68.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.61 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.57 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.86 0.362 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.71 16.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.95 84.59 7.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.573 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.76 153.56 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.533 HD23 HD13 ' B' ' 16' ' ' LEU . 54.3 tp -145.38 124.61 12.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.458 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.39 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.353 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.48 161.94 72.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.358 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.24 111.96 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 111.989 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.9 Cg_endo -71.45 148.26 53.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.386 . . . . 0.0 112.054 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.55 179.9 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' VAL . . . . . 0.521 HG13 HG21 ' B' ' 10' ' ' ILE . 25.8 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -129.49 136.49 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.597 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.486 ' CB ' HG21 ' B' ' 8' ' ' VAL . 79.1 m-20 -132.05 131.06 42.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.545 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.705 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.35 -171.5 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.654 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 91.7 p -91.67 179.44 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.607 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.8 mt-10 58.19 58.72 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.759 HG22 HG12 ' A' ' 8' ' ' VAL . 16.5 m -127.34 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.594 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.75 116.5 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.6 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.521 HG21 HG13 ' B' ' 1' ' ' VAL . 91.7 mt -125.14 125.14 68.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.539 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.96 131.58 1.52 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.51 145.54 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.615 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.74 16.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.534 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.62 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.653 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.57 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' A' ' 16' ' ' LEU . 54.6 tp -145.35 124.59 12.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.508 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.82 124.33 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.435 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.48 161.97 72.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.399 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.95 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 112.01 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.9 Cg_endo -71.48 148.25 53.79 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.91 2.407 . . . . 0.0 112.1 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.555 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.519 HG13 HG21 ' C' ' 10' ' ' ILE . 26.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 3' ' ' ASN . . . . . 0.486 ' CB ' HG21 ' C' ' 8' ' ' VAL . 78.9 m-20 -131.99 131.12 42.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.592 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -102.16 -55.41 2.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.692 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.3 -171.41 3.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.674 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 91.8 p -91.72 179.38 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.643 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.9 mt-10 58.22 58.82 3.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.597 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 8' ' ' VAL . . . . . 0.759 HG12 HG22 ' D' ' 8' ' ' VAL . 16.5 m -127.38 151.01 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.595 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.82 116.4 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.661 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.519 HG21 HG13 ' C' ' 1' ' ' VAL . 90.9 mt -125.02 125.06 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.693 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.56 34.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.1 26.64 16.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.494 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.68 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.5 43.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.585 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' B' ' 16' ' ' LEU . 54.4 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 70.4 t -113.85 124.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.366 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.47 162.02 72.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.432 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.28 111.99 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 111.989 -176.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.7 Cg_endo -71.54 148.27 53.47 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.835 2.356 . . . . 0.0 112.018 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.654 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 1' ' ' VAL . . . . . 0.52 HG13 HG21 ' D' ' 10' ' ' ILE . 26.0 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -129.55 136.5 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.485 ' CB ' HG21 ' D' ' 8' ' ' VAL . 78.9 m-20 -132.01 131.02 42.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.44 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.712 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -171.52 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.654 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.3 p -91.59 179.33 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.693 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 58.25 58.72 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.692 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 8' ' ' VAL . . . . . 0.759 HG22 HG12 ' C' ' 8' ' ' VAL . 16.5 m -127.37 150.96 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.571 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.77 116.46 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' ILE . . . . . 0.52 HG21 HG13 ' D' ' 1' ' ' VAL . 91.2 mt -125.03 125.07 68.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.56 1.51 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 26.75 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.556 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.97 84.59 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.7 153.53 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' LEU . . . . . 0.532 HD13 HD23 ' C' ' 16' ' ' LEU . 54.2 tp -145.34 124.64 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.48 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.35 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.38 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.49 162.06 72.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.28 111.94 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 112.017 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.0 Cg_endo -71.49 148.29 53.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.843 2.362 . . . . 0.0 112.089 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.576 180.0 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 1' ' ' VAL . . . . . 0.52 HG13 HG21 ' E' ' 10' ' ' ILE . 25.7 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.484 ' CB ' HG21 ' E' ' 8' ' ' VAL . 79.0 m-20 -132.0 131.06 42.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.551 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.705 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.33 -171.47 3.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.648 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 91.5 p -91.71 179.4 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.9 mt-10 58.3 58.67 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.758 HG22 HG12 ' D' ' 8' ' ' VAL . 16.5 m -127.31 150.96 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.78 116.45 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.52 HG21 HG13 ' E' ' 1' ' ' VAL . 91.7 mt -125.08 125.13 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.619 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.5 34.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.611 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.12 26.66 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.507 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.99 84.68 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.57 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.72 153.5 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.575 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 16' ' ' LEU . . . . . 0.532 HD13 HD23 ' D' ' 16' ' ' LEU . 54.5 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.89 124.35 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 18' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.4 162.06 72.41 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.432 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 19' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.33 112.01 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.786 2.324 . . . . 0.0 112.017 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.8 Cg_endo -71.59 148.32 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.869 2.379 . . . . 0.0 111.992 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.638 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 10' ' ' ILE . 44.8 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.1 129.66 21.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.543 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' A' ' 8' ' ' VAL . 81.2 m-20 -128.39 129.57 46.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.606 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.84 -170.92 3.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.6 p -91.02 178.62 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 62.3 mt-10 57.62 58.23 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.592 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.772 HG12 HG22 ' B' ' 8' ' ' VAL . 18.0 m -127.53 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.612 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.468 HG21 HG13 ' A' ' 1' ' ' VAL . 90.8 mt -123.18 124.68 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.78 145.75 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 110.544 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.69 27.25 16.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.631 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -87.21 85.16 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.678 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.07 153.45 43.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.581 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.535 HD23 HD13 ' B' ' 16' ' ' LEU . 54.3 tp -145.45 124.71 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.59 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.6 t -113.83 124.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.53 161.98 72.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.1 Cg_endo -77.3 111.94 3.28 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.78 2.32 . . . . 0.0 111.96 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.1 Cg_endo -71.0 146.59 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.067 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.592 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' B' ' 10' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -142.05 129.62 21.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.589 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.574 ' HB3' HG21 ' B' ' 8' ' ' VAL . 81.0 m-20 -128.36 129.49 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.653 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.673 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -171.0 3.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 93.7 p -90.91 178.61 5.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 62.2 mt-10 57.6 58.28 3.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.773 HG12 HG22 ' C' ' 8' ' ' VAL . 18.0 m -127.56 151.73 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.478 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' B' ' 1' ' ' VAL . 91.0 mt -123.18 124.69 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.7 27.25 16.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.23 85.18 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.04 153.42 43.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.535 HD13 HD23 ' A' ' 16' ' ' LEU . 54.3 tp -145.48 124.72 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.22 111.88 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.004 -176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.1 Cg_endo -70.94 146.59 53.28 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.817 2.345 . . . . 0.0 112.097 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.556 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' C' ' 10' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.07 129.71 21.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' C' ' 8' ' ' VAL . 81.1 m-20 -128.4 129.53 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.624 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.18 -55.27 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.682 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.622 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 93.5 p -90.98 178.61 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.545 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' B' ' 7' ' ' GLU . 62.2 mt-10 57.61 58.28 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.58 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 8' ' ' VAL . . . . . 0.773 HG22 HG12 ' B' ' 8' ' ' VAL . 17.9 m -127.49 151.69 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.545 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.58 114.95 4.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' C' ' 1' ' ' VAL . 90.9 mt -123.16 124.67 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.514 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.77 27.16 16.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.651 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.24 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.9 m -70.07 153.43 43.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.535 HD13 HD23 ' B' ' 16' ' ' LEU . 54.4 tp -145.48 124.68 12.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.17 111.87 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.33 . . . . 0.0 112.048 -176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.0 Cg_endo -70.98 146.59 53.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.097 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.568 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 1' ' ' VAL . . . . . 0.469 HG13 HG21 ' D' ' 10' ' ' ILE . 44.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.1 129.71 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.524 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' D' ' 8' ' ' VAL . 81.1 m-20 -128.34 129.64 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.18 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.82 -170.9 3.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 93.9 p -90.99 178.61 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 62.2 mt-10 57.58 58.27 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.642 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 8' ' ' VAL . . . . . 0.773 HG22 HG12 ' C' ' 8' ' ' VAL . 18.0 m -127.54 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.57 114.97 4.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.536 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' ILE . . . . . 0.469 HG21 HG13 ' D' ' 1' ' ' VAL . 90.8 mt -123.16 124.62 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.8 145.75 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.513 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.81 27.12 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.648 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.22 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.566 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.08 153.41 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' C' ' 16' ' ' LEU . 54.4 tp -145.43 124.74 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.591 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.27 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.54 161.99 72.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.409 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.21 111.87 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.783 2.322 . . . . 0.0 112.048 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 56.9 Cg_endo -71.02 146.62 52.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.773 2.316 . . . . 0.0 112.046 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.568 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' E' ' 10' ' ' ILE . 44.7 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.06 129.68 21.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.568 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.574 ' HB3' HG21 ' E' ' 8' ' ' VAL . 81.0 m-20 -128.4 129.59 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.568 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.16 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.91 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.622 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p -90.92 178.59 5.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.632 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 62.1 mt-10 57.58 58.23 3.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.772 HG22 HG12 ' D' ' 8' ' ' VAL . 18.0 m -127.47 151.78 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.64 114.97 4.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' E' ' 1' ' ' VAL . 90.8 mt -123.2 124.66 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.0 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.65 145.67 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.584 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.77 27.15 16.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.628 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.18 85.1 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -69.99 153.42 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.58 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' D' ' 16' ' ' LEU . 54.3 tp -145.46 124.74 12.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.591 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.5 162.0 72.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.87 3.27 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 112.013 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.1 Cg_endo -70.95 146.56 53.14 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.126 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.596 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.421 ' HA ' HD13 ' A' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.05 131.6 50.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.46 128.4 49.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.543 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.73 -59.39 1.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.72 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.8 -177.39 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.675 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 8' ' ' VAL . 95.9 p -84.55 173.99 10.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 59.49 42.96 16.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 8' ' ' VAL . 58.2 t -128.2 134.3 65.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.521 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -143.96 140.22 29.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.568 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 1' ' ' VAL . 88.0 mt -127.57 122.11 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.599 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.89 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.29 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.73 25.65 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.56 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.94 7.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.614 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -70.25 153.13 43.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.519 HD23 HD13 ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.509 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -114.35 123.59 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.39 161.59 74.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 57.1 Cg_endo -79.84 111.65 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.767 2.312 . . . . 0.0 112.01 -175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 18' ' ' ALA . 31.3 Cg_exo -60.69 142.3 97.41 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.909 2.406 . . . . 0.0 112.015 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.616 179.711 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' B' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -126.96 131.56 51.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.45 128.34 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.66 -59.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.84 -177.44 5.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' B' ' 8' ' ' VAL . 97.0 p -84.55 174.1 10.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.7 mt-10 59.37 43.05 17.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.624 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.433 HG13 ' O ' ' C' ' 8' ' ' VAL . 57.7 t -128.2 134.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.541 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.0 140.17 29.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.571 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' B' ' 1' ' ' VAL . 88.3 mt -127.57 122.04 58.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.577 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.48 132.87 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.14 147.21 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 110.63 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.87 25.53 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.552 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.1 85.94 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.652 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.1 m -70.18 153.08 43.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.587 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' A' ' 16' ' ' LEU . 53.9 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.461 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -114.32 123.56 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.358 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.59 74.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 57.2 Cg_endo -79.82 111.58 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.836 2.358 . . . . 0.0 112.007 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' B' ' 18' ' ' ALA . 31.3 Cg_exo -60.66 142.32 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.665 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' C' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -127.02 131.66 50.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.609 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -123.46 128.36 49.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.605 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.67 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.679 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.86 -177.39 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 6' ' ' SER . . . . . 0.401 ' O ' HG23 ' C' ' 8' ' ' VAL . 96.4 p -84.55 174.01 10.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.604 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 7' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.8 mt-10 59.39 43.03 17.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.65 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' B' ' 8' ' ' VAL . 57.8 t -128.18 134.26 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.567 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.9 140.2 29.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.598 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' C' ' 1' ' ' VAL . 88.0 mt -127.55 122.11 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.92 2.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.24 32.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.83 25.56 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.552 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.15 85.99 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.634 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.21 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.52 12.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.471 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 69.5 t -114.3 123.51 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.371 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.59 74.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 57.3 Cg_endo -79.75 111.64 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 18' ' ' ALA . 31.3 Cg_exo -60.74 142.33 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.834 2.356 . . . . 0.0 112.06 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.552 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.589 179.731 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' D' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -126.95 131.63 51.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -123.51 128.29 49.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -103.62 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.82 -177.4 5.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.683 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' SER . . . . . 0.403 ' O ' HG23 ' D' ' 8' ' ' VAL . 96.4 p -84.57 174.06 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.599 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 7' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 59.43 42.97 17.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.625 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' C' ' 8' ' ' VAL . 57.2 t -128.11 134.2 65.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.629 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.91 140.19 29.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.605 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' D' ' 1' ' ' VAL . 88.0 mt -127.58 122.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.623 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.56 132.9 2.08 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.26 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.78 25.61 15.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.96 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.624 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.23 153.07 43.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' LEU . . . . . 0.518 HD13 HD23 ' C' ' 16' ' ' LEU . 54.2 tp -145.19 124.49 13.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.522 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -114.35 123.62 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.342 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.41 161.65 73.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 57.2 Cg_endo -79.83 111.57 2.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.807 2.338 . . . . 0.0 111.969 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' D' ' 18' ' ' ALA . 31.2 Cg_exo -60.66 142.28 97.4 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.623 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 1' ' ' VAL . . . . . 0.418 ' HA ' HD13 ' E' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -127.02 131.55 50.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.63 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -123.45 128.35 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.616 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.64 -59.36 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.758 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.85 -177.38 5.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.648 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' E' ' 8' ' ' VAL . 96.5 p -84.56 174.03 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.595 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 7' ' ' GLU . . . . . 0.408 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.7 mt-10 59.39 43.08 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.611 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' D' ' 8' ' ' VAL . 58.2 t -128.21 134.25 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.592 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.92 140.17 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.655 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' E' ' 1' ' ' VAL . 87.9 mt -127.49 122.05 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.52 132.93 2.09 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.22 32.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 110.684 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.82 25.61 15.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.579 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -85.24 85.95 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.57 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.2 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.548 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 16' ' ' LEU . . . . . 0.518 HD13 HD23 ' D' ' 16' ' ' LEU . 54.2 tp -145.28 124.41 12.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.1 t -114.32 123.59 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.344 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 18' ' ' ALA . . . . . 0.526 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.35 161.65 74.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.416 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 19' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 57.2 Cg_endo -79.9 111.61 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.763 2.309 . . . . 0.0 111.976 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' E' ' 18' ' ' ALA . 31.2 Cg_exo -60.69 142.31 97.44 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.609 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.462 HG13 HG21 ' A' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.21 131.93 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.405 ' OD1' HG11 ' A' ' 8' ' ' VAL . 78.7 m-20 -126.19 129.55 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.7 -58.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.643 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.12 3.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.734 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.94 176.65 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.0 47.67 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG11 ' OD1' ' A' ' 3' ' ' ASN . 62.1 t -128.44 136.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.566 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.94 128.32 30.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.462 HG21 HG13 ' A' ' 1' ' ' VAL . 93.8 mt -125.03 121.11 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.33 1.12 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.98 146.32 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.841 0.353 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.56 27.05 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.549 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.26 80.51 8.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.618 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.01 114.65 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.11 53.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.573 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.68 124.93 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -73.71 162.34 74.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.404 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -78.59 111.76 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.806 2.337 . . . . 0.0 111.895 -175.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.8 Cg_endo -71.33 147.8 53.75 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.742 2.295 . . . . 0.0 112.105 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.6 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' VAL . . . . . 0.46 HG13 HG21 ' B' ' 10' ' ' ILE . 22.6 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.404 ' OD1' HG11 ' B' ' 8' ' ' VAL . 78.6 m-20 -126.19 129.49 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.66 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.682 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.75 -173.19 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.752 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.92 176.67 6.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.08 47.63 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.524 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.404 HG11 ' OD1' ' B' ' 3' ' ' ASN . 61.2 t -128.42 136.02 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.561 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.46 HG21 HG13 ' B' ' 1' ' ' VAL . 93.6 mt -124.93 121.09 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 177.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.5 127.29 1.12 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.9 146.29 33.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.572 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.54 27.07 16.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.592 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.35 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.4 m -67.06 114.74 6.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.17 53.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.551 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.79 124.93 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.562 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -73.69 162.41 74.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.5 Cg_endo -78.63 111.76 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.871 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.7 Cg_endo -71.37 147.79 53.46 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.802 2.335 . . . . 0.0 112.068 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.582 179.93 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.463 HG13 HG21 ' C' ' 10' ' ' ILE . 22.2 t . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.23 131.93 50.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.585 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 3' ' ' ASN . . . . . 0.406 ' OD1' HG11 ' C' ' 8' ' ' VAL . 78.5 m-20 -126.17 129.49 49.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.548 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.69 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.605 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.24 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.753 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p -90.82 176.63 6.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.02 47.68 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' VAL . . . . . 0.406 HG11 ' OD1' ' C' ' 3' ' ' ASN . 62.0 t -128.48 136.05 60.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.97 128.23 30.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.536 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.463 HG21 HG13 ' C' ' 1' ' ' VAL . 93.9 mt -125.06 121.18 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.547 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.56 127.24 1.11 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.79 146.24 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 61.55 27.07 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.613 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.33 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.618 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.04 114.65 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.621 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.25 127.1 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -109.82 124.94 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -73.69 162.36 74.52 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.447 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.5 Cg_endo -78.57 111.71 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.798 2.332 . . . . 0.0 111.957 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.7 Cg_endo -71.29 147.74 53.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.772 2.315 . . . . 0.0 112.105 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.652 179.867 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 1' ' ' VAL . . . . . 0.462 HG13 HG21 ' D' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.405 ' OD1' HG11 ' D' ' 8' ' ' VAL . 78.7 m-20 -126.19 129.51 49.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.68 -58.67 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.679 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.85 -173.2 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.87 176.68 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.543 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.02 47.71 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.566 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 8' ' ' VAL . . . . . 0.405 HG11 ' OD1' ' D' ' 3' ' ' ASN . 61.9 t -128.5 135.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.543 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -135.92 128.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.566 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 10' ' ' ILE . . . . . 0.462 HG21 HG13 ' D' ' 1' ' ' VAL . 94.0 mt -125.01 121.23 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.518 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.57 127.22 1.11 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.83 146.31 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.53 27.12 16.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.57 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.42 80.52 8.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.554 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -67.0 114.68 5.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.598 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.14 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -109.71 124.91 66.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -73.75 162.4 74.32 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.5 Cg_endo -78.59 111.79 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.828 2.352 . . . . 0.0 111.933 -175.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.6 Cg_endo -71.43 147.79 53.14 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.759 2.306 . . . . 0.0 112.029 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.644 179.888 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 1' ' ' VAL . . . . . 0.461 HG13 HG21 ' E' ' 10' ' ' ILE . 22.4 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -127.26 131.87 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.617 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.406 ' OD1' HG11 ' E' ' 8' ' ' VAL . 78.7 m-20 -126.17 129.49 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.523 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.63 -58.64 1.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.8 -173.19 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 92.1 p -90.92 176.7 6.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.543 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.05 47.63 11.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.524 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.406 HG11 ' OD1' ' E' ' 3' ' ' ASN . 61.7 t -128.44 136.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.517 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.487 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.461 HG21 HG13 ' E' ' 1' ' ' VAL . 93.6 mt -124.95 121.11 60.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.25 1.11 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.81 146.31 33.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.574 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.51 27.07 16.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.592 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.37 80.6 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.58 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 73.5 m -67.07 114.75 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.548 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.18 53.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.485 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.74 124.93 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.423 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -73.58 162.33 74.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -78.63 111.82 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.843 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.6 Cg_endo -71.42 147.71 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.049 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.618 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 1' ' ' VAL . 10.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.631 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -125.69 151.37 46.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.621 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.53 -56.74 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.704 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.81 -175.96 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 8' ' ' VAL . 93.6 p -88.49 174.12 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.562 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 58.99 45.5 14.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 6' ' ' SER . 46.5 t -130.9 140.04 49.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.569 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -149.01 138.75 21.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.635 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.19 124.26 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 136.5 2.89 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.56 31.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.623 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.95 25.34 15.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.548 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.21 85.42 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.628 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.05 153.14 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.514 HD23 HD13 ' B' ' 16' ' ' LEU . 54.9 tp -144.87 124.62 13.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.542 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.23 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.338 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.36 161.8 73.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.441 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.2 Cg_endo -77.88 111.97 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.71 2.273 . . . . 0.0 112.0 -176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.8 Cg_endo -72.1 147.07 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.874 2.383 . . . . 0.0 112.1 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.566 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 10.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' B' ' 10' ' ' ILE . 10.9 m120 -125.72 151.33 46.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.527 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.51 -56.75 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.97 4.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.633 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.452 ' O ' HG23 ' B' ' 8' ' ' VAL . 93.4 p -88.47 174.17 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.618 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 6' ' ' SER . 46.5 t -130.97 139.97 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.02 138.8 21.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' B' ' 3' ' ' ASN . 98.4 mt -127.2 124.21 63.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.41 2.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.54 31.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 61.98 25.37 15.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.548 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.2 85.35 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.609 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -69.96 153.1 43.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.581 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.516 HD23 HD13 ' C' ' 16' ' ' LEU . 54.4 tp -144.9 124.7 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.483 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.81 124.14 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.32 161.75 73.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.441 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.78 112.01 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.04 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.8 Cg_endo -72.13 147.11 47.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.874 2.383 . . . . 0.0 112.022 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.576 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' B' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -142.89 162.27 35.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.57 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' C' ' 10' ' ' ILE . 10.9 m120 -125.76 151.33 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.527 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.52 -56.73 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.727 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.72 -175.95 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.632 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' C' ' 8' ' ' VAL . 93.5 p -88.53 174.11 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.91 45.56 14.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.639 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' C' ' 6' ' ' SER . 46.5 t -130.9 140.02 49.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.09 138.75 21.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' C' ' 3' ' ' ASN . 98.5 mt -127.17 124.23 63.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.97 136.41 2.86 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.91 147.54 31.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.598 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.92 25.44 15.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.497 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.26 85.37 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.602 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.98 153.06 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.594 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.516 HD13 HD23 ' B' ' 16' ' ' LEU . 54.5 tp -144.84 124.71 13.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.453 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.9 t -113.82 124.19 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.35 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.37 161.72 73.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.402 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.4 Cg_endo -77.78 111.97 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.791 2.328 . . . . 0.0 111.972 -176.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.1 47.53 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.057 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.572 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 1' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' E' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.82 162.24 35.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.609 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' D' ' 10' ' ' ILE . 10.8 m120 -125.76 151.32 46.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.537 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.5 -56.75 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.95 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' D' ' 8' ' ' VAL . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.608 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.617 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' D' ' 6' ' ' SER . 46.4 t -130.88 140.04 49.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.572 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.07 138.76 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.603 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' D' ' 3' ' ' ASN . 98.5 mt -127.17 124.24 63.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.65 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.95 136.44 2.87 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.98 147.55 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.0 110.599 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.529 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.17 85.3 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.658 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.94 153.11 43.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' LEU . . . . . 0.515 HD13 HD23 ' C' ' 16' ' ' LEU . 54.6 tp -144.91 124.67 13.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.83 124.22 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.72 73.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 112.02 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.005 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -72.14 147.09 47.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.863 2.375 . . . . 0.0 111.993 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.561 179.877 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 1' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' D' ' 1' ' ' VAL . 10.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.82 162.27 35.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.653 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.409 HD21 ' CD1' ' E' ' 10' ' ' ILE . 10.9 m120 -125.74 151.28 46.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.51 -56.7 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.7 -175.96 4.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.624 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' E' ' 8' ' ' VAL . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.92 45.62 14.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' E' ' 6' ' ' SER . 46.7 t -130.95 140.04 49.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.516 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.1 138.84 21.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.409 ' CD1' HD21 ' E' ' 3' ' ' ASN . 98.4 mt -127.2 124.3 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.0 136.45 2.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.94 147.52 31.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.529 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.14 85.35 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.02 153.17 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 16' ' ' LEU . . . . . 0.514 HD13 HD23 ' D' ' 16' ' ' LEU . 54.7 tp -144.92 124.63 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.525 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.85 124.21 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.303 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.33 161.72 73.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.4 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -77.76 111.96 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.785 2.323 . . . . 0.0 112.035 -176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.9 Cg_endo -72.13 147.16 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.04 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.586 179.88 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.75 122.12 32.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.652 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.546 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' B' ' 4' ' ' ASN . 63.1 t30 -104.86 -59.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.707 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.75 -171.42 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.66 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.79 171.86 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.87 45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.577 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.662 HG12 HG22 ' B' ' 8' ' ' VAL . 32.5 m -135.95 155.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.585 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.49 19.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.23 125.86 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.617 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.48 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.26 147.25 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.663 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.89 26.12 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.54 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.31 84.79 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.29 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.56 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.516 HD23 HD13 ' B' ' 16' ' ' LEU . 55.0 tp -144.92 124.65 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.466 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.78 124.28 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.353 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.43 161.79 73.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.443 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.07 112.02 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.787 2.325 . . . . 0.0 111.99 -176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.4 Cg_endo -70.92 147.66 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.832 2.355 . . . . 0.0 112.107 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.65 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.77 122.16 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.557 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.546 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 4' ' ' ASN . 63.1 t30 -104.84 -59.68 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.78 -171.39 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.601 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.78 171.83 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.588 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.83 45.43 12.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.663 HG12 HG22 ' C' ' 8' ' ' VAL . 32.5 m -135.91 155.89 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -156.21 144.45 19.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.609 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.25 125.88 57.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.36 147.29 31.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.629 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.88 26.15 15.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.528 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.71 7.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.569 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.68 153.31 43.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.516 HD13 HD23 ' A' ' 16' ' ' LEU . 54.8 tp -144.92 124.68 13.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.32 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.83 73.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.429 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 55.8 Cg_endo -77.09 112.08 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.747 2.298 . . . . 0.0 111.99 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.615 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -127.74 122.13 32.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.569 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 4' ' ' ASN . 63.1 t30 -104.93 -59.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.668 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.82 -171.42 3.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.77 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.89 45.4 12.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.605 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' VAL . . . . . 0.663 HG22 HG12 ' B' ' 8' ' ' VAL . 32.6 m -135.89 155.92 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.607 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.18 144.57 19.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.545 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 92.6 mt -131.32 125.79 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.41 136.51 2.68 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.25 147.25 31.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.322 . . . . 0.0 110.663 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.86 26.1 15.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.568 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -86.23 84.78 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.72 153.32 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.514 HD13 HD23 ' B' ' 16' ' ' LEU . 54.8 tp -144.96 124.67 13.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.436 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.6 t -113.79 124.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.369 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.42 161.85 73.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.415 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.09 112.03 3.33 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.843 2.362 . . . . 0.0 111.984 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -71.04 147.75 55.34 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.316 . . . . 0.0 112.095 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.62 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.79 122.17 32.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.635 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.58 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' C' ' 4' ' ' ASN . 63.1 t30 -104.86 -59.61 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.708 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.79 -171.39 3.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.583 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.83 171.83 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.589 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.82 45.41 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.652 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' VAL . . . . . 0.662 HG22 HG12 ' C' ' 8' ' ' VAL . 32.5 m -135.87 155.82 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.641 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.55 20.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.621 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.32 125.9 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.556 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.33 147.28 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.323 . . . . 0.0 110.609 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 61.84 26.18 15.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.81 7.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.32 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.584 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' LEU . . . . . 0.515 HD23 HD13 ' E' ' 16' ' ' LEU . 54.7 tp -144.97 124.66 13.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.426 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.78 124.29 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.299 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.51 161.86 72.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.446 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 55.9 Cg_endo -77.02 111.99 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.791 2.327 . . . . 0.0 112.007 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.3 Cg_endo -70.97 147.74 55.71 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.787 2.325 . . . . 0.0 112.039 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.563 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.8 122.16 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.589 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.02 56.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.554 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' D' ' 4' ' ' ASN . 63.1 t30 -104.89 -59.64 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.682 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.73 -171.39 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.668 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 80.3 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.57 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.92 45.43 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.591 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.662 HG22 HG12 ' D' ' 8' ' ' VAL . 32.6 m -135.96 155.86 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.21 144.54 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -131.25 125.84 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.588 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.39 136.49 2.67 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.34 147.24 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.94 26.07 15.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -86.23 84.8 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.77 153.28 43.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 16' ' ' LEU . . . . . 0.515 HD13 HD23 ' D' ' 16' ' ' LEU . 54.8 tp -144.89 124.61 13.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.453 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.76 124.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.334 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.46 161.83 73.15 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.429 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 55.8 Cg_endo -77.03 112.03 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.0 111.991 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 20' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.598 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' A' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.15 161.42 38.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' A' ' 8' ' ' VAL . 61.6 m-80 -131.94 155.18 48.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.5 3.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.62 -171.34 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.568 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.6 p -95.06 -178.68 4.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.639 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.11 55.39 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.667 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.838 HG12 HG22 ' B' ' 8' ' ' VAL . 13.7 m -130.13 153.94 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.682 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.19 130.63 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.653 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' A' ' 1' ' ' VAL . 98.0 mt -132.68 124.48 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.15 131.77 1.6 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.61 145.7 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.33 28.48 17.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.526 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.1 83.29 7.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.4 m -70.09 114.12 7.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.566 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.85 127.39 53.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.56 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.73 125.38 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.384 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -74.41 161.85 76.29 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.8 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.968 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.4 Cg_endo -72.0 147.31 48.86 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.798 2.332 . . . . 0.0 112.059 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.677 179.814 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' VAL . . . . . 0.536 HG13 HG21 ' B' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.16 161.43 38.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' B' ' 8' ' ' VAL . 61.7 m-80 -131.94 155.22 48.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.614 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.09 -50.59 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -171.35 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.623 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.01 -178.64 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.37 6.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.656 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.838 HG22 HG12 ' A' ' 8' ' ' VAL . 13.7 m -130.11 153.91 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -155.17 130.69 9.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.601 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.536 HG21 HG13 ' B' ' 1' ' ' VAL . 98.0 mt -132.78 124.48 50.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.559 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.79 1.61 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.58 145.7 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.47 17.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.56 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.11 83.37 7.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.608 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.12 114.06 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.603 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.83 127.4 53.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.77 125.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -74.39 161.85 76.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.403 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 111.8 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.3 Cg_endo -72.03 147.28 48.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.85 2.366 . . . . 0.0 112.032 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.588 179.873 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' C' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -143.1 161.42 38.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.593 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' C' ' 8' ' ' VAL . 61.6 m-80 -131.93 155.18 48.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.52 3.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.36 3.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.629 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.03 -178.62 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.683 -176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.41 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' VAL . . . . . 0.841 HG12 HG22 ' D' ' 8' ' ' VAL . 14.1 m -130.21 153.91 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.57 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.16 130.75 9.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.595 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' C' ' 1' ' ' VAL . 98.0 mt -132.78 124.43 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.587 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.85 1.62 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.64 145.76 34.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.24 28.52 18.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.39 7.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.626 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.25 114.12 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.49 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.86 127.37 53.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.513 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -109.71 125.35 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.379 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' ALA . . . . . 0.556 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -74.3 161.86 76.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.375 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 19' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.1 Cg_endo -77.97 111.88 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.741 2.294 . . . . 0.0 111.975 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.4 Cg_endo -72.12 147.31 48.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.866 2.377 . . . . 0.0 111.98 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.595 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' D' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.12 161.37 38.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' D' ' 8' ' ' VAL . 61.8 m-80 -131.95 155.19 48.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.04 -50.6 3.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.49 -171.33 3.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -95.12 -178.63 4.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.63 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 57.04 55.46 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.646 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' VAL . . . . . 0.841 HG22 HG12 ' C' ' 8' ' ' VAL . 13.9 m -130.15 153.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.2 130.68 9.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' D' ' 1' ' ' VAL . 98.0 mt -132.72 124.41 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.604 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.11 131.75 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.54 145.8 34.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.22 28.5 18.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.602 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.33 7.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.18 114.18 8.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.525 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.92 127.33 53.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.51 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.7 125.4 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.35 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -74.35 161.8 76.59 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.434 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.82 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.944 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 20' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -71.97 147.24 48.93 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.861 2.374 . . . . 0.0 112.109 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.598 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' E' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.17 161.42 38.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' E' ' 8' ' ' VAL . 61.9 m-80 -131.95 155.22 48.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.534 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.1 -50.52 3.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.645 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.34 3.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.556 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 84.2 p -95.14 -178.63 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.569 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.07 55.43 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.838 HG22 HG12 ' D' ' 8' ' ' VAL . 14.0 m -130.13 154.0 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.63 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.23 130.66 9.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.573 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' E' ' 1' ' ' VAL . 98.0 mt -132.74 124.49 50.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.14 131.71 1.59 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.5 145.74 34.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.664 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.46 17.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.542 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.16 83.4 7.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.18 114.13 8.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.9 127.43 53.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.7 125.29 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.361 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -74.43 161.87 76.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.5 Cg_endo -77.8 111.82 3.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.755 2.303 . . . . 0.0 112.029 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.5 Cg_endo -72.06 147.28 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.782 2.322 . . . . 0.0 112.076 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.683 179.83 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.778 ' H2 ' HD13 ' A' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.96 117.78 11.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.417 ' OD1' HG11 ' A' ' 8' ' ' VAL . 81.0 m-20 -125.86 130.98 52.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.58 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.69 -56.15 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.691 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.77 4.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.3 p -91.57 176.15 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.7 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.59 48.94 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.716 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.417 HG11 ' OD1' ' A' ' 3' ' ' ASN . 46.5 t -130.54 140.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.43 127.8 24.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.613 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.778 HD13 ' H2 ' ' A' ' 1' ' ' VAL . 88.9 mt -127.89 129.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.94 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.576 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.98 83.99 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.601 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.4 m -69.7 153.66 43.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.588 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.524 HD23 HD13 ' B' ' 16' ' ' LEU . 55.4 tp -145.21 124.67 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.479 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.03 124.39 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.45 161.92 72.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.406 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.92 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.979 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.3 Cg_endo -70.86 146.38 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.902 2.402 . . . . 0.0 112.069 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' VAL . . . . . 0.778 ' H2 ' HD13 ' B' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -139.99 117.79 11.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.622 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' B' ' 8' ' ' VAL . 81.0 m-20 -125.88 131.02 52.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.72 -56.14 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.689 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.68 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.67 176.18 6.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.638 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.61 48.94 11.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' B' ' 3' ' ' ASN . 46.6 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.47 127.74 24.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.64 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.778 HD13 ' H2 ' ' B' ' 1' ' ' VAL . 88.8 mt -127.79 129.92 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.09 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.41 145.06 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.95 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.576 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.92 83.98 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 70.1 m -69.69 153.59 43.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.524 HD13 HD23 ' A' ' 16' ' ' LEU . 55.4 tp -145.22 124.65 13.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.98 124.36 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.339 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 162.0 72.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.17 111.9 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.824 2.349 . . . . 0.0 112.016 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 179.654 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.777 ' H2 ' HD13 ' C' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.93 117.77 11.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 3' ' ' ASN . . . . . 0.417 ' OD1' HG11 ' C' ' 8' ' ' VAL . 81.0 m-20 -125.86 131.01 52.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.65 -56.22 2.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.693 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.72 4.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.69 176.19 6.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.596 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.62 48.95 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 8' ' ' VAL . . . . . 0.417 HG11 ' OD1' ' C' ' 3' ' ' ASN . 46.5 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.591 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.777 HD13 ' H2 ' ' C' ' 1' ' ' VAL . 88.9 mt -127.87 129.91 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.08 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 62.0 27.89 16.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.574 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.9 84.02 6.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.611 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -69.62 153.6 43.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.658 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.524 HD13 HD23 ' B' ' 16' ' ' LEU . 55.3 tp -145.28 124.72 13.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.9 t -113.98 124.34 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.92 72.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.951 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -70.89 146.38 53.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.872 2.381 . . . . 0.0 112.069 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 1' ' ' VAL . . . . . 0.777 ' H2 ' HD13 ' D' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.95 117.74 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.645 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' D' ' 8' ' ' VAL . 80.9 m-20 -125.83 130.99 52.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.613 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.69 -56.24 2.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.686 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.67 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.682 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.69 176.25 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.6 48.93 11.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.669 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' D' ' 3' ' ' ASN . 46.5 t -130.59 140.43 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.48 127.72 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.647 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' ILE . . . . . 0.777 HD13 ' H2 ' ' D' ' 1' ' ' VAL . 88.6 mt -127.85 129.97 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.566 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.48 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.36 145.03 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.669 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.96 16.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.575 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.89 83.98 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 70.0 m -69.75 153.63 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.564 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' LEU . . . . . 0.526 HD23 HD13 ' E' ' 16' ' ' LEU . 55.4 tp -145.23 124.73 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.94 124.35 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.356 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.43 161.92 72.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.15 111.94 3.31 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.766 2.311 . . . . 0.0 112.021 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 20' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 1' ' ' VAL . . . . . 0.711 ' H2 ' HD13 ' E' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.92 117.73 11.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.659 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' E' ' 8' ' ' VAL . 81.0 m-20 -125.82 131.01 52.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.575 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.67 -56.12 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.7 4.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.73 176.26 6.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.57 48.91 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.681 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' E' ' 3' ' ' ASN . 46.6 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.711 HD13 ' H2 ' ' E' ' 1' ' ' VAL . 88.8 mt -127.89 129.93 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.15 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.43 145.01 35.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.65 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.98 16.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.575 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -89.0 84.04 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -69.67 153.62 43.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 16' ' ' LEU . . . . . 0.526 HD13 HD23 ' D' ' 16' ' ' LEU . 55.3 tp -145.25 124.7 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.9 t -113.91 124.37 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.318 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.45 161.87 73.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.406 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 55.9 Cg_endo -77.2 112.0 3.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.806 2.337 . . . . 0.0 111.951 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.2 Cg_endo -70.96 146.4 52.69 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.828 2.352 . . . . 0.0 112.048 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.584 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.484 HG13 HG21 ' A' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.74 127.9 19.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.65 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.29 128.95 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' B' ' 4' ' ' ASN . 61.3 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.91 47.37 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.593 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.94 137.68 56.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.657 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.613 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG21 HG13 ' A' ' 1' ' ' VAL . 93.1 mt -125.21 126.53 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.591 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.3 1.38 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -77.66 144.52 37.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 61.96 27.75 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.78 85.74 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.28 153.09 43.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.555 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.533 HD23 HD13 ' B' ' 16' ' ' LEU . 55.6 tp -144.83 124.7 13.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.84 124.26 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.49 161.85 73.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.426 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.8 Cg_endo -77.28 112.02 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.985 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.2 Cg_endo -71.05 146.54 52.51 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.885 2.39 . . . . 0.0 112.031 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.62 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.48 HG13 HG21 ' B' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -141.83 127.89 19.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.627 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.3 128.91 50.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.618 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' C' ' 4' ' ' ASN . 61.1 t30 -104.71 -57.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.766 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.95 -177.08 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.625 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 96.8 p -87.04 174.97 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.599 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.95 47.32 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.653 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.93 137.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.58 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.61 127.58 27.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.48 HG21 HG13 ' B' ' 1' ' ' VAL . 92.8 mt -125.24 126.49 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.645 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.29 1.37 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.67 144.5 37.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.644 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.96 27.7 16.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.69 85.69 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.646 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.21 153.05 43.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.567 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' A' ' 16' ' ' LEU . 55.9 tp -144.83 124.68 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.89 124.22 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.365 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.41 161.85 73.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.426 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.23 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.876 2.384 . . . . 0.0 111.945 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.3 Cg_endo -71.02 146.63 52.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.834 2.356 . . . . 0.0 112.059 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.547 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.481 HG13 HG21 ' C' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.76 127.91 19.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.32 128.94 50.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.592 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' B' ' 4' ' ' ASN . 61.2 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.1 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.633 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.99 47.32 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.602 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.92 137.66 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.613 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.481 HG21 HG13 ' C' ' 1' ' ' VAL . 92.9 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.619 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.62 131.3 1.37 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.62 144.53 37.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.773 0.321 . . . . 0.0 110.672 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.94 27.72 16.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.526 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.79 85.78 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.592 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.7 m -70.26 153.12 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' B' ' 16' ' ' LEU . 55.7 tp -144.94 124.65 13.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.79 124.2 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.38 161.83 73.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.478 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.0 Cg_endo -77.31 111.99 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.955 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -70.96 146.51 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.581 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.481 HG13 HG21 ' D' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.81 127.91 19.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.595 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.33 128.97 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' C' ' 4' ' ' ASN . 61.2 t30 -104.74 -57.66 2.0 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.645 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p -86.99 174.92 8.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.64 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.96 47.29 12.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.626 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 137.76 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.603 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.64 127.64 27.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' ILE . . . . . 0.481 HG21 HG13 ' D' ' 1' ' ' VAL . 92.6 mt -125.24 126.5 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.34 1.38 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.78 144.58 37.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.621 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.97 27.71 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.72 85.74 7.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.1 m -70.25 153.07 43.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' LEU . . . . . 0.534 HD23 HD13 ' E' ' 16' ' ' LEU . 55.9 tp -144.87 124.69 13.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.88 124.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.338 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.44 161.85 73.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.426 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.1 Cg_endo -77.25 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.806 2.338 . . . . 0.0 111.95 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.4 Cg_endo -70.96 146.61 53.21 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.385 . . . . 0.0 112.081 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.57 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' VAL . . . . . 0.482 HG13 HG21 ' E' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.8 127.93 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.613 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -123.39 129.02 50.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' D' ' 4' ' ' ASN . 61.2 t30 -104.8 -57.56 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.03 -177.07 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.62 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -87.01 174.89 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.606 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.98 47.34 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.64 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.91 137.64 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.59 27.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.565 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.482 HG21 HG13 ' E' ' 1' ' ' VAL . 93.1 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.619 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.61 131.27 1.37 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.64 144.5 37.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.95 27.74 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.75 85.81 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.23 153.09 43.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' D' ' 16' ' ' LEU . 55.7 tp -144.94 124.69 13.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.17 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.44 161.87 73.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.42 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 19' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.24 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.771 2.314 . . . . 0.0 112.034 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.4 Cg_endo -70.95 146.53 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.063 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.536 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' A' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' B' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.519 HD23 HD13 ' B' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 10' ' ' ILE . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' A' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' B' ' 10' ' ' ILE . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' C' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' A' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' B' ' 10' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' B' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' C' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' D' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' B' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' C' ' 10' ' ' ILE . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' C' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' D' ' 10' ' ' ILE . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' E' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' C' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' D' ' 10' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' D' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 7' ' ' GLU . . . . . 0.42 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' E' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.743 ' HB ' HD12 ' D' ' 10' ' ' ILE . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' D' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 18' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.522 HG13 HG21 ' A' ' 10' ' ' ILE . 25.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.46 136.45 49.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.65 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.485 ' CB ' HG21 ' A' ' 8' ' ' VAL . 78.9 m-20 -131.96 131.08 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.588 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.07 -55.49 2.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.42 -171.51 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.2 p -91.61 179.37 5.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 58.2 58.81 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.66 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.759 HG12 HG22 ' B' ' 8' ' ' VAL . 16.5 m -127.44 150.93 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.54 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.76 116.44 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.633 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 1' ' ' VAL . 91.3 mt -125.07 125.08 68.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.61 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.57 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.86 0.362 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.71 16.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.95 84.59 7.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.573 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.76 153.56 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.533 HD23 HD13 ' B' ' 16' ' ' LEU . 54.3 tp -145.38 124.61 12.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.458 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.39 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.353 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.48 161.94 72.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.358 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.24 111.96 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 111.989 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.9 Cg_endo -71.45 148.26 53.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.386 . . . . 0.0 112.054 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.55 179.9 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.521 HG13 HG21 ' B' ' 10' ' ' ILE . 25.8 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -129.49 136.49 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.597 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.486 ' CB ' HG21 ' B' ' 8' ' ' VAL . 79.1 m-20 -132.05 131.06 42.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.545 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.705 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.35 -171.5 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.654 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 91.7 p -91.67 179.44 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.607 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.8 mt-10 58.19 58.72 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.759 HG22 HG12 ' A' ' 8' ' ' VAL . 16.5 m -127.34 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.594 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.75 116.5 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.6 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.521 HG21 HG13 ' B' ' 1' ' ' VAL . 91.7 mt -125.14 125.14 68.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.539 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.96 131.58 1.52 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.51 145.54 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.615 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.74 16.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.534 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.62 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.653 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.57 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' A' ' 16' ' ' LEU . 54.6 tp -145.35 124.59 12.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.508 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.82 124.33 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.435 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.48 161.97 72.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.399 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.95 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 112.01 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.9 Cg_endo -71.48 148.25 53.79 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.91 2.407 . . . . 0.0 112.1 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.555 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.519 HG13 HG21 ' C' ' 10' ' ' ILE . 26.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.486 ' CB ' HG21 ' C' ' 8' ' ' VAL . 78.9 m-20 -131.99 131.12 42.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.592 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -102.16 -55.41 2.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.692 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.3 -171.41 3.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.674 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 91.8 p -91.72 179.38 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.643 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.9 mt-10 58.22 58.82 3.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.597 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 8' ' ' VAL . . . . . 0.759 HG12 HG22 ' D' ' 8' ' ' VAL . 16.5 m -127.38 151.01 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.595 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.82 116.4 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.661 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.519 HG21 HG13 ' C' ' 1' ' ' VAL . 90.9 mt -125.02 125.06 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.693 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.56 34.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.1 26.64 16.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.494 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.68 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.5 43.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.585 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' B' ' 16' ' ' LEU . 54.4 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 70.4 t -113.85 124.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.366 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.47 162.02 72.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.432 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.28 111.99 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 111.989 -176.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.7 Cg_endo -71.54 148.27 53.47 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.835 2.356 . . . . 0.0 112.018 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.654 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.52 HG13 HG21 ' D' ' 10' ' ' ILE . 26.0 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -129.55 136.5 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.485 ' CB ' HG21 ' D' ' 8' ' ' VAL . 78.9 m-20 -132.01 131.02 42.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.44 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.712 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -171.52 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.654 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.3 p -91.59 179.33 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.693 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 58.25 58.72 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.692 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' VAL . . . . . 0.759 HG22 HG12 ' C' ' 8' ' ' VAL . 16.5 m -127.37 150.96 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.571 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.77 116.46 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' ILE . . . . . 0.52 HG21 HG13 ' D' ' 1' ' ' VAL . 91.2 mt -125.03 125.07 68.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.56 1.51 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 26.75 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.556 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.97 84.59 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.7 153.53 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' LEU . . . . . 0.532 HD13 HD23 ' C' ' 16' ' ' LEU . 54.2 tp -145.34 124.64 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.48 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.35 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.38 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.49 162.06 72.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.28 111.94 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 112.017 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.0 Cg_endo -71.49 148.29 53.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.843 2.362 . . . . 0.0 112.089 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.576 180.0 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 1' ' ' VAL . . . . . 0.52 HG13 HG21 ' E' ' 10' ' ' ILE . 25.7 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.484 ' CB ' HG21 ' E' ' 8' ' ' VAL . 79.0 m-20 -132.0 131.06 42.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.551 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.705 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.33 -171.47 3.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.648 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 91.5 p -91.71 179.4 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.9 mt-10 58.3 58.67 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.758 HG22 HG12 ' D' ' 8' ' ' VAL . 16.5 m -127.31 150.96 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.78 116.45 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.52 HG21 HG13 ' E' ' 1' ' ' VAL . 91.7 mt -125.08 125.13 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.619 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.5 34.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.611 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.12 26.66 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.507 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.99 84.68 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.57 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.72 153.5 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.575 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.532 HD13 HD23 ' D' ' 16' ' ' LEU . 54.5 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.89 124.35 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 18' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.4 162.06 72.41 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.432 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 19' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.33 112.01 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.786 2.324 . . . . 0.0 112.017 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.8 Cg_endo -71.59 148.32 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.869 2.379 . . . . 0.0 111.992 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.638 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 10' ' ' ILE . 44.8 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.1 129.66 21.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.543 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' A' ' 8' ' ' VAL . 81.2 m-20 -128.39 129.57 46.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.606 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.84 -170.92 3.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.6 p -91.02 178.62 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 62.3 mt-10 57.62 58.23 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.592 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.772 HG12 HG22 ' B' ' 8' ' ' VAL . 18.0 m -127.53 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.612 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.468 HG21 HG13 ' A' ' 1' ' ' VAL . 90.8 mt -123.18 124.68 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.78 145.75 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 110.544 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.69 27.25 16.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.631 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -87.21 85.16 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.678 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.07 153.45 43.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.581 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.535 HD23 HD13 ' B' ' 16' ' ' LEU . 54.3 tp -145.45 124.71 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.59 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.6 t -113.83 124.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.53 161.98 72.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.1 Cg_endo -77.3 111.94 3.28 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.78 2.32 . . . . 0.0 111.96 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.1 Cg_endo -71.0 146.59 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.067 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.592 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' B' ' 10' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -142.05 129.62 21.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.589 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.574 ' HB3' HG21 ' B' ' 8' ' ' VAL . 81.0 m-20 -128.36 129.49 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.653 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.673 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -171.0 3.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 93.7 p -90.91 178.61 5.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 62.2 mt-10 57.6 58.28 3.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.773 HG12 HG22 ' C' ' 8' ' ' VAL . 18.0 m -127.56 151.73 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.478 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' B' ' 1' ' ' VAL . 91.0 mt -123.18 124.69 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.7 27.25 16.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.23 85.18 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.04 153.42 43.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.535 HD13 HD23 ' A' ' 16' ' ' LEU . 54.3 tp -145.48 124.72 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.22 111.88 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.004 -176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.1 Cg_endo -70.94 146.59 53.28 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.817 2.345 . . . . 0.0 112.097 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.556 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' C' ' 10' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.07 129.71 21.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' C' ' 8' ' ' VAL . 81.1 m-20 -128.4 129.53 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.624 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.18 -55.27 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.682 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.622 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 93.5 p -90.98 178.61 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.545 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' B' ' 7' ' ' GLU . 62.2 mt-10 57.61 58.28 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.58 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' VAL . . . . . 0.773 HG22 HG12 ' B' ' 8' ' ' VAL . 17.9 m -127.49 151.69 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.545 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.58 114.95 4.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' C' ' 1' ' ' VAL . 90.9 mt -123.16 124.67 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.514 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.77 27.16 16.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.651 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.24 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.9 m -70.07 153.43 43.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.535 HD13 HD23 ' B' ' 16' ' ' LEU . 54.4 tp -145.48 124.68 12.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.17 111.87 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.33 . . . . 0.0 112.048 -176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.0 Cg_endo -70.98 146.59 53.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.097 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.568 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.469 HG13 HG21 ' D' ' 10' ' ' ILE . 44.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.1 129.71 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.524 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' D' ' 8' ' ' VAL . 81.1 m-20 -128.34 129.64 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.18 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.82 -170.9 3.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 93.9 p -90.99 178.61 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 62.2 mt-10 57.58 58.27 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.642 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 8' ' ' VAL . . . . . 0.773 HG22 HG12 ' C' ' 8' ' ' VAL . 18.0 m -127.54 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.57 114.97 4.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.536 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' ILE . . . . . 0.469 HG21 HG13 ' D' ' 1' ' ' VAL . 90.8 mt -123.16 124.62 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.8 145.75 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.513 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.81 27.12 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.648 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.22 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.566 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.08 153.41 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' C' ' 16' ' ' LEU . 54.4 tp -145.43 124.74 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.591 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.27 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.54 161.99 72.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.409 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.21 111.87 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.783 2.322 . . . . 0.0 112.048 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 56.9 Cg_endo -71.02 146.62 52.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.773 2.316 . . . . 0.0 112.046 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.568 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' E' ' 10' ' ' ILE . 44.7 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.06 129.68 21.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.568 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.574 ' HB3' HG21 ' E' ' 8' ' ' VAL . 81.0 m-20 -128.4 129.59 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.568 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.16 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.91 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.622 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p -90.92 178.59 5.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.632 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 62.1 mt-10 57.58 58.23 3.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.772 HG22 HG12 ' D' ' 8' ' ' VAL . 18.0 m -127.47 151.78 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.64 114.97 4.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' E' ' 1' ' ' VAL . 90.8 mt -123.2 124.66 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.0 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.65 145.67 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.584 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.77 27.15 16.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.628 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.18 85.1 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -69.99 153.42 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.58 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' D' ' 16' ' ' LEU . 54.3 tp -145.46 124.74 12.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.591 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.5 162.0 72.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.87 3.27 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 112.013 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.1 Cg_endo -70.95 146.56 53.14 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.126 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.596 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' HA ' HD13 ' A' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.05 131.6 50.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.46 128.4 49.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.543 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.73 -59.39 1.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.72 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.8 -177.39 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.675 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 8' ' ' VAL . 95.9 p -84.55 173.99 10.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 59.49 42.96 16.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 8' ' ' VAL . 58.2 t -128.2 134.3 65.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.521 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -143.96 140.22 29.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.568 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 1' ' ' VAL . 88.0 mt -127.57 122.11 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.599 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.89 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.29 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.73 25.65 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.56 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.94 7.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.614 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -70.25 153.13 43.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.519 HD23 HD13 ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.509 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -114.35 123.59 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.39 161.59 74.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 57.1 Cg_endo -79.84 111.65 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.767 2.312 . . . . 0.0 112.01 -175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 18' ' ' ALA . 31.3 Cg_exo -60.69 142.3 97.41 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.909 2.406 . . . . 0.0 112.015 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.616 179.711 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' B' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -126.96 131.56 51.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.45 128.34 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.66 -59.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.84 -177.44 5.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' B' ' 8' ' ' VAL . 97.0 p -84.55 174.1 10.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.7 mt-10 59.37 43.05 17.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.624 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.433 HG13 ' O ' ' C' ' 8' ' ' VAL . 57.7 t -128.2 134.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.541 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.0 140.17 29.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.571 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' B' ' 1' ' ' VAL . 88.3 mt -127.57 122.04 58.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.577 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.48 132.87 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.14 147.21 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 110.63 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.87 25.53 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.552 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.1 85.94 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.652 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.1 m -70.18 153.08 43.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.587 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' A' ' 16' ' ' LEU . 53.9 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.461 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -114.32 123.56 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.358 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.59 74.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 57.2 Cg_endo -79.82 111.58 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.836 2.358 . . . . 0.0 112.007 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' B' ' 18' ' ' ALA . 31.3 Cg_exo -60.66 142.32 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.665 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' C' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -127.02 131.66 50.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.609 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -123.46 128.36 49.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.605 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.67 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.679 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.86 -177.39 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.401 ' O ' HG23 ' C' ' 8' ' ' VAL . 96.4 p -84.55 174.01 10.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.604 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.8 mt-10 59.39 43.03 17.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.65 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' B' ' 8' ' ' VAL . 57.8 t -128.18 134.26 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.567 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.9 140.2 29.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.598 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' C' ' 1' ' ' VAL . 88.0 mt -127.55 122.11 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.92 2.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.24 32.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.83 25.56 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.552 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.15 85.99 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.634 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.21 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.52 12.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.471 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 69.5 t -114.3 123.51 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.371 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.59 74.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 57.3 Cg_endo -79.75 111.64 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 18' ' ' ALA . 31.3 Cg_exo -60.74 142.33 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.834 2.356 . . . . 0.0 112.06 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.552 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.589 179.731 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' D' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -126.95 131.63 51.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -123.51 128.29 49.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -103.62 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.82 -177.4 5.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.683 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' SER . . . . . 0.403 ' O ' HG23 ' D' ' 8' ' ' VAL . 96.4 p -84.57 174.06 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.599 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 59.43 42.97 17.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.625 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' C' ' 8' ' ' VAL . 57.2 t -128.11 134.2 65.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.629 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.91 140.19 29.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.605 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' D' ' 1' ' ' VAL . 88.0 mt -127.58 122.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.623 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.56 132.9 2.08 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.26 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.78 25.61 15.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.96 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.624 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.23 153.07 43.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' LEU . . . . . 0.518 HD13 HD23 ' C' ' 16' ' ' LEU . 54.2 tp -145.19 124.49 13.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.522 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -114.35 123.62 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.342 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.41 161.65 73.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 57.2 Cg_endo -79.83 111.57 2.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.807 2.338 . . . . 0.0 111.969 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' D' ' 18' ' ' ALA . 31.2 Cg_exo -60.66 142.28 97.4 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.623 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 1' ' ' VAL . . . . . 0.418 ' HA ' HD13 ' E' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -127.02 131.55 50.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.63 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -123.45 128.35 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.616 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.64 -59.36 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.758 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.85 -177.38 5.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.648 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' E' ' 8' ' ' VAL . 96.5 p -84.56 174.03 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.595 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 7' ' ' GLU . . . . . 0.408 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.7 mt-10 59.39 43.08 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.611 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' D' ' 8' ' ' VAL . 58.2 t -128.21 134.25 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.592 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.92 140.17 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.655 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' E' ' 1' ' ' VAL . 87.9 mt -127.49 122.05 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.52 132.93 2.09 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.22 32.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 110.684 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.82 25.61 15.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.579 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -85.24 85.95 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.57 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.2 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.548 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.518 HD13 HD23 ' D' ' 16' ' ' LEU . 54.2 tp -145.28 124.41 12.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.1 t -114.32 123.59 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.344 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 18' ' ' ALA . . . . . 0.526 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.35 161.65 74.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.416 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 19' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 57.2 Cg_endo -79.9 111.61 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.763 2.309 . . . . 0.0 111.976 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' E' ' 18' ' ' ALA . 31.2 Cg_exo -60.69 142.31 97.44 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.609 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.462 HG13 HG21 ' A' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.21 131.93 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.405 ' OD1' HG11 ' A' ' 8' ' ' VAL . 78.7 m-20 -126.19 129.55 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.7 -58.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.643 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.12 3.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.734 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.94 176.65 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.0 47.67 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG11 ' OD1' ' A' ' 3' ' ' ASN . 62.1 t -128.44 136.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.566 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.94 128.32 30.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.462 HG21 HG13 ' A' ' 1' ' ' VAL . 93.8 mt -125.03 121.11 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.33 1.12 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.98 146.32 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.841 0.353 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.56 27.05 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.549 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.26 80.51 8.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.618 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.01 114.65 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.11 53.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.573 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.68 124.93 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -73.71 162.34 74.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.404 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -78.59 111.76 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.806 2.337 . . . . 0.0 111.895 -175.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.8 Cg_endo -71.33 147.8 53.75 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.742 2.295 . . . . 0.0 112.105 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.6 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.46 HG13 HG21 ' B' ' 10' ' ' ILE . 22.6 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.404 ' OD1' HG11 ' B' ' 8' ' ' VAL . 78.6 m-20 -126.19 129.49 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.66 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.682 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.75 -173.19 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.752 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.92 176.67 6.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.08 47.63 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.524 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.404 HG11 ' OD1' ' B' ' 3' ' ' ASN . 61.2 t -128.42 136.02 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.561 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.46 HG21 HG13 ' B' ' 1' ' ' VAL . 93.6 mt -124.93 121.09 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 177.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.5 127.29 1.12 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.9 146.29 33.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.572 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.54 27.07 16.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.592 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.35 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.4 m -67.06 114.74 6.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.17 53.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.551 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.79 124.93 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.562 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -73.69 162.41 74.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.5 Cg_endo -78.63 111.76 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.871 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.7 Cg_endo -71.37 147.79 53.46 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.802 2.335 . . . . 0.0 112.068 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.582 179.93 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.463 HG13 HG21 ' C' ' 10' ' ' ILE . 22.2 t . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.23 131.93 50.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.585 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.406 ' OD1' HG11 ' C' ' 8' ' ' VAL . 78.5 m-20 -126.17 129.49 49.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.548 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.69 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.605 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.24 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.753 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p -90.82 176.63 6.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.02 47.68 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' VAL . . . . . 0.406 HG11 ' OD1' ' C' ' 3' ' ' ASN . 62.0 t -128.48 136.05 60.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.97 128.23 30.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.536 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.463 HG21 HG13 ' C' ' 1' ' ' VAL . 93.9 mt -125.06 121.18 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.547 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.56 127.24 1.11 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.79 146.24 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 61.55 27.07 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.613 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.33 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.618 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.04 114.65 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.621 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.25 127.1 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -109.82 124.94 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -73.69 162.36 74.52 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.447 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.5 Cg_endo -78.57 111.71 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.798 2.332 . . . . 0.0 111.957 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.7 Cg_endo -71.29 147.74 53.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.772 2.315 . . . . 0.0 112.105 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.652 179.867 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.462 HG13 HG21 ' D' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.405 ' OD1' HG11 ' D' ' 8' ' ' VAL . 78.7 m-20 -126.19 129.51 49.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.68 -58.67 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.679 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.85 -173.2 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.87 176.68 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.543 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.02 47.71 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.566 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' VAL . . . . . 0.405 HG11 ' OD1' ' D' ' 3' ' ' ASN . 61.9 t -128.5 135.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.543 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -135.92 128.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.566 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' ILE . . . . . 0.462 HG21 HG13 ' D' ' 1' ' ' VAL . 94.0 mt -125.01 121.23 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.518 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.57 127.22 1.11 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.83 146.31 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.53 27.12 16.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.57 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.42 80.52 8.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.554 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -67.0 114.68 5.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.598 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.14 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -109.71 124.91 66.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -73.75 162.4 74.32 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.5 Cg_endo -78.59 111.79 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.828 2.352 . . . . 0.0 111.933 -175.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.6 Cg_endo -71.43 147.79 53.14 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.759 2.306 . . . . 0.0 112.029 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.644 179.888 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 1' ' ' VAL . . . . . 0.461 HG13 HG21 ' E' ' 10' ' ' ILE . 22.4 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -127.26 131.87 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.617 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.406 ' OD1' HG11 ' E' ' 8' ' ' VAL . 78.7 m-20 -126.17 129.49 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.523 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.63 -58.64 1.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.8 -173.19 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 92.1 p -90.92 176.7 6.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.543 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.05 47.63 11.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.524 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.406 HG11 ' OD1' ' E' ' 3' ' ' ASN . 61.7 t -128.44 136.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.517 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.487 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.461 HG21 HG13 ' E' ' 1' ' ' VAL . 93.6 mt -124.95 121.11 60.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.25 1.11 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.81 146.31 33.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.574 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.51 27.07 16.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.592 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.37 80.6 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.58 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 73.5 m -67.07 114.75 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.548 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.18 53.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.485 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.74 124.93 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.423 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -73.58 162.33 74.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -78.63 111.82 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.843 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.6 Cg_endo -71.42 147.71 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.049 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.618 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 1' ' ' VAL . 10.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.631 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -125.69 151.37 46.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.621 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.53 -56.74 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.704 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.81 -175.96 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 8' ' ' VAL . 93.6 p -88.49 174.12 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.562 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 58.99 45.5 14.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 6' ' ' SER . 46.5 t -130.9 140.04 49.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.569 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -149.01 138.75 21.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.635 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.19 124.26 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 136.5 2.89 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.56 31.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.623 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.95 25.34 15.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.548 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.21 85.42 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.628 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.05 153.14 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.514 HD23 HD13 ' B' ' 16' ' ' LEU . 54.9 tp -144.87 124.62 13.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.542 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.23 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.338 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.36 161.8 73.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.441 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.2 Cg_endo -77.88 111.97 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.71 2.273 . . . . 0.0 112.0 -176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.8 Cg_endo -72.1 147.07 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.874 2.383 . . . . 0.0 112.1 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.566 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 10.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' B' ' 10' ' ' ILE . 10.9 m120 -125.72 151.33 46.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.527 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.51 -56.75 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.97 4.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.633 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.452 ' O ' HG23 ' B' ' 8' ' ' VAL . 93.4 p -88.47 174.17 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.618 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 6' ' ' SER . 46.5 t -130.97 139.97 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.02 138.8 21.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' B' ' 3' ' ' ASN . 98.4 mt -127.2 124.21 63.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.41 2.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.54 31.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 61.98 25.37 15.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.548 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.2 85.35 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.609 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -69.96 153.1 43.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.581 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.516 HD23 HD13 ' C' ' 16' ' ' LEU . 54.4 tp -144.9 124.7 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.483 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.81 124.14 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.32 161.75 73.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.441 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.78 112.01 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.04 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.8 Cg_endo -72.13 147.11 47.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.874 2.383 . . . . 0.0 112.022 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.576 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' B' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -142.89 162.27 35.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.57 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' C' ' 10' ' ' ILE . 10.9 m120 -125.76 151.33 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.527 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.52 -56.73 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.727 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.72 -175.95 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.632 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' C' ' 8' ' ' VAL . 93.5 p -88.53 174.11 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.91 45.56 14.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.639 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' C' ' 6' ' ' SER . 46.5 t -130.9 140.02 49.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.09 138.75 21.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' C' ' 3' ' ' ASN . 98.5 mt -127.17 124.23 63.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.97 136.41 2.86 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.91 147.54 31.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.598 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.92 25.44 15.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.497 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.26 85.37 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.602 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.98 153.06 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.594 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.516 HD13 HD23 ' B' ' 16' ' ' LEU . 54.5 tp -144.84 124.71 13.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.453 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.9 t -113.82 124.19 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.35 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.37 161.72 73.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.402 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.4 Cg_endo -77.78 111.97 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.791 2.328 . . . . 0.0 111.972 -176.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.1 47.53 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.057 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.572 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' E' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.82 162.24 35.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.609 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' D' ' 10' ' ' ILE . 10.8 m120 -125.76 151.32 46.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.537 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.5 -56.75 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.95 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' D' ' 8' ' ' VAL . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.608 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.617 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' D' ' 6' ' ' SER . 46.4 t -130.88 140.04 49.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.572 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.07 138.76 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.603 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' D' ' 3' ' ' ASN . 98.5 mt -127.17 124.24 63.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.65 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.95 136.44 2.87 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.98 147.55 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.0 110.599 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.529 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.17 85.3 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.658 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.94 153.11 43.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' LEU . . . . . 0.515 HD13 HD23 ' C' ' 16' ' ' LEU . 54.6 tp -144.91 124.67 13.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.83 124.22 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.72 73.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 112.02 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.005 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -72.14 147.09 47.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.863 2.375 . . . . 0.0 111.993 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.561 179.877 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 1' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' D' ' 1' ' ' VAL . 10.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.82 162.27 35.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.653 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.409 HD21 ' CD1' ' E' ' 10' ' ' ILE . 10.9 m120 -125.74 151.28 46.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.51 -56.7 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.7 -175.96 4.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.624 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' E' ' 8' ' ' VAL . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.92 45.62 14.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' E' ' 6' ' ' SER . 46.7 t -130.95 140.04 49.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.516 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.1 138.84 21.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.409 ' CD1' HD21 ' E' ' 3' ' ' ASN . 98.4 mt -127.2 124.3 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.0 136.45 2.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.94 147.52 31.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.529 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.14 85.35 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.02 153.17 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.514 HD13 HD23 ' D' ' 16' ' ' LEU . 54.7 tp -144.92 124.63 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.525 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.85 124.21 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.303 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.33 161.72 73.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.4 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -77.76 111.96 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.785 2.323 . . . . 0.0 112.035 -176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.9 Cg_endo -72.13 147.16 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.04 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.586 179.88 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.75 122.12 32.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.652 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.546 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' B' ' 4' ' ' ASN . 63.1 t30 -104.86 -59.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.707 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.75 -171.42 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.66 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.79 171.86 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.87 45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.577 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.662 HG12 HG22 ' B' ' 8' ' ' VAL . 32.5 m -135.95 155.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.585 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.49 19.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.23 125.86 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.617 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.48 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.26 147.25 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.663 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.89 26.12 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.54 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.31 84.79 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.29 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.56 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.516 HD23 HD13 ' B' ' 16' ' ' LEU . 55.0 tp -144.92 124.65 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.466 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.78 124.28 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.353 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.43 161.79 73.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.443 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.07 112.02 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.787 2.325 . . . . 0.0 111.99 -176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.4 Cg_endo -70.92 147.66 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.832 2.355 . . . . 0.0 112.107 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.65 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.77 122.16 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.557 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.546 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 4' ' ' ASN . 63.1 t30 -104.84 -59.68 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.78 -171.39 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.601 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.78 171.83 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.588 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.83 45.43 12.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.663 HG12 HG22 ' C' ' 8' ' ' VAL . 32.5 m -135.91 155.89 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -156.21 144.45 19.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.609 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.25 125.88 57.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.36 147.29 31.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.629 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.88 26.15 15.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.528 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.71 7.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.569 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.68 153.31 43.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.516 HD13 HD23 ' A' ' 16' ' ' LEU . 54.8 tp -144.92 124.68 13.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.32 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.83 73.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.429 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 55.8 Cg_endo -77.09 112.08 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.747 2.298 . . . . 0.0 111.99 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.615 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -127.74 122.13 32.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.569 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 4' ' ' ASN . 63.1 t30 -104.93 -59.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.668 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.82 -171.42 3.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.77 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.89 45.4 12.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.605 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' VAL . . . . . 0.663 HG22 HG12 ' B' ' 8' ' ' VAL . 32.6 m -135.89 155.92 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.607 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.18 144.57 19.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.545 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 92.6 mt -131.32 125.79 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.41 136.51 2.68 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.25 147.25 31.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.322 . . . . 0.0 110.663 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.86 26.1 15.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.568 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -86.23 84.78 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.72 153.32 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.514 HD13 HD23 ' B' ' 16' ' ' LEU . 54.8 tp -144.96 124.67 13.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.436 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.6 t -113.79 124.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.369 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.42 161.85 73.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.415 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.09 112.03 3.33 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.843 2.362 . . . . 0.0 111.984 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -71.04 147.75 55.34 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.316 . . . . 0.0 112.095 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.62 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.79 122.17 32.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.635 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.58 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' C' ' 4' ' ' ASN . 63.1 t30 -104.86 -59.61 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.708 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.79 -171.39 3.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.583 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.83 171.83 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.589 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.82 45.41 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.652 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' VAL . . . . . 0.662 HG22 HG12 ' C' ' 8' ' ' VAL . 32.5 m -135.87 155.82 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.641 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.55 20.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.621 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.32 125.9 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.556 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.33 147.28 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.323 . . . . 0.0 110.609 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 61.84 26.18 15.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.81 7.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.32 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.584 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' LEU . . . . . 0.515 HD23 HD13 ' E' ' 16' ' ' LEU . 54.7 tp -144.97 124.66 13.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.426 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.78 124.29 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.299 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.51 161.86 72.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.446 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 55.9 Cg_endo -77.02 111.99 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.791 2.327 . . . . 0.0 112.007 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.3 Cg_endo -70.97 147.74 55.71 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.787 2.325 . . . . 0.0 112.039 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.563 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.8 122.16 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.589 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.02 56.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.554 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' D' ' 4' ' ' ASN . 63.1 t30 -104.89 -59.64 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.682 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.73 -171.39 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.668 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 80.3 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.57 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.92 45.43 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.591 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.662 HG22 HG12 ' D' ' 8' ' ' VAL . 32.6 m -135.96 155.86 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.21 144.54 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -131.25 125.84 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.588 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.39 136.49 2.67 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.34 147.24 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.94 26.07 15.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -86.23 84.8 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.77 153.28 43.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.515 HD13 HD23 ' D' ' 16' ' ' LEU . 54.8 tp -144.89 124.61 13.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.453 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.76 124.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.334 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.46 161.83 73.15 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.429 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 55.8 Cg_endo -77.03 112.03 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.0 111.991 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 20' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.598 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' A' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.15 161.42 38.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' A' ' 8' ' ' VAL . 61.6 m-80 -131.94 155.18 48.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.5 3.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.62 -171.34 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.568 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.6 p -95.06 -178.68 4.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.639 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.11 55.39 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.667 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.838 HG12 HG22 ' B' ' 8' ' ' VAL . 13.7 m -130.13 153.94 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.682 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.19 130.63 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.653 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' A' ' 1' ' ' VAL . 98.0 mt -132.68 124.48 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.15 131.77 1.6 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.61 145.7 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.33 28.48 17.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.526 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.1 83.29 7.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.4 m -70.09 114.12 7.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.566 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.85 127.39 53.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.56 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.73 125.38 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.384 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -74.41 161.85 76.29 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.8 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.968 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.4 Cg_endo -72.0 147.31 48.86 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.798 2.332 . . . . 0.0 112.059 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.677 179.814 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.536 HG13 HG21 ' B' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.16 161.43 38.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' B' ' 8' ' ' VAL . 61.7 m-80 -131.94 155.22 48.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.614 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.09 -50.59 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -171.35 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.623 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.01 -178.64 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.37 6.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.656 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.838 HG22 HG12 ' A' ' 8' ' ' VAL . 13.7 m -130.11 153.91 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -155.17 130.69 9.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.601 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.536 HG21 HG13 ' B' ' 1' ' ' VAL . 98.0 mt -132.78 124.48 50.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.559 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.79 1.61 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.58 145.7 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.47 17.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.56 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.11 83.37 7.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.608 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.12 114.06 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.603 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.83 127.4 53.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.77 125.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -74.39 161.85 76.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.403 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 111.8 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.3 Cg_endo -72.03 147.28 48.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.85 2.366 . . . . 0.0 112.032 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.588 179.873 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' C' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -143.1 161.42 38.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.593 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' C' ' 8' ' ' VAL . 61.6 m-80 -131.93 155.18 48.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.52 3.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.36 3.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.629 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.03 -178.62 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.683 -176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.41 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' VAL . . . . . 0.841 HG12 HG22 ' D' ' 8' ' ' VAL . 14.1 m -130.21 153.91 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.57 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.16 130.75 9.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.595 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' C' ' 1' ' ' VAL . 98.0 mt -132.78 124.43 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.587 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.85 1.62 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.64 145.76 34.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.24 28.52 18.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.39 7.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.626 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.25 114.12 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.49 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.86 127.37 53.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.513 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -109.71 125.35 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.379 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' ALA . . . . . 0.556 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -74.3 161.86 76.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.375 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 19' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.1 Cg_endo -77.97 111.88 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.741 2.294 . . . . 0.0 111.975 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.4 Cg_endo -72.12 147.31 48.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.866 2.377 . . . . 0.0 111.98 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.595 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' D' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.12 161.37 38.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' D' ' 8' ' ' VAL . 61.8 m-80 -131.95 155.19 48.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.04 -50.6 3.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.49 -171.33 3.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -95.12 -178.63 4.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.63 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 57.04 55.46 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.646 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' VAL . . . . . 0.841 HG22 HG12 ' C' ' 8' ' ' VAL . 13.9 m -130.15 153.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.2 130.68 9.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' D' ' 1' ' ' VAL . 98.0 mt -132.72 124.41 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.604 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.11 131.75 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.54 145.8 34.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.22 28.5 18.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.602 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.33 7.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.18 114.18 8.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.525 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.92 127.33 53.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.51 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.7 125.4 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.35 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -74.35 161.8 76.59 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.434 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.82 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.944 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 20' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -71.97 147.24 48.93 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.861 2.374 . . . . 0.0 112.109 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.598 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' E' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.17 161.42 38.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' E' ' 8' ' ' VAL . 61.9 m-80 -131.95 155.22 48.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.534 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.1 -50.52 3.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.645 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.34 3.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.556 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 84.2 p -95.14 -178.63 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.569 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.07 55.43 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.838 HG22 HG12 ' D' ' 8' ' ' VAL . 14.0 m -130.13 154.0 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.63 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.23 130.66 9.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.573 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' E' ' 1' ' ' VAL . 98.0 mt -132.74 124.49 50.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.14 131.71 1.59 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.5 145.74 34.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.664 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.46 17.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.542 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.16 83.4 7.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.18 114.13 8.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.9 127.43 53.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.7 125.29 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.361 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -74.43 161.87 76.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.5 Cg_endo -77.8 111.82 3.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.755 2.303 . . . . 0.0 112.029 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.5 Cg_endo -72.06 147.28 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.782 2.322 . . . . 0.0 112.076 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.683 179.83 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.778 ' H2 ' HD13 ' A' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.96 117.78 11.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.417 ' OD1' HG11 ' A' ' 8' ' ' VAL . 81.0 m-20 -125.86 130.98 52.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.58 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.69 -56.15 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.691 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.77 4.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.3 p -91.57 176.15 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.7 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.59 48.94 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.716 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.417 HG11 ' OD1' ' A' ' 3' ' ' ASN . 46.5 t -130.54 140.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.43 127.8 24.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.613 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.778 HD13 ' H2 ' ' A' ' 1' ' ' VAL . 88.9 mt -127.89 129.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.94 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.576 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.98 83.99 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.601 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.4 m -69.7 153.66 43.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.588 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.524 HD23 HD13 ' B' ' 16' ' ' LEU . 55.4 tp -145.21 124.67 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.479 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.03 124.39 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.45 161.92 72.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.406 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.92 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.979 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.3 Cg_endo -70.86 146.38 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.902 2.402 . . . . 0.0 112.069 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.778 ' H2 ' HD13 ' B' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -139.99 117.79 11.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.622 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' B' ' 8' ' ' VAL . 81.0 m-20 -125.88 131.02 52.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.72 -56.14 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.689 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.68 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.67 176.18 6.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.638 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.61 48.94 11.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' B' ' 3' ' ' ASN . 46.6 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.47 127.74 24.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.64 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.778 HD13 ' H2 ' ' B' ' 1' ' ' VAL . 88.8 mt -127.79 129.92 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.09 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.41 145.06 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.95 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.576 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.92 83.98 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 70.1 m -69.69 153.59 43.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.524 HD13 HD23 ' A' ' 16' ' ' LEU . 55.4 tp -145.22 124.65 13.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.98 124.36 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.339 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 162.0 72.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.17 111.9 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.824 2.349 . . . . 0.0 112.016 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 179.654 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.777 ' H2 ' HD13 ' C' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.93 117.77 11.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.417 ' OD1' HG11 ' C' ' 8' ' ' VAL . 81.0 m-20 -125.86 131.01 52.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.65 -56.22 2.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.693 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.72 4.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.69 176.19 6.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.596 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.62 48.95 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' VAL . . . . . 0.417 HG11 ' OD1' ' C' ' 3' ' ' ASN . 46.5 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.591 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.777 HD13 ' H2 ' ' C' ' 1' ' ' VAL . 88.9 mt -127.87 129.91 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.08 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 62.0 27.89 16.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.574 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.9 84.02 6.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.611 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -69.62 153.6 43.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.658 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.524 HD13 HD23 ' B' ' 16' ' ' LEU . 55.3 tp -145.28 124.72 13.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.9 t -113.98 124.34 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.92 72.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.951 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -70.89 146.38 53.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.872 2.381 . . . . 0.0 112.069 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.777 ' H2 ' HD13 ' D' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.95 117.74 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.645 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' D' ' 8' ' ' VAL . 80.9 m-20 -125.83 130.99 52.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.613 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.69 -56.24 2.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.686 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.67 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.682 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.69 176.25 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.6 48.93 11.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.669 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' D' ' 3' ' ' ASN . 46.5 t -130.59 140.43 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.48 127.72 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.647 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' ILE . . . . . 0.777 HD13 ' H2 ' ' D' ' 1' ' ' VAL . 88.6 mt -127.85 129.97 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.566 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.48 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.36 145.03 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.669 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.96 16.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.575 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.89 83.98 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 70.0 m -69.75 153.63 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.564 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' LEU . . . . . 0.526 HD23 HD13 ' E' ' 16' ' ' LEU . 55.4 tp -145.23 124.73 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.94 124.35 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.356 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.43 161.92 72.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.15 111.94 3.31 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.766 2.311 . . . . 0.0 112.021 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 20' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 1' ' ' VAL . . . . . 0.711 ' H2 ' HD13 ' E' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.92 117.73 11.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.659 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' E' ' 8' ' ' VAL . 81.0 m-20 -125.82 131.01 52.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.575 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.67 -56.12 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.7 4.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.73 176.26 6.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.57 48.91 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.681 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' E' ' 3' ' ' ASN . 46.6 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.711 HD13 ' H2 ' ' E' ' 1' ' ' VAL . 88.8 mt -127.89 129.93 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.15 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.43 145.01 35.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.65 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.98 16.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.575 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -89.0 84.04 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -69.67 153.62 43.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.526 HD13 HD23 ' D' ' 16' ' ' LEU . 55.3 tp -145.25 124.7 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.9 t -113.91 124.37 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.318 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.45 161.87 73.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.406 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 55.9 Cg_endo -77.2 112.0 3.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.806 2.337 . . . . 0.0 111.951 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.2 Cg_endo -70.96 146.4 52.69 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.828 2.352 . . . . 0.0 112.048 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.584 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.484 HG13 HG21 ' A' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.74 127.9 19.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.65 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.29 128.95 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' B' ' 4' ' ' ASN . 61.3 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.91 47.37 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.593 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.94 137.68 56.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.657 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.613 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG21 HG13 ' A' ' 1' ' ' VAL . 93.1 mt -125.21 126.53 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.591 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.3 1.38 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -77.66 144.52 37.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 61.96 27.75 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.78 85.74 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.28 153.09 43.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.555 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.533 HD23 HD13 ' B' ' 16' ' ' LEU . 55.6 tp -144.83 124.7 13.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.84 124.26 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.49 161.85 73.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.426 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.8 Cg_endo -77.28 112.02 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.985 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.2 Cg_endo -71.05 146.54 52.51 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.885 2.39 . . . . 0.0 112.031 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.62 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' VAL . . . . . 0.48 HG13 HG21 ' B' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -141.83 127.89 19.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.627 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.3 128.91 50.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.618 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' C' ' 4' ' ' ASN . 61.1 t30 -104.71 -57.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.766 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.95 -177.08 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.625 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 96.8 p -87.04 174.97 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.599 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.95 47.32 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.653 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.93 137.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.58 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.61 127.58 27.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.48 HG21 HG13 ' B' ' 1' ' ' VAL . 92.8 mt -125.24 126.49 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.645 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.29 1.37 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.67 144.5 37.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.644 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.96 27.7 16.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.69 85.69 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.646 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.21 153.05 43.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.567 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' A' ' 16' ' ' LEU . 55.9 tp -144.83 124.68 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.89 124.22 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.365 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.41 161.85 73.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.426 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.23 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.876 2.384 . . . . 0.0 111.945 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.3 Cg_endo -71.02 146.63 52.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.834 2.356 . . . . 0.0 112.059 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.547 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.481 HG13 HG21 ' C' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.76 127.91 19.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.32 128.94 50.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.592 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' B' ' 4' ' ' ASN . 61.2 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.1 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.633 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.99 47.32 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.602 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.92 137.66 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.613 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.481 HG21 HG13 ' C' ' 1' ' ' VAL . 92.9 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.619 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.62 131.3 1.37 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.62 144.53 37.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.773 0.321 . . . . 0.0 110.672 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.94 27.72 16.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.526 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.79 85.78 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.592 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.7 m -70.26 153.12 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' B' ' 16' ' ' LEU . 55.7 tp -144.94 124.65 13.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.79 124.2 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.38 161.83 73.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.478 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.0 Cg_endo -77.31 111.99 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.955 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -70.96 146.51 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.581 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 1' ' ' VAL . . . . . 0.481 HG13 HG21 ' D' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.81 127.91 19.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.595 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.33 128.97 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' E' ' 4' ' ' ASN . 61.2 t30 -104.74 -57.66 2.0 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.645 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p -86.99 174.92 8.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.64 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.96 47.29 12.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.626 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 137.76 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.603 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.64 127.64 27.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' ILE . . . . . 0.481 HG21 HG13 ' D' ' 1' ' ' VAL . 92.6 mt -125.24 126.5 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.34 1.38 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.78 144.58 37.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.621 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.97 27.71 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.72 85.74 7.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.1 m -70.25 153.07 43.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' LEU . . . . . 0.534 HD23 HD13 ' E' ' 16' ' ' LEU . 55.9 tp -144.87 124.69 13.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.88 124.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.338 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.44 161.85 73.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.426 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.1 Cg_endo -77.25 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.806 2.338 . . . . 0.0 111.95 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.4 Cg_endo -70.96 146.61 53.21 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.385 . . . . 0.0 112.081 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.57 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 1' ' ' VAL . . . . . 0.482 HG13 HG21 ' E' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.8 127.93 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.613 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -123.39 129.02 50.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' D' ' 4' ' ' ASN . 61.2 t30 -104.8 -57.56 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.03 -177.07 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.62 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -87.01 174.89 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.606 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.98 47.34 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.64 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.91 137.64 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.59 27.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.565 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.482 HG21 HG13 ' E' ' 1' ' ' VAL . 93.1 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.619 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.61 131.27 1.37 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.64 144.5 37.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.95 27.74 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.75 85.81 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.23 153.09 43.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' D' ' 16' ' ' LEU . 55.7 tp -144.94 124.69 13.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.17 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.44 161.87 73.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.42 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.24 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.771 2.314 . . . . 0.0 112.034 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.4 Cg_endo -70.95 146.53 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.063 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.536 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' A' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' B' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.519 HD23 HD13 ' B' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 10' ' ' ILE . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' A' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' B' ' 10' ' ' ILE . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' C' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' A' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' B' ' 10' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' B' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' C' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' D' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' B' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' C' ' 10' ' ' ILE . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' C' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' D' ' 10' ' ' ILE . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' E' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' C' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' D' ' 10' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' D' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' GLU . . . . . 0.42 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' E' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.743 ' HB ' HD12 ' D' ' 10' ' ' ILE . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' D' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.522 HG13 HG21 ' A' ' 10' ' ' ILE . 25.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.46 136.45 49.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.65 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.485 ' CB ' HG21 ' A' ' 8' ' ' VAL . 78.9 m-20 -131.96 131.08 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.588 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.07 -55.49 2.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.42 -171.51 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.2 p -91.61 179.37 5.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 58.2 58.81 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.66 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.759 HG12 HG22 ' B' ' 8' ' ' VAL . 16.5 m -127.44 150.93 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.54 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.76 116.44 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.633 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 1' ' ' VAL . 91.3 mt -125.07 125.08 68.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.61 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.57 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.86 0.362 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.71 16.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.95 84.59 7.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.573 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.76 153.56 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.533 HD23 HD13 ' B' ' 16' ' ' LEU . 54.3 tp -145.38 124.61 12.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.458 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.39 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.353 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.48 161.94 72.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.358 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.24 111.96 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 111.989 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.9 Cg_endo -71.45 148.26 53.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.386 . . . . 0.0 112.054 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.55 179.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' VAL . . . . . 0.521 HG13 HG21 ' B' ' 10' ' ' ILE . 25.8 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -129.49 136.49 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.597 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.486 ' CB ' HG21 ' B' ' 8' ' ' VAL . 79.1 m-20 -132.05 131.06 42.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.545 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.705 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.35 -171.5 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.654 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 91.7 p -91.67 179.44 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.607 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.8 mt-10 58.19 58.72 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.759 HG22 HG12 ' A' ' 8' ' ' VAL . 16.5 m -127.34 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.594 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.75 116.5 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.6 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.521 HG21 HG13 ' B' ' 1' ' ' VAL . 91.7 mt -125.14 125.14 68.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.539 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.96 131.58 1.52 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.51 145.54 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.615 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.74 16.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.534 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.62 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.653 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.57 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' A' ' 16' ' ' LEU . 54.6 tp -145.35 124.59 12.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.508 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.82 124.33 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.435 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.48 161.97 72.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.399 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.95 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 112.01 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.9 Cg_endo -71.48 148.25 53.79 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.91 2.407 . . . . 0.0 112.1 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.555 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.519 HG13 HG21 ' C' ' 10' ' ' ILE . 26.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' ASN . . . . . 0.486 ' CB ' HG21 ' C' ' 8' ' ' VAL . 78.9 m-20 -131.99 131.12 42.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.592 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -102.16 -55.41 2.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.692 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.3 -171.41 3.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.674 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 91.8 p -91.72 179.38 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.643 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.9 mt-10 58.22 58.82 3.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.597 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' VAL . . . . . 0.759 HG12 HG22 ' D' ' 8' ' ' VAL . 16.5 m -127.38 151.01 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.595 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.82 116.4 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.661 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.519 HG21 HG13 ' C' ' 1' ' ' VAL . 90.9 mt -125.02 125.06 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.693 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.56 34.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.1 26.64 16.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.494 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.68 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.5 43.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.585 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' B' ' 16' ' ' LEU . 54.4 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 70.4 t -113.85 124.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.366 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.47 162.02 72.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.432 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.28 111.99 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 111.989 -176.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.7 Cg_endo -71.54 148.27 53.47 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.835 2.356 . . . . 0.0 112.018 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.654 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 1' ' ' VAL . . . . . 0.52 HG13 HG21 ' D' ' 10' ' ' ILE . 26.0 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -129.55 136.5 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.485 ' CB ' HG21 ' D' ' 8' ' ' VAL . 78.9 m-20 -132.01 131.02 42.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.44 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.712 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -171.52 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.654 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.3 p -91.59 179.33 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.693 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 58.25 58.72 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.692 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' VAL . . . . . 0.759 HG22 HG12 ' C' ' 8' ' ' VAL . 16.5 m -127.37 150.96 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.571 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.77 116.46 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' ILE . . . . . 0.52 HG21 HG13 ' D' ' 1' ' ' VAL . 91.2 mt -125.03 125.07 68.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.56 1.51 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 26.75 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.556 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.97 84.59 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.7 153.53 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' LEU . . . . . 0.532 HD13 HD23 ' C' ' 16' ' ' LEU . 54.2 tp -145.34 124.64 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.48 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.35 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.38 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.49 162.06 72.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.28 111.94 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 112.017 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.0 Cg_endo -71.49 148.29 53.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.843 2.362 . . . . 0.0 112.089 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.576 180.0 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 1' ' ' VAL . . . . . 0.52 HG13 HG21 ' E' ' 10' ' ' ILE . 25.7 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.484 ' CB ' HG21 ' E' ' 8' ' ' VAL . 79.0 m-20 -132.0 131.06 42.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.551 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.705 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.33 -171.47 3.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.648 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 91.5 p -91.71 179.4 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.9 mt-10 58.3 58.67 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.758 HG22 HG12 ' D' ' 8' ' ' VAL . 16.5 m -127.31 150.96 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.78 116.45 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.52 HG21 HG13 ' E' ' 1' ' ' VAL . 91.7 mt -125.08 125.13 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.619 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.5 34.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.611 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.12 26.66 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.507 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.99 84.68 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.57 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.72 153.5 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.575 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . 0.532 HD13 HD23 ' D' ' 16' ' ' LEU . 54.5 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.89 124.35 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.4 162.06 72.41 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.432 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.33 112.01 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.786 2.324 . . . . 0.0 112.017 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.8 Cg_endo -71.59 148.32 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.869 2.379 . . . . 0.0 111.992 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.638 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 10' ' ' ILE . 44.8 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.1 129.66 21.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.543 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' A' ' 8' ' ' VAL . 81.2 m-20 -128.39 129.57 46.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.606 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.84 -170.92 3.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.6 p -91.02 178.62 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 62.3 mt-10 57.62 58.23 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.592 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.772 HG12 HG22 ' B' ' 8' ' ' VAL . 18.0 m -127.53 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.612 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.468 HG21 HG13 ' A' ' 1' ' ' VAL . 90.8 mt -123.18 124.68 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.78 145.75 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 110.544 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.69 27.25 16.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.631 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -87.21 85.16 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.678 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.07 153.45 43.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.581 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.535 HD23 HD13 ' B' ' 16' ' ' LEU . 54.3 tp -145.45 124.71 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.59 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.6 t -113.83 124.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.53 161.98 72.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.1 Cg_endo -77.3 111.94 3.28 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.78 2.32 . . . . 0.0 111.96 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.1 Cg_endo -71.0 146.59 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.067 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.592 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' B' ' 10' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -142.05 129.62 21.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.589 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.574 ' HB3' HG21 ' B' ' 8' ' ' VAL . 81.0 m-20 -128.36 129.49 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.653 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.673 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -171.0 3.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 93.7 p -90.91 178.61 5.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 62.2 mt-10 57.6 58.28 3.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.773 HG12 HG22 ' C' ' 8' ' ' VAL . 18.0 m -127.56 151.73 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.478 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' B' ' 1' ' ' VAL . 91.0 mt -123.18 124.69 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.7 27.25 16.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.23 85.18 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.04 153.42 43.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.535 HD13 HD23 ' A' ' 16' ' ' LEU . 54.3 tp -145.48 124.72 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.22 111.88 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.004 -176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.1 Cg_endo -70.94 146.59 53.28 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.817 2.345 . . . . 0.0 112.097 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.556 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' C' ' 10' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.07 129.71 21.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' C' ' 8' ' ' VAL . 81.1 m-20 -128.4 129.53 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.624 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.18 -55.27 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.682 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.622 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 93.5 p -90.98 178.61 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.545 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' B' ' 7' ' ' GLU . 62.2 mt-10 57.61 58.28 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.58 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' VAL . . . . . 0.773 HG12 HG22 ' D' ' 8' ' ' VAL . 17.9 m -127.49 151.69 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.545 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.58 114.95 4.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' C' ' 1' ' ' VAL . 90.9 mt -123.16 124.67 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.514 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.77 27.16 16.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.651 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.24 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.9 m -70.07 153.43 43.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.535 HD13 HD23 ' B' ' 16' ' ' LEU . 54.4 tp -145.48 124.68 12.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.17 111.87 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.33 . . . . 0.0 112.048 -176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.0 Cg_endo -70.98 146.59 53.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.097 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.568 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 1' ' ' VAL . . . . . 0.469 HG13 HG21 ' D' ' 10' ' ' ILE . 44.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.1 129.71 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.524 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' D' ' 8' ' ' VAL . 81.1 m-20 -128.34 129.64 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.18 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.82 -170.9 3.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 93.9 p -90.99 178.61 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 62.2 mt-10 57.58 58.27 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.642 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' VAL . . . . . 0.773 HG22 HG12 ' C' ' 8' ' ' VAL . 18.0 m -127.54 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.57 114.97 4.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.536 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' ILE . . . . . 0.469 HG21 HG13 ' D' ' 1' ' ' VAL . 90.8 mt -123.16 124.62 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.8 145.75 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.513 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.81 27.12 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.648 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.22 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.566 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.08 153.41 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' C' ' 16' ' ' LEU . 54.4 tp -145.43 124.74 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.591 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.27 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.54 161.99 72.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.409 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.21 111.87 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.783 2.322 . . . . 0.0 112.048 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 56.9 Cg_endo -71.02 146.62 52.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.773 2.316 . . . . 0.0 112.046 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.568 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' E' ' 10' ' ' ILE . 44.7 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.06 129.68 21.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.568 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.574 ' HB3' HG21 ' E' ' 8' ' ' VAL . 81.0 m-20 -128.4 129.59 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.568 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.16 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.91 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.622 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p -90.92 178.59 5.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.632 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 62.1 mt-10 57.58 58.23 3.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.772 HG22 HG12 ' D' ' 8' ' ' VAL . 18.0 m -127.47 151.78 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.64 114.97 4.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' E' ' 1' ' ' VAL . 90.8 mt -123.2 124.66 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.0 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.65 145.67 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.584 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.77 27.15 16.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.628 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.18 85.1 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -69.99 153.42 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.58 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' D' ' 16' ' ' LEU . 54.3 tp -145.46 124.74 12.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.591 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.5 162.0 72.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.87 3.27 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 112.013 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.1 Cg_endo -70.95 146.56 53.14 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.126 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.596 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.421 ' HA ' HD13 ' A' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.05 131.6 50.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.46 128.4 49.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.543 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.73 -59.39 1.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.72 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.8 -177.39 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.675 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 8' ' ' VAL . 95.9 p -84.55 173.99 10.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 59.49 42.96 16.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 8' ' ' VAL . 58.2 t -128.2 134.3 65.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.521 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -143.96 140.22 29.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.568 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 1' ' ' VAL . 88.0 mt -127.57 122.11 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.599 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.89 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.29 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.73 25.65 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.56 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.94 7.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.614 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -70.25 153.13 43.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.519 HD23 HD13 ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.509 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -114.35 123.59 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.39 161.59 74.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 57.1 Cg_endo -79.84 111.65 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.767 2.312 . . . . 0.0 112.01 -175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 18' ' ' ALA . 31.3 Cg_exo -60.69 142.3 97.41 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.909 2.406 . . . . 0.0 112.015 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.616 179.711 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' B' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -126.96 131.56 51.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.45 128.34 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.66 -59.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.84 -177.44 5.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' B' ' 8' ' ' VAL . 97.0 p -84.55 174.1 10.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.7 mt-10 59.37 43.05 17.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.624 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.433 HG13 ' O ' ' C' ' 8' ' ' VAL . 57.7 t -128.2 134.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.541 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.0 140.17 29.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.571 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' B' ' 1' ' ' VAL . 88.3 mt -127.57 122.04 58.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.577 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.48 132.87 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.14 147.21 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 110.63 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.87 25.53 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.552 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.1 85.94 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.652 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.1 m -70.18 153.08 43.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.587 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' A' ' 16' ' ' LEU . 53.9 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.461 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -114.32 123.56 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.358 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.59 74.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 57.2 Cg_endo -79.82 111.58 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.836 2.358 . . . . 0.0 112.007 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' B' ' 18' ' ' ALA . 31.3 Cg_exo -60.66 142.32 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.665 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' C' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -127.02 131.66 50.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.609 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -123.46 128.36 49.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.605 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.67 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.679 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.86 -177.39 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' SER . . . . . 0.401 ' O ' HG23 ' C' ' 8' ' ' VAL . 96.4 p -84.55 174.01 10.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.604 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.8 mt-10 59.39 43.03 17.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.65 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' B' ' 8' ' ' VAL . 57.8 t -128.18 134.26 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.567 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.9 140.2 29.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.598 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' C' ' 1' ' ' VAL . 88.0 mt -127.55 122.11 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.92 2.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.24 32.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.83 25.56 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.552 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.15 85.99 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.634 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.21 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.52 12.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.471 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 69.5 t -114.3 123.51 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.371 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.59 74.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 57.3 Cg_endo -79.75 111.64 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 18' ' ' ALA . 31.3 Cg_exo -60.74 142.33 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.834 2.356 . . . . 0.0 112.06 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.552 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.589 179.731 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' D' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -126.95 131.63 51.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -123.51 128.29 49.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -103.62 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.82 -177.4 5.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.683 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' SER . . . . . 0.403 ' O ' HG23 ' D' ' 8' ' ' VAL . 96.4 p -84.57 174.06 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.599 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 59.43 42.97 17.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.625 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' C' ' 8' ' ' VAL . 57.2 t -128.11 134.2 65.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.629 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.91 140.19 29.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.605 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' D' ' 1' ' ' VAL . 88.0 mt -127.58 122.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.623 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.56 132.9 2.08 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.26 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.78 25.61 15.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.96 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.624 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.23 153.07 43.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' LEU . . . . . 0.518 HD13 HD23 ' C' ' 16' ' ' LEU . 54.2 tp -145.19 124.49 13.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.522 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -114.35 123.62 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.342 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.41 161.65 73.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 57.2 Cg_endo -79.83 111.57 2.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.807 2.338 . . . . 0.0 111.969 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' D' ' 18' ' ' ALA . 31.2 Cg_exo -60.66 142.28 97.4 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.623 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 1' ' ' VAL . . . . . 0.418 ' HA ' HD13 ' E' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -127.02 131.55 50.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.63 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -123.45 128.35 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.616 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.64 -59.36 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.758 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.85 -177.38 5.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.648 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' E' ' 8' ' ' VAL . 96.5 p -84.56 174.03 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.595 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' GLU . . . . . 0.408 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.7 mt-10 59.39 43.08 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.611 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' D' ' 8' ' ' VAL . 58.2 t -128.21 134.25 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.592 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.92 140.17 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.655 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' E' ' 1' ' ' VAL . 87.9 mt -127.49 122.05 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.52 132.93 2.09 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.22 32.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 110.684 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.82 25.61 15.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.579 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -85.24 85.95 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.57 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.2 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.548 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . 0.518 HD13 HD23 ' D' ' 16' ' ' LEU . 54.2 tp -145.28 124.41 12.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.1 t -114.32 123.59 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.344 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' ALA . . . . . 0.526 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.35 161.65 74.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.416 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 57.2 Cg_endo -79.9 111.61 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.763 2.309 . . . . 0.0 111.976 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' E' ' 18' ' ' ALA . 31.2 Cg_exo -60.69 142.31 97.44 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.609 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.462 HG13 HG21 ' A' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.21 131.93 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.405 ' OD1' HG11 ' A' ' 8' ' ' VAL . 78.7 m-20 -126.19 129.55 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.7 -58.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.643 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.12 3.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.734 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.94 176.65 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.0 47.67 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG11 ' OD1' ' A' ' 3' ' ' ASN . 62.1 t -128.44 136.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.566 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.94 128.32 30.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.462 HG21 HG13 ' A' ' 1' ' ' VAL . 93.8 mt -125.03 121.11 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.33 1.12 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.98 146.32 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.841 0.353 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.56 27.05 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.549 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.26 80.51 8.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.618 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.01 114.65 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.11 53.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.573 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.68 124.93 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -73.71 162.34 74.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.404 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -78.59 111.76 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.806 2.337 . . . . 0.0 111.895 -175.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.8 Cg_endo -71.33 147.8 53.75 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.742 2.295 . . . . 0.0 112.105 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.6 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' VAL . . . . . 0.46 HG13 HG21 ' B' ' 10' ' ' ILE . 22.6 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.404 ' OD1' HG11 ' B' ' 8' ' ' VAL . 78.6 m-20 -126.19 129.49 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.66 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.682 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.75 -173.19 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.752 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.92 176.67 6.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.08 47.63 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.524 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.404 HG11 ' OD1' ' B' ' 3' ' ' ASN . 61.2 t -128.42 136.02 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.561 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.46 HG21 HG13 ' B' ' 1' ' ' VAL . 93.6 mt -124.93 121.09 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 177.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.5 127.29 1.12 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.9 146.29 33.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.572 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.54 27.07 16.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.592 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.35 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.4 m -67.06 114.74 6.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.17 53.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.551 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.79 124.93 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.562 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -73.69 162.41 74.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.5 Cg_endo -78.63 111.76 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.871 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.7 Cg_endo -71.37 147.79 53.46 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.802 2.335 . . . . 0.0 112.068 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.582 179.93 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.463 HG13 HG21 ' C' ' 10' ' ' ILE . 22.2 t . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.23 131.93 50.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.585 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' ASN . . . . . 0.406 ' OD1' HG11 ' C' ' 8' ' ' VAL . 78.5 m-20 -126.17 129.49 49.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.548 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.69 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.605 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.24 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.753 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p -90.82 176.63 6.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.02 47.68 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' VAL . . . . . 0.406 HG11 ' OD1' ' C' ' 3' ' ' ASN . 62.0 t -128.48 136.05 60.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.97 128.23 30.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.536 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.463 HG21 HG13 ' C' ' 1' ' ' VAL . 93.9 mt -125.06 121.18 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.547 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.56 127.24 1.11 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.79 146.24 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 61.55 27.07 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.613 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.33 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.618 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.04 114.65 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.621 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.25 127.1 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -109.82 124.94 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -73.69 162.36 74.52 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.447 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.5 Cg_endo -78.57 111.71 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.798 2.332 . . . . 0.0 111.957 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.7 Cg_endo -71.29 147.74 53.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.772 2.315 . . . . 0.0 112.105 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.652 179.867 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 1' ' ' VAL . . . . . 0.462 HG13 HG21 ' D' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.405 ' OD1' HG11 ' D' ' 8' ' ' VAL . 78.7 m-20 -126.19 129.51 49.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.68 -58.67 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.679 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.85 -173.2 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.87 176.68 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.543 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.02 47.71 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.566 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' VAL . . . . . 0.405 HG11 ' OD1' ' D' ' 3' ' ' ASN . 61.9 t -128.5 135.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.543 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -135.92 128.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.566 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' ILE . . . . . 0.462 HG21 HG13 ' D' ' 1' ' ' VAL . 94.0 mt -125.01 121.23 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.518 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.57 127.22 1.11 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.83 146.31 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.53 27.12 16.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.57 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.42 80.52 8.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.554 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -67.0 114.68 5.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.598 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.14 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -109.71 124.91 66.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -73.75 162.4 74.32 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.5 Cg_endo -78.59 111.79 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.828 2.352 . . . . 0.0 111.933 -175.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.6 Cg_endo -71.43 147.79 53.14 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.759 2.306 . . . . 0.0 112.029 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.644 179.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 1' ' ' VAL . . . . . 0.461 HG13 HG21 ' E' ' 10' ' ' ILE . 22.4 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -127.26 131.87 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.617 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.406 ' OD1' HG11 ' E' ' 8' ' ' VAL . 78.7 m-20 -126.17 129.49 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.523 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.63 -58.64 1.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.8 -173.19 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 92.1 p -90.92 176.7 6.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.543 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.05 47.63 11.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.524 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.406 HG11 ' OD1' ' E' ' 3' ' ' ASN . 61.7 t -128.44 136.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.517 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.487 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.461 HG21 HG13 ' E' ' 1' ' ' VAL . 93.6 mt -124.95 121.11 60.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.25 1.11 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.81 146.31 33.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.574 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.51 27.07 16.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.592 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.37 80.6 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.58 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 73.5 m -67.07 114.75 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.548 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.18 53.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.485 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.74 124.93 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.423 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -73.58 162.33 74.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -78.63 111.82 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.843 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.6 Cg_endo -71.42 147.71 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.049 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.618 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 1' ' ' VAL . 10.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.631 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.411 HD21 ' CD1' ' A' ' 10' ' ' ILE . 10.9 m120 -125.69 151.37 46.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.621 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.53 -56.74 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.704 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.81 -175.96 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 8' ' ' VAL . 93.6 p -88.49 174.12 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.562 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 58.99 45.5 14.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 6' ' ' SER . 46.5 t -130.9 140.04 49.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.569 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -149.01 138.75 21.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.635 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.411 ' CD1' HD21 ' A' ' 3' ' ' ASN . 98.5 mt -127.19 124.26 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 136.5 2.89 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.56 31.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.623 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.95 25.34 15.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.548 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.21 85.42 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.628 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.05 153.14 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.514 HD23 HD13 ' B' ' 16' ' ' LEU . 54.9 tp -144.87 124.62 13.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.542 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.23 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.338 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.36 161.8 73.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.441 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.2 Cg_endo -77.88 111.97 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.71 2.273 . . . . 0.0 112.0 -176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.8 Cg_endo -72.1 147.07 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.874 2.383 . . . . 0.0 112.1 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.566 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 10.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' B' ' 10' ' ' ILE . 10.9 m120 -125.72 151.33 46.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.527 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.51 -56.75 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.97 4.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.633 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.452 ' O ' HG23 ' B' ' 8' ' ' VAL . 93.4 p -88.47 174.17 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.618 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 6' ' ' SER . 46.5 t -130.97 139.97 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.02 138.8 21.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' B' ' 3' ' ' ASN . 98.4 mt -127.2 124.21 63.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.41 2.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.54 31.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 61.98 25.37 15.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.548 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.2 85.35 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.609 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -69.96 153.1 43.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.581 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.516 HD23 HD13 ' C' ' 16' ' ' LEU . 54.4 tp -144.9 124.7 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.483 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.81 124.14 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.32 161.75 73.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.441 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.78 112.01 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.04 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.8 Cg_endo -72.13 147.11 47.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.874 2.383 . . . . 0.0 112.022 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.576 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' B' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -142.89 162.27 35.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.57 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' C' ' 10' ' ' ILE . 10.9 m120 -125.76 151.33 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.527 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.52 -56.73 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.727 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.72 -175.95 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.632 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' C' ' 8' ' ' VAL . 93.5 p -88.53 174.11 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.91 45.56 14.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.639 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' C' ' 6' ' ' SER . 46.5 t -130.9 140.02 49.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.09 138.75 21.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' C' ' 3' ' ' ASN . 98.5 mt -127.17 124.23 63.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.97 136.41 2.86 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.91 147.54 31.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.598 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.92 25.44 15.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.497 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.26 85.37 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.602 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.98 153.06 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.594 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.516 HD13 HD23 ' B' ' 16' ' ' LEU . 54.5 tp -144.84 124.71 13.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.453 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.9 t -113.82 124.19 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.35 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.37 161.72 73.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.402 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.4 Cg_endo -77.78 111.97 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.791 2.328 . . . . 0.0 111.972 -176.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.1 47.53 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.057 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.572 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 1' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' E' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.82 162.24 35.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.609 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' D' ' 10' ' ' ILE . 10.8 m120 -125.76 151.32 46.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.537 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.5 -56.75 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.95 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' D' ' 8' ' ' VAL . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.608 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.617 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' D' ' 6' ' ' SER . 46.4 t -130.88 140.04 49.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.572 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.07 138.76 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.603 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' D' ' 3' ' ' ASN . 98.5 mt -127.17 124.24 63.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.65 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.95 136.44 2.87 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.98 147.55 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.0 110.599 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.529 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.17 85.3 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.658 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.94 153.11 43.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' LEU . . . . . 0.515 HD13 HD23 ' C' ' 16' ' ' LEU . 54.6 tp -144.91 124.67 13.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.83 124.22 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.72 73.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 112.02 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.005 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -72.14 147.09 47.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.863 2.375 . . . . 0.0 111.993 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.561 179.877 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 1' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' D' ' 1' ' ' VAL . 10.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.82 162.27 35.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.653 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.409 HD21 ' CD1' ' E' ' 10' ' ' ILE . 10.9 m120 -125.74 151.28 46.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.51 -56.7 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.7 -175.96 4.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.624 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' E' ' 8' ' ' VAL . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.92 45.62 14.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' E' ' 6' ' ' SER . 46.7 t -130.95 140.04 49.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.516 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.1 138.84 21.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.409 ' CD1' HD21 ' E' ' 3' ' ' ASN . 98.4 mt -127.2 124.3 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.0 136.45 2.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.94 147.52 31.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.529 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.14 85.35 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.02 153.17 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . 0.514 HD13 HD23 ' D' ' 16' ' ' LEU . 54.7 tp -144.92 124.63 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.525 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.85 124.21 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.303 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.33 161.72 73.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.4 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -77.76 111.96 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.785 2.323 . . . . 0.0 112.035 -176.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.9 Cg_endo -72.13 147.16 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.04 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.586 179.88 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.75 122.12 32.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.652 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.546 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' B' ' 4' ' ' ASN . 63.1 t30 -104.86 -59.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.707 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.75 -171.42 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.66 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.79 171.86 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.87 45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.577 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.662 HG12 HG22 ' B' ' 8' ' ' VAL . 32.5 m -135.95 155.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.585 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.49 19.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.23 125.86 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.617 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.48 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.26 147.25 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.663 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.89 26.12 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.54 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.31 84.79 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.29 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.56 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.516 HD23 HD13 ' B' ' 16' ' ' LEU . 55.0 tp -144.92 124.65 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.466 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.78 124.28 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.353 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.43 161.79 73.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.443 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.07 112.02 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.787 2.325 . . . . 0.0 111.99 -176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.4 Cg_endo -70.92 147.66 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.832 2.355 . . . . 0.0 112.107 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.65 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.77 122.16 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.557 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.546 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 4' ' ' ASN . 63.1 t30 -104.84 -59.68 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.78 -171.39 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.601 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.78 171.83 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.588 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.83 45.43 12.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.663 HG12 HG22 ' C' ' 8' ' ' VAL . 32.5 m -135.91 155.89 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -156.21 144.45 19.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.609 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.25 125.88 57.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.36 147.29 31.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.629 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.88 26.15 15.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.528 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.71 7.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.569 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.68 153.31 43.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.516 HD13 HD23 ' A' ' 16' ' ' LEU . 54.8 tp -144.92 124.68 13.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.32 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.83 73.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.429 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 55.8 Cg_endo -77.09 112.08 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.747 2.298 . . . . 0.0 111.99 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.615 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -127.74 122.13 32.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.569 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 4' ' ' ASN . 63.1 t30 -104.93 -59.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.668 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.82 -171.42 3.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.77 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.89 45.4 12.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.605 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' VAL . . . . . 0.663 HG22 HG12 ' B' ' 8' ' ' VAL . 32.6 m -135.89 155.92 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.607 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.18 144.57 19.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.545 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 92.6 mt -131.32 125.79 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.41 136.51 2.68 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.25 147.25 31.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.322 . . . . 0.0 110.663 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.86 26.1 15.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.568 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -86.23 84.78 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.72 153.32 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.514 HD13 HD23 ' B' ' 16' ' ' LEU . 54.8 tp -144.96 124.67 13.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.436 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.6 t -113.79 124.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.369 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.42 161.85 73.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.415 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.09 112.03 3.33 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.843 2.362 . . . . 0.0 111.984 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -71.04 147.75 55.34 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.316 . . . . 0.0 112.095 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.62 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.79 122.17 32.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.635 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.58 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' C' ' 4' ' ' ASN . 63.1 t30 -104.86 -59.61 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.708 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.79 -171.39 3.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.583 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.83 171.83 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.589 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.82 45.41 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.652 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' VAL . . . . . 0.662 HG22 HG12 ' C' ' 8' ' ' VAL . 32.5 m -135.87 155.82 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.641 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.55 20.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.621 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.32 125.9 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.556 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.33 147.28 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.323 . . . . 0.0 110.609 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 61.84 26.18 15.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.81 7.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.32 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.584 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' LEU . . . . . 0.515 HD23 HD13 ' E' ' 16' ' ' LEU . 54.7 tp -144.97 124.66 13.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.426 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.78 124.29 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.299 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.51 161.86 72.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.446 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 55.9 Cg_endo -77.02 111.99 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.791 2.327 . . . . 0.0 112.007 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.3 Cg_endo -70.97 147.74 55.71 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.787 2.325 . . . . 0.0 112.039 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.563 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.8 122.16 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.589 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.02 56.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.554 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' D' ' 4' ' ' ASN . 63.1 t30 -104.89 -59.64 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.682 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.73 -171.39 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.668 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 80.3 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.57 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.92 45.43 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.591 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.662 HG22 HG12 ' D' ' 8' ' ' VAL . 32.6 m -135.96 155.86 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.21 144.54 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -131.25 125.84 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.588 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.39 136.49 2.67 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.34 147.24 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.94 26.07 15.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -86.23 84.8 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.77 153.28 43.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . 0.515 HD13 HD23 ' D' ' 16' ' ' LEU . 54.8 tp -144.89 124.61 13.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.453 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.76 124.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.334 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.46 161.83 73.15 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.429 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 55.8 Cg_endo -77.03 112.03 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.0 111.991 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.598 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' A' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.15 161.42 38.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' A' ' 8' ' ' VAL . 61.6 m-80 -131.94 155.18 48.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.5 3.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.62 -171.34 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.568 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.6 p -95.06 -178.68 4.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.639 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.11 55.39 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.667 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.838 HG12 HG22 ' B' ' 8' ' ' VAL . 13.7 m -130.13 153.94 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.682 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.19 130.63 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.653 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' A' ' 1' ' ' VAL . 98.0 mt -132.68 124.48 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.15 131.77 1.6 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.61 145.7 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.33 28.48 17.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.526 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.1 83.29 7.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.4 m -70.09 114.12 7.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.566 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.85 127.39 53.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.56 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.73 125.38 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.384 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -74.41 161.85 76.29 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.8 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.968 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.4 Cg_endo -72.0 147.31 48.86 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.798 2.332 . . . . 0.0 112.059 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.677 179.814 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' VAL . . . . . 0.536 HG13 HG21 ' B' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.16 161.43 38.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' B' ' 8' ' ' VAL . 61.7 m-80 -131.94 155.22 48.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.614 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.09 -50.59 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -171.35 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.623 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.01 -178.64 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.37 6.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.656 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.838 HG22 HG12 ' A' ' 8' ' ' VAL . 13.7 m -130.11 153.91 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -155.17 130.69 9.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.601 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.536 HG21 HG13 ' B' ' 1' ' ' VAL . 98.0 mt -132.78 124.48 50.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.559 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.79 1.61 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.58 145.7 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.47 17.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.56 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.11 83.37 7.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.608 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.12 114.06 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.603 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.83 127.4 53.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.77 125.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -74.39 161.85 76.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.403 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 111.8 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.3 Cg_endo -72.03 147.28 48.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.85 2.366 . . . . 0.0 112.032 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.588 179.873 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' C' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -143.1 161.42 38.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.593 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' C' ' 8' ' ' VAL . 61.6 m-80 -131.93 155.18 48.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.52 3.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.36 3.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.629 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.03 -178.62 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.683 -176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.41 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' VAL . . . . . 0.841 HG12 HG22 ' D' ' 8' ' ' VAL . 14.1 m -130.21 153.91 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.57 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.16 130.75 9.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.595 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' C' ' 1' ' ' VAL . 98.0 mt -132.78 124.43 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.587 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.85 1.62 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.64 145.76 34.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.24 28.52 18.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.39 7.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.626 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.25 114.12 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.49 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.86 127.37 53.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.513 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -109.71 125.35 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.379 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' ALA . . . . . 0.556 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -74.3 161.86 76.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.375 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.1 Cg_endo -77.97 111.88 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.741 2.294 . . . . 0.0 111.975 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.4 Cg_endo -72.12 147.31 48.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.866 2.377 . . . . 0.0 111.98 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.595 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' D' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.12 161.37 38.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' D' ' 8' ' ' VAL . 61.8 m-80 -131.95 155.19 48.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.04 -50.6 3.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.49 -171.33 3.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -95.12 -178.63 4.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.63 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 57.04 55.46 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.646 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' VAL . . . . . 0.841 HG22 HG12 ' C' ' 8' ' ' VAL . 13.9 m -130.15 153.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.2 130.68 9.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' D' ' 1' ' ' VAL . 98.0 mt -132.72 124.41 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.604 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.11 131.75 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.54 145.8 34.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.22 28.5 18.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.602 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.33 7.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.18 114.18 8.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.525 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.92 127.33 53.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.51 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.7 125.4 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.35 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -74.35 161.8 76.59 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.434 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.82 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.944 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -71.97 147.24 48.93 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.861 2.374 . . . . 0.0 112.109 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.598 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' E' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.17 161.42 38.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' E' ' 8' ' ' VAL . 61.9 m-80 -131.95 155.22 48.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.534 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.1 -50.52 3.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.645 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.34 3.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.556 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 84.2 p -95.14 -178.63 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.569 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.07 55.43 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.838 HG22 HG12 ' D' ' 8' ' ' VAL . 14.0 m -130.13 154.0 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.63 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.23 130.66 9.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.573 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' E' ' 1' ' ' VAL . 98.0 mt -132.74 124.49 50.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.14 131.71 1.59 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.5 145.74 34.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.664 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.46 17.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.542 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.16 83.4 7.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.18 114.13 8.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.9 127.43 53.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.7 125.29 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.361 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -74.43 161.87 76.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.5 Cg_endo -77.8 111.82 3.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.755 2.303 . . . . 0.0 112.029 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.5 Cg_endo -72.06 147.28 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.782 2.322 . . . . 0.0 112.076 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.683 179.83 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.778 ' H2 ' HD13 ' A' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.96 117.78 11.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.417 ' OD1' HG11 ' A' ' 8' ' ' VAL . 81.0 m-20 -125.86 130.98 52.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.58 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.69 -56.15 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.691 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.77 4.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.3 p -91.57 176.15 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.7 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.59 48.94 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.716 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.417 HG11 ' OD1' ' A' ' 3' ' ' ASN . 46.5 t -130.54 140.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.43 127.8 24.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.613 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.778 HD13 ' H2 ' ' A' ' 1' ' ' VAL . 88.9 mt -127.89 129.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.94 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.576 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.98 83.99 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.601 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.4 m -69.7 153.66 43.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.588 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.524 HD23 HD13 ' B' ' 16' ' ' LEU . 55.4 tp -145.21 124.67 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.479 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.03 124.39 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.45 161.92 72.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.406 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.92 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.979 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.3 Cg_endo -70.86 146.38 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.902 2.402 . . . . 0.0 112.069 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' VAL . . . . . 0.778 ' H2 ' HD13 ' B' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -139.99 117.79 11.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.622 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' B' ' 8' ' ' VAL . 81.0 m-20 -125.88 131.02 52.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.72 -56.14 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.689 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.68 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.67 176.18 6.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.638 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.61 48.94 11.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' B' ' 3' ' ' ASN . 46.6 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.47 127.74 24.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.64 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.778 HD13 ' H2 ' ' B' ' 1' ' ' VAL . 88.8 mt -127.79 129.92 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.09 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.41 145.06 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.95 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.576 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.92 83.98 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 70.1 m -69.69 153.59 43.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.524 HD13 HD23 ' A' ' 16' ' ' LEU . 55.4 tp -145.22 124.65 13.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.98 124.36 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.339 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 162.0 72.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.17 111.9 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.824 2.349 . . . . 0.0 112.016 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 179.654 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.777 ' H2 ' HD13 ' C' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.93 117.77 11.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' ASN . . . . . 0.417 ' OD1' HG11 ' C' ' 8' ' ' VAL . 81.0 m-20 -125.86 131.01 52.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.65 -56.22 2.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.693 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.72 4.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.69 176.19 6.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.596 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.62 48.95 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' VAL . . . . . 0.417 HG11 ' OD1' ' C' ' 3' ' ' ASN . 46.5 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.591 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.777 HD13 ' H2 ' ' C' ' 1' ' ' VAL . 88.9 mt -127.87 129.91 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.08 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 62.0 27.89 16.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.574 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.9 84.02 6.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.611 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -69.62 153.6 43.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.658 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.524 HD13 HD23 ' B' ' 16' ' ' LEU . 55.3 tp -145.28 124.72 13.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.9 t -113.98 124.34 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.92 72.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.951 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -70.89 146.38 53.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.872 2.381 . . . . 0.0 112.069 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 1' ' ' VAL . . . . . 0.777 ' H2 ' HD13 ' D' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.95 117.74 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.645 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' D' ' 8' ' ' VAL . 80.9 m-20 -125.83 130.99 52.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.613 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.69 -56.24 2.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.686 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.67 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.682 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.69 176.25 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.6 48.93 11.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.669 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' D' ' 3' ' ' ASN . 46.5 t -130.59 140.43 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.48 127.72 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.647 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' ILE . . . . . 0.777 HD13 ' H2 ' ' D' ' 1' ' ' VAL . 88.6 mt -127.85 129.97 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.566 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.48 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.36 145.03 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.669 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.96 16.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.575 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.89 83.98 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 70.0 m -69.75 153.63 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.564 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' LEU . . . . . 0.526 HD23 HD13 ' E' ' 16' ' ' LEU . 55.4 tp -145.23 124.73 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.94 124.35 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.356 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.43 161.92 72.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.15 111.94 3.31 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.766 2.311 . . . . 0.0 112.021 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 1' ' ' VAL . . . . . 0.711 ' H2 ' HD13 ' E' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.92 117.73 11.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.659 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' E' ' 8' ' ' VAL . 81.0 m-20 -125.82 131.01 52.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.575 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.67 -56.12 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.7 4.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.73 176.26 6.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.57 48.91 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.681 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' E' ' 3' ' ' ASN . 46.6 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.711 HD13 ' H2 ' ' E' ' 1' ' ' VAL . 88.8 mt -127.89 129.93 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.15 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.43 145.01 35.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.65 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.98 16.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.575 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -89.0 84.04 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -69.67 153.62 43.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . 0.526 HD13 HD23 ' D' ' 16' ' ' LEU . 55.3 tp -145.25 124.7 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.9 t -113.91 124.37 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.318 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.45 161.87 73.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.406 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 55.9 Cg_endo -77.2 112.0 3.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.806 2.337 . . . . 0.0 111.951 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.2 Cg_endo -70.96 146.4 52.69 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.828 2.352 . . . . 0.0 112.048 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.584 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.484 HG13 HG21 ' A' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.74 127.9 19.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.65 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.29 128.95 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' B' ' 4' ' ' ASN . 61.3 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.91 47.37 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.593 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.94 137.68 56.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.657 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.613 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG21 HG13 ' A' ' 1' ' ' VAL . 93.1 mt -125.21 126.53 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.591 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.3 1.38 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -77.66 144.52 37.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 61.96 27.75 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.468 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.78 85.74 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.28 153.09 43.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.555 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.533 HD23 HD13 ' B' ' 16' ' ' LEU . 55.6 tp -144.83 124.7 13.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.84 124.26 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.49 161.85 73.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.426 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.8 Cg_endo -77.28 112.02 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.985 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.2 Cg_endo -71.05 146.54 52.51 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.885 2.39 . . . . 0.0 112.031 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.62 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.48 HG13 HG21 ' B' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -141.83 127.89 19.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.627 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -123.3 128.91 50.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.618 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' C' ' 4' ' ' ASN . 61.1 t30 -104.71 -57.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.766 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.95 -177.08 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.625 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 96.8 p -87.04 174.97 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.599 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.95 47.32 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.653 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.93 137.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.58 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.61 127.58 27.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.48 HG21 HG13 ' B' ' 1' ' ' VAL . 92.8 mt -125.24 126.49 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.645 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.29 1.37 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.67 144.5 37.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.644 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.96 27.7 16.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.69 85.69 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.646 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.21 153.05 43.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.567 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' A' ' 16' ' ' LEU . 55.9 tp -144.83 124.68 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.89 124.22 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.365 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.41 161.85 73.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.426 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.23 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.876 2.384 . . . . 0.0 111.945 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.3 Cg_endo -71.02 146.63 52.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.834 2.356 . . . . 0.0 112.059 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.547 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.481 HG13 HG21 ' C' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.76 127.91 19.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.32 128.94 50.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.592 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' B' ' 4' ' ' ASN . 61.2 t30 -104.75 -57.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.677 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.1 5.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -86.98 174.91 8.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.633 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.99 47.32 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.602 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.92 137.66 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.57 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.613 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.481 HG21 HG13 ' C' ' 1' ' ' VAL . 92.9 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.619 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.62 131.3 1.37 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.62 144.53 37.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.773 0.321 . . . . 0.0 110.672 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.94 27.72 16.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.526 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -87.79 85.78 7.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.592 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.7 m -70.26 153.12 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' B' ' 16' ' ' LEU . 55.7 tp -144.94 124.65 13.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.79 124.2 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.38 161.83 73.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.478 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.0 Cg_endo -77.31 111.99 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.799 2.333 . . . . 0.0 111.955 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -70.96 146.51 52.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.078 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.581 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.481 HG13 HG21 ' D' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -141.81 127.91 19.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.595 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -123.33 128.97 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' E' ' 4' ' ' ASN . 61.2 t30 -104.74 -57.66 2.0 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.96 -177.08 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.645 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p -86.99 174.92 8.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.64 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 58.96 47.29 12.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.626 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 137.76 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.603 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.64 127.64 27.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' ILE . . . . . 0.481 HG21 HG13 ' D' ' 1' ' ' VAL . 92.6 mt -125.24 126.5 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.66 131.34 1.38 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.78 144.58 37.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 110.621 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.97 27.71 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.488 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.72 85.74 7.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.1 m -70.25 153.07 43.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.602 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' LEU . . . . . 0.534 HD23 HD13 ' E' ' 16' ' ' LEU . 55.9 tp -144.87 124.69 13.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.88 124.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.338 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.44 161.85 73.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.426 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.1 Cg_endo -77.25 111.98 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.806 2.338 . . . . 0.0 111.95 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.4 Cg_endo -70.96 146.61 53.21 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.385 . . . . 0.0 112.081 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.57 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' VAL . . . . . 0.482 HG13 HG21 ' E' ' 10' ' ' ILE . 48.3 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -141.8 127.93 19.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.613 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -123.39 129.02 50.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' D' ' 4' ' ' ASN . 61.2 t30 -104.8 -57.56 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.03 -177.07 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.62 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 96.9 p -87.01 174.89 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.606 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.98 47.34 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.64 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.91 137.64 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -136.58 127.59 27.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.565 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.482 HG21 HG13 ' E' ' 1' ' ' VAL . 93.1 mt -125.23 126.52 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.619 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.61 131.27 1.37 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -77.64 144.5 37.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 61.95 27.74 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -87.75 85.81 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -70.23 153.09 43.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' D' ' 16' ' ' LEU . 55.7 tp -144.94 124.69 13.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.17 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.44 161.87 73.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.42 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.24 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.771 2.314 . . . . 0.0 112.034 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.4 Cg_endo -70.95 146.53 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.914 2.409 . . . . 0.0 112.063 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.536 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' A' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' B' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.519 HD23 HD13 ' B' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 10' ' ' ILE . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' A' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' B' ' 10' ' ' ILE . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' C' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' A' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' B' ' 10' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' B' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' C' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' D' ' 3' ' ' ASN . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' B' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' C' ' 10' ' ' ILE . 45.1 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' C' ' 10' ' ' ILE . 38.5 m-20 -121.19 125.33 46.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.529 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.39 -58.97 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.7 179.21 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.651 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -80.89 174.02 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.49 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' VAL . . . . . . . . . . . . . 67.7 t -128.75 132.81 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' D' ' 10' ' ' ILE . 18.3 pt20 -146.04 139.12 25.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' ILE . . . . . 0.893 HD11 HD21 ' E' ' 3' ' ' ASN . 46.9 mm -123.13 119.83 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 131.03 1.92 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.67 147.88 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 61.75 24.74 14.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.75 86.64 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.552 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m -70.08 153.01 43.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' C' ' 16' ' ' LEU . 55.0 tp -144.9 124.55 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.462 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.71 112.01 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.732 2.288 . . . . 0.0 111.915 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.23 47.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.806 2.337 . . . . 0.0 112.079 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.594 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' VAL . . . . . 0.451 HG11 HG21 ' D' ' 10' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.25 124.26 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.618 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.893 HD21 HD11 ' D' ' 10' ' ' ILE . 38.2 m-20 -121.18 125.29 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.543 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -103.38 -58.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.66 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -90.76 179.2 5.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.651 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -80.92 174.02 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.501 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' GLU . . . . . 0.42 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.8 mt-10 60.62 44.5 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.78 132.83 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . 0.431 ' O ' HD13 ' E' ' 10' ' ' ILE . 18.3 pt20 -146.01 139.09 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.557 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.743 ' HB ' HD12 ' D' ' 10' ' ' ILE . 47.1 mm -123.14 119.85 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.607 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.16 130.99 1.91 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.63 147.88 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.615 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 61.79 24.68 14.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -83.74 86.59 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m -70.07 153.0 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' D' ' 16' ' ' LEU . 54.9 tp -144.92 124.59 13.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.54 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.7 124.07 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.31 161.6 74.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.3 Cg_endo -77.69 111.97 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.725 2.283 . . . . 0.0 111.978 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.8 Cg_endo -72.15 147.23 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.836 2.357 . . . . 0.0 112.05 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.592 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.522 HG13 HG21 ' A' ' 10' ' ' ILE . 25.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.46 136.45 49.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.65 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.485 ' CB ' HG21 ' A' ' 8' ' ' VAL . 78.9 m-20 -131.96 131.08 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.588 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.07 -55.49 2.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.42 -171.51 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.2 p -91.61 179.37 5.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 58.2 58.81 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.66 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.759 HG12 HG22 ' B' ' 8' ' ' VAL . 16.5 m -127.44 150.93 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.54 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.76 116.44 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.633 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 1' ' ' VAL . 91.3 mt -125.07 125.08 68.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.61 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.57 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.86 0.362 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.71 16.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.95 84.59 7.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.573 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.76 153.56 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.533 HD23 HD13 ' B' ' 16' ' ' LEU . 54.3 tp -145.38 124.61 12.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.458 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.39 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.353 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.48 161.94 72.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.358 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.24 111.96 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 111.989 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.9 Cg_endo -71.45 148.26 53.98 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.878 2.386 . . . . 0.0 112.054 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.55 179.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.521 HG13 HG21 ' B' ' 10' ' ' ILE . 25.8 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -129.49 136.49 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.597 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.486 ' CB ' HG21 ' B' ' 8' ' ' VAL . 79.1 m-20 -132.05 131.06 42.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.545 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.705 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.35 -171.5 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.654 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 91.7 p -91.67 179.44 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.607 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.8 mt-10 58.19 58.72 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.759 HG22 HG12 ' A' ' 8' ' ' VAL . 16.5 m -127.34 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.594 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.75 116.5 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.6 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.521 HG21 HG13 ' B' ' 1' ' ' VAL . 91.7 mt -125.14 125.14 68.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.539 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.96 131.58 1.52 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.51 145.54 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.615 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.02 26.74 16.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.534 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.62 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.653 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.57 43.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' A' ' 16' ' ' LEU . 54.6 tp -145.35 124.59 12.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.508 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.82 124.33 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.435 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.48 161.97 72.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.399 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.95 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.81 2.34 . . . . 0.0 112.01 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.9 Cg_endo -71.48 148.25 53.79 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.91 2.407 . . . . 0.0 112.1 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.555 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.519 HG13 HG21 ' C' ' 10' ' ' ILE . 26.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.486 ' CB ' HG21 ' C' ' 8' ' ' VAL . 78.9 m-20 -131.99 131.12 42.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.592 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -102.16 -55.41 2.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.692 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.3 -171.41 3.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.674 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 91.8 p -91.72 179.38 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.643 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.9 mt-10 58.22 58.82 3.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.597 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . 0.759 HG12 HG22 ' D' ' 8' ' ' VAL . 16.5 m -127.38 151.01 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.595 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.82 116.4 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.661 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.519 HG21 HG13 ' C' ' 1' ' ' VAL . 90.9 mt -125.02 125.06 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.693 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.56 34.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 62.1 26.64 16.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.494 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.96 84.68 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -69.77 153.5 43.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.585 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.533 HD13 HD23 ' B' ' 16' ' ' LEU . 54.4 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 70.4 t -113.85 124.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.366 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.47 162.02 72.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.432 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.28 111.99 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 111.989 -176.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.7 Cg_endo -71.54 148.27 53.47 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.835 2.356 . . . . 0.0 112.018 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.654 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.52 HG13 HG21 ' D' ' 10' ' ' ILE . 26.0 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -129.55 136.5 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.485 ' CB ' HG21 ' D' ' 8' ' ' VAL . 78.9 m-20 -132.01 131.02 42.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.44 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.712 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -171.52 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.654 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.3 p -91.59 179.33 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.693 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 58.25 58.72 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.692 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' VAL . . . . . 0.759 HG22 HG12 ' C' ' 8' ' ' VAL . 16.5 m -127.37 150.96 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.571 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.77 116.46 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' ILE . . . . . 0.52 HG21 HG13 ' D' ' 1' ' ' VAL . 91.2 mt -125.03 125.07 68.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.56 1.51 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.54 145.57 34.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.615 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 26.75 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.556 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.97 84.59 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.7 153.53 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' LEU . . . . . 0.532 HD13 HD23 ' C' ' 16' ' ' LEU . 54.2 tp -145.34 124.64 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.48 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.3 t -113.81 124.35 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.38 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.49 162.06 72.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.28 111.94 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.798 2.332 . . . . 0.0 112.017 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.0 Cg_endo -71.49 148.29 53.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.843 2.362 . . . . 0.0 112.089 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.576 180.0 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' VAL . . . . . 0.52 HG13 HG21 ' E' ' 10' ' ' ILE . 25.7 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -129.55 136.45 49.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.484 ' CB ' HG21 ' E' ' 8' ' ' VAL . 79.0 m-20 -132.0 131.06 42.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.551 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -102.1 -55.46 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.705 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.33 -171.47 3.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.648 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 91.5 p -91.71 179.4 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.9 mt-10 58.3 58.67 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.758 HG22 HG12 ' D' ' 8' ' ' VAL . 16.5 m -127.31 150.96 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -152.78 116.45 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.52 HG21 HG13 ' E' ' 1' ' ' VAL . 91.7 mt -125.08 125.13 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.619 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 176.99 131.6 1.52 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -78.57 145.5 34.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.611 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.12 26.66 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.507 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -86.99 84.68 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.57 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -69.72 153.5 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.575 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.532 HD13 HD23 ' D' ' 16' ' ' LEU . 54.5 tp -145.3 124.68 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.89 124.35 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.387 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.4 162.06 72.41 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.432 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.2 Cg_endo -77.33 112.01 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.786 2.324 . . . . 0.0 112.017 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.8 Cg_endo -71.59 148.32 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.869 2.379 . . . . 0.0 111.992 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.218 -0.571 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.638 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 10' ' ' ILE . 44.8 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.1 129.66 21.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.543 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' A' ' 8' ' ' VAL . 81.2 m-20 -128.39 129.57 46.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.606 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.84 -170.92 3.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.6 p -91.02 178.62 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 62.3 mt-10 57.62 58.23 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.592 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.772 HG12 HG22 ' B' ' 8' ' ' VAL . 18.0 m -127.53 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.612 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.468 HG21 HG13 ' A' ' 1' ' ' VAL . 90.8 mt -123.18 124.68 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.78 145.75 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 110.544 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.69 27.25 16.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.631 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -87.21 85.16 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.678 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.07 153.45 43.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.581 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.535 HD23 HD13 ' B' ' 16' ' ' LEU . 54.3 tp -145.45 124.71 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.59 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.6 t -113.83 124.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.53 161.98 72.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.1 Cg_endo -77.3 111.94 3.28 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.78 2.32 . . . . 0.0 111.96 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.1 Cg_endo -71.0 146.59 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.067 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.592 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' B' ' 10' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -142.05 129.62 21.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.589 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.574 ' HB3' HG21 ' B' ' 8' ' ' VAL . 81.0 m-20 -128.36 129.49 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.653 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.26 -55.17 2.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.673 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -171.0 3.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.603 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 93.7 p -90.91 178.61 5.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 62.2 mt-10 57.6 58.28 3.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.773 HG12 HG22 ' C' ' 8' ' ' VAL . 18.0 m -127.56 151.73 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.478 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.55 114.88 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' B' ' 1' ' ' VAL . 91.0 mt -123.18 124.69 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.7 27.25 16.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.23 85.18 7.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.1 m -70.04 153.42 43.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.535 HD13 HD23 ' A' ' 16' ' ' LEU . 54.3 tp -145.48 124.72 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.22 111.88 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.004 -176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.1 Cg_endo -70.94 146.59 53.28 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.817 2.345 . . . . 0.0 112.097 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.556 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' C' ' 10' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.07 129.71 21.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' C' ' 8' ' ' VAL . 81.1 m-20 -128.4 129.53 46.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.624 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.18 -55.27 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.682 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.87 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.622 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 93.5 p -90.98 178.61 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.545 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' B' ' 7' ' ' GLU . 62.2 mt-10 57.61 58.28 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.58 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . 0.773 HG12 HG22 ' D' ' 8' ' ' VAL . 17.9 m -127.49 151.69 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.545 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.58 114.95 4.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' C' ' 1' ' ' VAL . 90.9 mt -123.16 124.67 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.514 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 131.99 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.7 145.71 34.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.597 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.77 27.16 16.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.651 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.24 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.9 m -70.07 153.43 43.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.535 HD13 HD23 ' B' ' 16' ' ' LEU . 54.4 tp -145.48 124.68 12.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.53 161.87 72.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.38 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.2 Cg_endo -77.17 111.87 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.33 . . . . 0.0 112.048 -176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.0 Cg_endo -70.98 146.59 53.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.097 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.568 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.469 HG13 HG21 ' D' ' 10' ' ' ILE . 44.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.1 129.71 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.524 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' D' ' 8' ' ' VAL . 81.1 m-20 -128.34 129.64 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.18 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.82 -170.9 3.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 93.9 p -90.99 178.61 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 62.2 mt-10 57.58 58.27 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.642 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' VAL . . . . . 0.773 HG22 HG12 ' C' ' 8' ' ' VAL . 18.0 m -127.54 151.76 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.57 114.97 4.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.536 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' ILE . . . . . 0.469 HG21 HG13 ' D' ' 1' ' ' VAL . 90.8 mt -123.16 124.62 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.03 1.62 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.8 145.75 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.513 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.81 27.12 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.648 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.29 85.22 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.566 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.08 153.41 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' C' ' 16' ' ' LEU . 54.4 tp -145.43 124.74 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.591 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.27 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.54 161.99 72.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.409 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.2 Cg_endo -77.21 111.87 3.28 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.783 2.322 . . . . 0.0 112.048 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 56.9 Cg_endo -71.02 146.62 52.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.773 2.316 . . . . 0.0 112.046 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.568 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' VAL . . . . . 0.47 HG13 HG21 ' E' ' 10' ' ' ILE . 44.7 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -142.06 129.68 21.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.568 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.574 ' HB3' HG21 ' E' ' 8' ' ' VAL . 81.0 m-20 -128.4 129.59 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.568 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -101.32 -55.16 2.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.91 -170.95 3.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.622 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p -90.92 178.59 5.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.632 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 62.1 mt-10 57.58 58.23 3.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.772 HG22 HG12 ' D' ' 8' ' ' VAL . 18.0 m -127.47 151.78 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -153.64 114.97 4.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.47 HG21 HG13 ' E' ' 1' ' ' VAL . 90.8 mt -123.2 124.66 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.75 132.0 1.62 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.65 145.67 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 110.584 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.77 27.15 16.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.628 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -87.18 85.1 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.661 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.4 m -69.99 153.42 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.58 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.534 HD13 HD23 ' D' ' 16' ' ' LEU . 54.3 tp -145.46 124.74 12.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.591 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -113.84 124.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.5 162.0 72.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.1 Cg_endo -77.28 111.87 3.27 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 112.013 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.1 Cg_endo -70.95 146.56 53.14 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.126 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.596 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' HA ' HD13 ' A' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.05 131.6 50.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.46 128.4 49.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.543 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.73 -59.39 1.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.72 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.8 -177.39 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.675 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 8' ' ' VAL . 95.9 p -84.55 173.99 10.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HB2' ' H ' ' B' ' 7' ' ' GLU . 61.8 mt-10 59.49 42.96 16.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 8' ' ' VAL . 58.2 t -128.2 134.3 65.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.521 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -143.96 140.22 29.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.568 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 1' ' ' VAL . 88.0 mt -127.57 122.11 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.599 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.89 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.29 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.73 25.65 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.56 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.94 7.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.614 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -70.25 153.13 43.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.519 HD23 HD13 ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.509 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -114.35 123.59 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.39 161.59 74.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 57.1 Cg_endo -79.84 111.65 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.767 2.312 . . . . 0.0 112.01 -175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 18' ' ' ALA . 31.3 Cg_exo -60.69 142.3 97.41 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.909 2.406 . . . . 0.0 112.015 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.616 179.711 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' B' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -126.96 131.56 51.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.45 128.34 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -103.66 -59.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.84 -177.44 5.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' B' ' 8' ' ' VAL . 97.0 p -84.55 174.1 10.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 7' ' ' GLU . 61.7 mt-10 59.37 43.05 17.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.624 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.433 HG13 ' O ' ' C' ' 8' ' ' VAL . 57.7 t -128.2 134.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.541 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.0 140.17 29.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.571 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' B' ' 1' ' ' VAL . 88.3 mt -127.57 122.04 58.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.577 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.48 132.87 2.08 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.14 147.21 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 110.63 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.87 25.53 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.552 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.1 85.94 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.652 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.1 m -70.18 153.08 43.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.587 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' A' ' 16' ' ' LEU . 53.9 tp -145.27 124.58 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.461 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -114.32 123.56 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.358 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.59 74.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.416 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 57.2 Cg_endo -79.82 111.58 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.836 2.358 . . . . 0.0 112.007 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' B' ' 18' ' ' ALA . 31.3 Cg_exo -60.66 142.32 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.665 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' C' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -127.02 131.66 50.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.609 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -123.46 128.36 49.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.605 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.67 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.679 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 t -89.86 -177.39 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.401 ' O ' HG23 ' C' ' 8' ' ' VAL . 96.4 p -84.55 174.01 10.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.604 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' D' ' 7' ' ' GLU . 61.8 mt-10 59.39 43.03 17.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.65 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' B' ' 8' ' ' VAL . 57.8 t -128.18 134.26 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.567 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.9 140.2 29.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.598 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' C' ' 1' ' ' VAL . 88.0 mt -127.55 122.11 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.92 2.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.24 32.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.83 25.56 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.552 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.15 85.99 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.634 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.21 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.519 HD13 HD23 ' B' ' 16' ' ' LEU . 54.1 tp -145.27 124.52 12.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.471 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 69.5 t -114.3 123.51 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.371 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.59 74.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 57.3 Cg_endo -79.75 111.64 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 18' ' ' ALA . 31.3 Cg_exo -60.74 142.33 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.834 2.356 . . . . 0.0 112.06 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.552 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.589 179.731 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' D' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -126.95 131.63 51.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -123.51 128.29 49.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -103.62 -59.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.82 -177.4 5.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.683 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . 0.403 ' O ' HG23 ' D' ' 8' ' ' VAL . 96.4 p -84.57 174.06 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.599 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' C' ' 7' ' ' GLU . 61.8 mt-10 59.43 42.97 17.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.625 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' C' ' 8' ' ' VAL . 57.2 t -128.11 134.2 65.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.629 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.91 140.19 29.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.605 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' D' ' 1' ' ' VAL . 88.0 mt -127.58 122.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.623 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.56 132.9 2.08 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.15 147.26 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.612 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 61.78 25.61 15.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.17 85.96 7.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.624 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.23 153.07 43.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' LEU . . . . . 0.518 HD13 HD23 ' C' ' 16' ' ' LEU . 54.2 tp -145.19 124.49 13.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.522 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -114.35 123.62 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.342 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.41 161.65 73.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 57.2 Cg_endo -79.83 111.57 2.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.807 2.338 . . . . 0.0 111.969 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' D' ' 18' ' ' ALA . 31.2 Cg_exo -60.66 142.28 97.4 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 0.0 112.015 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.623 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' VAL . . . . . 0.418 ' HA ' HD13 ' E' ' 10' ' ' ILE . 21.2 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -127.02 131.55 50.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.63 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -123.45 128.35 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.616 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.64 -59.36 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.758 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.85 -177.38 5.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.648 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' SER . . . . . 0.402 ' O ' HG23 ' E' ' 8' ' ' VAL . 96.5 p -84.56 174.03 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.595 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' GLU . . . . . 0.408 ' H ' ' HB2' ' D' ' 7' ' ' GLU . 61.7 mt-10 59.39 43.08 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.611 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.433 ' O ' HG13 ' D' ' 8' ' ' VAL . 58.2 t -128.21 134.25 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.592 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -143.92 140.17 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.655 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' E' ' 1' ' ' VAL . 87.9 mt -127.49 122.05 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.627 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.52 132.93 2.09 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.16 147.22 32.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 110.684 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 61.82 25.61 15.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.579 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -85.24 85.95 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.57 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.2 153.12 43.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.548 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.518 HD13 HD23 ' D' ' 16' ' ' LEU . 54.2 tp -145.28 124.41 12.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.1 t -114.32 123.59 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.344 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . 0.526 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.35 161.65 74.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.416 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 57.2 Cg_endo -79.9 111.61 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.763 2.309 . . . . 0.0 111.976 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' E' ' 18' ' ' ALA . 31.2 Cg_exo -60.69 142.31 97.44 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 . . . . . 0 C--O 1.219 -0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.609 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.462 HG13 HG21 ' A' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.21 131.93 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.405 ' OD1' HG11 ' A' ' 8' ' ' VAL . 78.7 m-20 -126.19 129.55 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.487 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.7 -58.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.643 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.12 3.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.734 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.94 176.65 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.0 47.67 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG11 ' OD1' ' A' ' 3' ' ' ASN . 62.1 t -128.44 136.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.566 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.94 128.32 30.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.462 HG21 HG13 ' A' ' 1' ' ' VAL . 93.8 mt -125.03 121.11 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.33 1.12 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.98 146.32 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.841 0.353 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 61.56 27.05 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.549 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.26 80.51 8.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.618 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.01 114.65 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.11 53.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.573 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.68 124.93 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -73.71 162.34 74.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.404 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -78.59 111.76 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.806 2.337 . . . . 0.0 111.895 -175.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.8 Cg_endo -71.33 147.8 53.75 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.742 2.295 . . . . 0.0 112.105 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.6 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.46 HG13 HG21 ' B' ' 10' ' ' ILE . 22.6 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.404 ' OD1' HG11 ' B' ' 8' ' ' VAL . 78.6 m-20 -126.19 129.49 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.66 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.682 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.75 -173.19 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.752 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.92 176.67 6.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.08 47.63 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.524 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.404 HG11 ' OD1' ' B' ' 3' ' ' ASN . 61.2 t -128.42 136.02 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.561 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.46 HG21 HG13 ' B' ' 1' ' ' VAL . 93.6 mt -124.93 121.09 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 177.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.5 127.29 1.12 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.9 146.29 33.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.572 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.54 27.07 16.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.592 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.35 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.4 m -67.06 114.74 6.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.17 53.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.551 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.79 124.93 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.562 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -73.69 162.41 74.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.5 Cg_endo -78.63 111.76 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.871 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.7 Cg_endo -71.37 147.79 53.46 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.802 2.335 . . . . 0.0 112.068 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.582 179.93 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.463 HG13 HG21 ' C' ' 10' ' ' ILE . 22.2 t . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.23 131.93 50.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.585 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.406 ' OD1' HG11 ' C' ' 8' ' ' VAL . 78.5 m-20 -126.17 129.49 49.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.548 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -103.69 -58.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.605 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.86 -173.24 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.753 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p -90.82 176.63 6.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 59.02 47.68 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . 0.406 HG11 ' OD1' ' C' ' 3' ' ' ASN . 62.0 t -128.48 136.05 60.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -135.97 128.23 30.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.536 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.463 HG21 HG13 ' C' ' 1' ' ' VAL . 93.9 mt -125.06 121.18 60.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.547 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.56 127.24 1.11 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.79 146.24 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 61.55 27.07 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.613 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.33 80.57 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.618 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -67.04 114.65 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.621 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.25 127.1 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.8 t -109.82 124.94 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.401 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -73.69 162.36 74.52 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.447 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.5 Cg_endo -78.57 111.71 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.798 2.332 . . . . 0.0 111.957 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.7 Cg_endo -71.29 147.74 53.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.772 2.315 . . . . 0.0 112.105 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.652 179.867 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.462 HG13 HG21 ' D' ' 10' ' ' ILE . 22.3 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.21 131.94 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.405 ' OD1' HG11 ' D' ' 8' ' ' VAL . 78.7 m-20 -126.19 129.51 49.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.68 -58.67 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.679 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.85 -173.2 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -90.87 176.68 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.543 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 59.02 47.71 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.566 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' VAL . . . . . 0.405 HG11 ' OD1' ' D' ' 3' ' ' ASN . 61.9 t -128.5 135.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.543 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -135.92 128.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.566 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' ILE . . . . . 0.462 HG21 HG13 ' D' ' 1' ' ' VAL . 94.0 mt -125.01 121.23 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.518 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.57 127.22 1.11 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.83 146.31 33.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.53 27.12 16.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.57 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -86.42 80.52 8.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.554 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -67.0 114.68 5.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.598 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.29 127.14 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -109.71 124.91 66.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -73.75 162.4 74.32 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.5 Cg_endo -78.59 111.79 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.828 2.352 . . . . 0.0 111.933 -175.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.6 Cg_endo -71.43 147.79 53.14 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.759 2.306 . . . . 0.0 112.029 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.644 179.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' VAL . . . . . 0.461 HG13 HG21 ' E' ' 10' ' ' ILE . 22.4 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -127.26 131.87 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.617 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.406 ' OD1' HG11 ' E' ' 8' ' ' VAL . 78.7 m-20 -126.17 129.49 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.523 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -103.63 -58.64 1.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.8 -173.19 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 92.1 p -90.92 176.7 6.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.543 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 59.05 47.63 11.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.524 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.406 HG11 ' OD1' ' E' ' 3' ' ' ASN . 61.7 t -128.44 136.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.517 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.01 128.24 30.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.487 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.461 HG21 HG13 ' E' ' 1' ' ' VAL . 93.6 mt -124.95 121.11 60.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.55 127.25 1.11 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -78.81 146.31 33.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.574 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 61.51 27.07 16.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.592 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.37 80.6 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.58 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 73.5 m -67.07 114.75 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.548 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -118.38 127.18 53.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.485 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -109.74 124.93 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.423 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -73.58 162.33 74.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -78.63 111.82 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.794 2.329 . . . . 0.0 111.843 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.6 Cg_endo -71.42 147.71 53.06 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.049 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.618 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 1' ' ' VAL . 10.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.631 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.411 HD21 ' CD1' ' A' ' 10' ' ' ILE . 10.9 m120 -125.69 151.37 46.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.621 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.53 -56.74 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.704 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.81 -175.96 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 8' ' ' VAL . 93.6 p -88.49 174.12 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.562 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 58.99 45.5 14.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 6' ' ' SER . 46.5 t -130.9 140.04 49.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.569 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -149.01 138.75 21.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.635 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.411 ' CD1' HD21 ' A' ' 3' ' ' ASN . 98.5 mt -127.19 124.26 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.98 136.5 2.89 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.56 31.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.623 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.95 25.34 15.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.548 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.21 85.42 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.628 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -70.05 153.14 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.514 HD23 HD13 ' B' ' 16' ' ' LEU . 54.9 tp -144.87 124.62 13.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.542 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.23 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.338 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.36 161.8 73.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.441 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.2 Cg_endo -77.88 111.97 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.71 2.273 . . . . 0.0 112.0 -176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.8 Cg_endo -72.1 147.07 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.874 2.383 . . . . 0.0 112.1 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.566 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 10.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.85 162.21 36.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' B' ' 10' ' ' ILE . 10.9 m120 -125.72 151.33 46.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.527 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.51 -56.75 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.97 4.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.633 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.452 ' O ' HG23 ' B' ' 8' ' ' VAL . 93.4 p -88.47 174.17 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.618 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 6' ' ' SER . 46.5 t -130.97 139.97 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.02 138.8 21.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' B' ' 3' ' ' ASN . 98.4 mt -127.2 124.21 63.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.41 2.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.9 147.54 31.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 61.98 25.37 15.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.548 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.2 85.35 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.609 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 73.9 m -69.96 153.1 43.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.581 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.516 HD23 HD13 ' C' ' 16' ' ' LEU . 54.4 tp -144.9 124.7 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.483 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.81 124.14 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.32 161.75 73.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.441 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.78 112.01 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.04 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.8 Cg_endo -72.13 147.11 47.73 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.874 2.383 . . . . 0.0 112.022 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.576 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' B' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -142.89 162.27 35.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.57 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' C' ' 10' ' ' ILE . 10.9 m120 -125.76 151.33 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.527 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.52 -56.73 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.727 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.72 -175.95 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.632 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' C' ' 8' ' ' VAL . 93.5 p -88.53 174.11 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.91 45.56 14.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.639 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' C' ' 6' ' ' SER . 46.5 t -130.9 140.02 49.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.545 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.09 138.75 21.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' C' ' 3' ' ' ASN . 98.5 mt -127.17 124.23 63.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.97 136.41 2.86 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.91 147.54 31.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.598 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.92 25.44 15.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.497 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.26 85.37 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.602 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.98 153.06 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.594 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.516 HD13 HD23 ' B' ' 16' ' ' LEU . 54.5 tp -144.84 124.71 13.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.453 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.9 t -113.82 124.19 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.35 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.37 161.72 73.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.402 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.4 Cg_endo -77.78 111.97 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.791 2.328 . . . . 0.0 111.972 -176.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.7 Cg_endo -72.16 147.1 47.53 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.057 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.572 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' E' ' 1' ' ' VAL . 10.3 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -142.82 162.24 35.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.609 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.41 HD21 ' CD1' ' D' ' 10' ' ' ILE . 10.8 m120 -125.76 151.32 46.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.537 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.5 -56.75 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.77 -175.95 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' D' ' 8' ' ' VAL . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.608 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.89 45.59 15.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.617 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' D' ' 6' ' ' SER . 46.4 t -130.88 140.04 49.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.572 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.07 138.76 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.603 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' D' ' 3' ' ' ASN . 98.5 mt -127.17 124.24 63.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.65 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.95 136.44 2.87 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.98 147.55 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.0 110.599 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.529 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -85.17 85.3 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.658 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -69.94 153.11 43.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' LEU . . . . . 0.515 HD13 HD23 ' C' ' 16' ' ' LEU . 54.6 tp -144.91 124.67 13.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.83 124.22 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.31 161.72 73.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 112.02 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.716 2.277 . . . . 0.0 112.005 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -72.14 147.09 47.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.863 2.375 . . . . 0.0 111.993 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.561 179.877 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' D' ' 1' ' ' VAL . 10.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -142.82 162.27 35.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.653 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.409 HD21 ' CD1' ' E' ' 10' ' ' ILE . 10.9 m120 -125.74 151.28 46.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.51 -56.7 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.7 -175.96 4.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.624 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' SER . . . . . 0.451 ' O ' HG23 ' E' ' 8' ' ' VAL . 93.2 p -88.51 174.12 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 58.92 45.62 14.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' E' ' 6' ' ' SER . 46.7 t -130.95 140.04 49.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.516 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -149.1 138.84 21.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.409 ' CD1' HD21 ' E' ' 3' ' ' ASN . 98.4 mt -127.2 124.3 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.0 136.45 2.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.94 147.52 31.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 61.94 25.39 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.529 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.14 85.35 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -70.02 153.17 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.514 HD13 HD23 ' D' ' 16' ' ' LEU . 54.7 tp -144.92 124.63 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.525 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -113.85 124.21 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.303 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . 0.552 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.33 161.72 73.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.4 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . 0.552 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.4 Cg_endo -77.76 111.96 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.785 2.323 . . . . 0.0 112.035 -176.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.9 Cg_endo -72.13 147.16 47.84 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.827 2.351 . . . . 0.0 112.04 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.586 179.88 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.75 122.12 32.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.652 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.546 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' B' ' 4' ' ' ASN . 63.1 t30 -104.86 -59.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.707 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.75 -171.42 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.66 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.79 171.86 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.579 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.87 45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.577 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.662 HG12 HG22 ' B' ' 8' ' ' VAL . 32.5 m -135.95 155.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.585 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.49 19.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.23 125.86 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.617 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.48 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.26 147.25 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.663 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.89 26.12 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.54 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.31 84.79 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.29 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.56 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.516 HD23 HD13 ' B' ' 16' ' ' LEU . 55.0 tp -144.92 124.65 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.466 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.78 124.28 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.353 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.43 161.79 73.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.443 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.0 Cg_endo -77.07 112.02 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.787 2.325 . . . . 0.0 111.99 -176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.4 Cg_endo -70.92 147.66 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.832 2.355 . . . . 0.0 112.107 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.65 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.77 122.16 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.557 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.546 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 4' ' ' ASN . 63.1 t30 -104.84 -59.68 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.78 -171.39 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.601 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.78 171.83 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.588 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.83 45.43 12.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.663 HG12 HG22 ' C' ' 8' ' ' VAL . 32.5 m -135.91 155.89 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -156.21 144.45 19.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.609 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.25 125.88 57.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.36 147.29 31.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.629 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.88 26.15 15.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.528 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.71 7.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.569 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.68 153.31 43.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.516 HD13 HD23 ' A' ' 16' ' ' LEU . 54.8 tp -144.92 124.68 13.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.83 124.32 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 161.83 73.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.429 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.565 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 55.8 Cg_endo -77.09 112.08 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.747 2.298 . . . . 0.0 111.99 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.615 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -127.74 122.13 32.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.53 130.06 56.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.569 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 4' ' ' ASN . 63.1 t30 -104.93 -59.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.668 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.82 -171.42 3.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.77 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.89 45.4 12.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.605 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . 0.663 HG22 HG12 ' B' ' 8' ' ' VAL . 32.6 m -135.89 155.92 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.607 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.18 144.57 19.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.545 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 92.6 mt -131.32 125.79 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.41 136.51 2.68 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.25 147.25 31.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.322 . . . . 0.0 110.663 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.86 26.1 15.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.568 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -86.23 84.78 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.72 153.32 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.514 HD13 HD23 ' B' ' 16' ' ' LEU . 54.8 tp -144.96 124.67 13.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.436 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.6 t -113.79 124.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.369 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.42 161.85 73.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.415 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.09 112.03 3.33 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.843 2.362 . . . . 0.0 111.984 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -71.04 147.75 55.34 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.775 2.316 . . . . 0.0 112.095 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.62 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -127.79 122.17 32.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.635 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.58 130.06 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' C' ' 4' ' ' ASN . 63.1 t30 -104.86 -59.61 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.708 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 t -86.79 -171.39 3.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.583 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -95.83 171.83 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.589 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.82 45.41 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.652 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' VAL . . . . . 0.662 HG22 HG12 ' C' ' 8' ' ' VAL . 32.5 m -135.87 155.82 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.641 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.13 144.55 20.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.621 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' ILE . . . . . . . . . . . . . 92.7 mt -131.32 125.9 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.556 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.35 136.51 2.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.33 147.28 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.323 . . . . 0.0 110.609 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 61.84 26.18 15.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.26 84.81 7.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -69.66 153.32 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.584 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' LEU . . . . . 0.515 HD23 HD13 ' E' ' 16' ' ' LEU . 54.7 tp -144.97 124.66 13.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.426 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.78 124.29 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.299 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.51 161.86 72.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.446 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 55.9 Cg_endo -77.02 111.99 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.791 2.327 . . . . 0.0 112.007 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.3 Cg_endo -70.97 147.74 55.71 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.787 2.325 . . . . 0.0 112.039 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.563 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.8 122.16 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.589 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -112.57 130.02 56.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.554 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' D' ' 4' ' ' ASN . 63.1 t30 -104.89 -59.64 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.682 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.73 -171.39 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.668 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 80.3 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.57 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 59.92 45.43 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.591 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.662 HG22 HG12 ' D' ' 8' ' ' VAL . 32.6 m -135.96 155.86 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -156.21 144.54 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.541 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -131.25 125.84 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.588 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.39 136.49 2.67 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -80.34 147.24 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 61.94 26.07 15.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -86.23 84.8 7.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 71.6 m -69.77 153.28 43.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.515 HD13 HD23 ' D' ' 16' ' ' LEU . 54.8 tp -144.89 124.61 13.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.453 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -113.76 124.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.334 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.46 161.83 73.15 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.429 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 55.8 Cg_endo -77.03 112.03 3.34 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.0 111.991 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.2 Cg_endo -71.04 147.67 55.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.821 2.347 . . . . 0.0 112.076 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.598 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' A' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.15 161.42 38.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' A' ' 8' ' ' VAL . 61.6 m-80 -131.94 155.18 48.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.5 3.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.62 -171.34 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.568 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.6 p -95.06 -178.68 4.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.639 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.11 55.39 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.667 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.838 HG12 HG22 ' B' ' 8' ' ' VAL . 13.7 m -130.13 153.94 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.682 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.19 130.63 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.653 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' A' ' 1' ' ' VAL . 98.0 mt -132.68 124.48 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.559 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.15 131.77 1.6 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.61 145.7 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.33 28.48 17.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.526 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.1 83.29 7.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.4 m -70.09 114.12 7.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.566 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.85 127.39 53.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.56 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.73 125.38 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.384 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -74.41 161.85 76.29 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.8 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.968 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 58.4 Cg_endo -72.0 147.31 48.86 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.798 2.332 . . . . 0.0 112.059 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.677 179.814 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.536 HG13 HG21 ' B' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.16 161.43 38.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' B' ' 8' ' ' VAL . 61.7 m-80 -131.94 155.22 48.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.614 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.09 -50.59 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -171.35 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.623 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.01 -178.64 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.61 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.37 6.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.656 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.838 HG22 HG12 ' A' ' 8' ' ' VAL . 13.7 m -130.11 153.91 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -155.17 130.69 9.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.601 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.536 HG21 HG13 ' B' ' 1' ' ' VAL . 98.0 mt -132.78 124.48 50.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.559 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.79 1.61 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.58 145.7 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 110.584 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.47 17.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.56 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.11 83.37 7.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.608 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.12 114.06 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.603 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.83 127.4 53.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.77 125.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -74.39 161.85 76.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.403 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.3 Cg_endo -77.82 111.8 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 58.3 Cg_endo -72.03 147.28 48.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.85 2.366 . . . . 0.0 112.032 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.588 179.873 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' C' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -143.1 161.42 38.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.593 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' C' ' 8' ' ' VAL . 61.6 m-80 -131.93 155.18 48.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.11 -50.52 3.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.36 3.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.629 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 84.9 p -95.03 -178.62 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.683 -176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.09 55.41 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . 0.841 HG12 HG22 ' D' ' 8' ' ' VAL . 14.1 m -130.21 153.91 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.57 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.16 130.75 9.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.595 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' C' ' 1' ' ' VAL . 98.0 mt -132.78 124.43 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.587 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.17 131.85 1.62 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.64 145.76 34.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 61.24 28.52 18.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.39 7.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.626 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.25 114.12 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.49 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.86 127.37 53.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.513 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -109.71 125.35 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.379 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . 0.556 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -74.3 161.86 76.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.375 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 56.1 Cg_endo -77.97 111.88 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.741 2.294 . . . . 0.0 111.975 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 58.4 Cg_endo -72.12 147.31 48.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.866 2.377 . . . . 0.0 111.98 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.595 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' D' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.12 161.37 38.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' D' ' 8' ' ' VAL . 61.8 m-80 -131.95 155.19 48.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.04 -50.6 3.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.49 -171.33 3.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -95.12 -178.63 4.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.63 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 57.04 55.46 6.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.646 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' VAL . . . . . 0.841 HG22 HG12 ' C' ' 8' ' ' VAL . 13.9 m -130.15 153.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.2 130.68 9.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' D' ' 1' ' ' VAL . 98.0 mt -132.72 124.41 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.604 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.11 131.75 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.54 145.8 34.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.22 28.5 18.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.602 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -87.09 83.33 7.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 72.3 m -70.18 114.18 8.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.525 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.92 127.33 53.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.51 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.7 125.4 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.35 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -74.35 161.8 76.59 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.434 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.3 Cg_endo -77.9 111.82 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.819 2.346 . . . . 0.0 111.944 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 58.7 Cg_endo -71.97 147.24 48.93 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.861 2.374 . . . . 0.0 112.109 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.598 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' VAL . . . . . 0.537 HG13 HG21 ' E' ' 10' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -143.17 161.42 38.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' E' ' 8' ' ' VAL . 61.9 m-80 -131.95 155.22 48.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.534 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -102.1 -50.52 3.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.645 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 -171.34 3.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.556 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 84.2 p -95.14 -178.63 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.569 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 57.07 55.43 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.838 HG22 HG12 ' D' ' 8' ' ' VAL . 14.0 m -130.13 154.0 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.63 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.23 130.66 9.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.573 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.537 HG21 HG13 ' E' ' 1' ' ' VAL . 98.0 mt -132.74 124.49 50.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.14 131.71 1.59 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -78.5 145.74 34.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.664 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 61.32 28.46 17.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.542 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -87.16 83.4 7.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 72.5 m -70.18 114.13 8.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.9 127.43 53.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.7 125.29 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.361 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -74.43 161.87 76.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 56.5 Cg_endo -77.8 111.82 3.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.755 2.303 . . . . 0.0 112.029 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 58.5 Cg_endo -72.06 147.28 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.782 2.322 . . . . 0.0 112.076 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.683 179.83 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.778 ' H2 ' HD13 ' A' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.96 117.78 11.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.417 ' OD1' HG11 ' A' ' 8' ' ' VAL . 81.0 m-20 -125.86 130.98 52.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.58 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.69 -56.15 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.691 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.77 4.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.3 p -91.57 176.15 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.7 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.59 48.94 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.716 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.417 HG11 ' OD1' ' A' ' 3' ' ' ASN . 46.5 t -130.54 140.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.43 127.8 24.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.613 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.778 HD13 ' H2 ' ' A' ' 1' ' ' VAL . 88.9 mt -127.89 129.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.94 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.576 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.98 83.99 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.601 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.4 m -69.7 153.66 43.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.588 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.524 HD23 HD13 ' B' ' 16' ' ' LEU . 55.4 tp -145.21 124.67 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.479 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.03 124.39 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -76.45 161.92 72.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.406 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.92 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.979 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 19' ' ' PRO . 57.3 Cg_endo -70.86 146.38 53.25 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.902 2.402 . . . . 0.0 112.069 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.778 ' H2 ' HD13 ' B' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -139.99 117.79 11.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.622 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' B' ' 8' ' ' VAL . 81.0 m-20 -125.88 131.02 52.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.72 -56.14 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.689 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.68 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.682 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.67 176.18 6.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.638 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.61 48.94 11.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' B' ' 3' ' ' ASN . 46.6 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.47 127.74 24.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.64 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.778 HD13 ' H2 ' ' B' ' 1' ' ' VAL . 88.8 mt -127.79 129.92 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.638 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.09 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.41 145.06 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.99 27.95 16.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.576 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.92 83.98 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 70.1 m -69.69 153.59 43.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.524 HD13 HD23 ' A' ' 16' ' ' LEU . 55.4 tp -145.22 124.65 13.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.98 124.36 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.339 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' B' ' 19' ' ' PRO . . . -76.43 162.0 72.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' B' ' 18' ' ' ALA . 56.1 Cg_endo -77.17 111.9 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.824 2.349 . . . . 0.0 112.016 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 19' ' ' PRO . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 179.654 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.777 ' H2 ' HD13 ' C' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -139.93 117.77 11.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.417 ' OD1' HG11 ' C' ' 8' ' ' VAL . 81.0 m-20 -125.86 131.01 52.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.65 -56.22 2.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.693 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.54 -173.72 4.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.69 176.19 6.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.596 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.62 48.95 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' VAL . . . . . 0.417 HG11 ' OD1' ' C' ' 3' ' ' ASN . 46.5 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.591 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.777 HD13 ' H2 ' ' C' ' 1' ' ' VAL . 88.9 mt -127.87 129.91 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.49 133.08 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.39 145.05 35.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.647 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 62.0 27.89 16.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.574 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.9 84.02 6.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.611 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -69.62 153.6 43.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.658 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.524 HD13 HD23 ' B' ' 16' ' ' LEU . 55.3 tp -145.28 124.72 13.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 73.9 t -113.98 124.34 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' C' ' 19' ' ' PRO . . . -76.41 161.92 72.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' C' ' 18' ' ' ALA . 55.9 Cg_endo -77.25 111.97 3.3 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.794 2.33 . . . . 0.0 111.951 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' C' ' 19' ' ' PRO . 57.3 Cg_endo -70.89 146.38 53.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.872 2.381 . . . . 0.0 112.069 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.603 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.777 ' H2 ' HD13 ' D' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.95 117.74 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.645 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' D' ' 8' ' ' VAL . 80.9 m-20 -125.83 130.99 52.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.613 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -104.69 -56.24 2.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.686 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.67 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.682 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 89.9 p -91.69 176.25 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.6 48.93 11.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.669 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' D' ' 3' ' ' ASN . 46.5 t -130.59 140.43 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.48 127.72 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.647 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' ILE . . . . . 0.777 HD13 ' H2 ' ' D' ' 1' ' ' VAL . 88.6 mt -127.85 129.97 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.566 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.48 133.09 1.55 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.36 145.03 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 110.669 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.96 16.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.575 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -88.89 83.98 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 70.0 m -69.75 153.63 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.564 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' LEU . . . . . 0.526 HD23 HD13 ' E' ' 16' ' ' LEU . 55.4 tp -145.23 124.73 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.94 124.35 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.356 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' D' ' 19' ' ' PRO . . . -76.43 161.92 72.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' D' ' 18' ' ' ALA . 56.0 Cg_endo -77.15 111.94 3.31 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.766 2.311 . . . . 0.0 112.021 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' D' ' 19' ' ' PRO . 57.2 Cg_endo -70.95 146.44 52.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.823 2.349 . . . . 0.0 112.036 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' VAL . . . . . 0.711 ' H2 ' HD13 ' E' ' 10' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -139.92 117.73 11.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.659 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.416 ' OD1' HG11 ' E' ' 8' ' ' VAL . 81.0 m-20 -125.82 131.01 52.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.575 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -104.67 -56.12 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -88.46 -173.7 4.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' SER . . . . . . . . . . . . . 89.8 p -91.73 176.26 6.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.57 48.91 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.681 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.416 HG11 ' OD1' ' E' ' 3' ' ' ASN . 46.6 t -130.54 140.42 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -138.45 127.75 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.711 HD13 ' H2 ' ' E' ' 1' ' ' VAL . 88.8 mt -127.89 129.93 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.5 133.15 1.56 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.43 145.01 35.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.65 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 61.97 27.98 16.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.575 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -89.0 84.04 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -69.67 153.62 43.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.526 HD13 HD23 ' D' ' 16' ' ' LEU . 55.3 tp -145.25 124.7 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . . . . . . . . . 74.9 t -113.91 124.37 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.318 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' E' ' 19' ' ' PRO . . . -76.45 161.87 73.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.406 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' E' ' 18' ' ' ALA . 55.9 Cg_endo -77.2 112.0 3.31 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.806 2.337 . . . . 0.0 111.951 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' E' ' 19' ' ' PRO . 57.2 Cg_endo -70.96 146.4 52.69 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.828 2.352 . . . . 0.0 112.048 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.584 179.654 . . . . . . . . 0 0 . 1 stop_ save_